[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 92 of about 92
1. Kelly LS, Birken S, Puett D: Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance. Mol Cell Endocrinol; 2007 Jan 2;260-262:33-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The ability to reliably detect aberrant glycosylation of human chorionic gonadotropin (hCG) may have profound implications for the diagnosis and monitoring of malignant gestational trophoblastic neoplasia, germ cell tumors, other malignancies, and pregnancy complications.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1988 Mar 1;48(5):1356-60 [3342414.001]
  • [Cites] Cancer Res. 1988 Mar 1;48(5):1361-6 [2449279.001]
  • [Cites] Jpn J Cancer Res. 1988 Feb;79(2):160-4 [3130349.001]
  • [Cites] Endocrinology. 1988 Jul;123(1):572-83 [2454811.001]
  • [Cites] Biochimie. 1988 Nov;70(11):1575-85 [2853976.001]
  • [Cites] Am J Physiol. 1989 Jun;256(6 Pt 1):E721-4 [2472071.001]
  • [Cites] Endocrinology. 1989 Nov;125(5):2267-72 [2477227.001]
  • [Cites] Obstet Gynecol. 1991 Jan;77(1):53-9 [1984227.001]
  • [Cites] Eur J Cancer. 1991;27(3):277-80 [1851025.001]
  • [Cites] J Endocrinol. 1999 Apr;161(1):99-106 [10194533.001]
  • [Cites] Int J Cancer. 1999 Jun 21;84(3):304-8 [10371351.001]
  • [Cites] Endocrinology. 1992 Apr;130(4):2052-8 [1547728.001]
  • [Cites] J Endocrinol. 1993 Dec;139(3):519-32 [7510772.001]
  • [Cites] J Clin Endocrinol Metab. 1994 Jun;78(6):1419-23 [7515388.001]
  • [Cites] Tumour Biol. 1994;15(4):230-5 [7939172.001]
  • [Cites] Endocr Rev. 1994 Oct;15(5):650-83 [7843071.001]
  • [Cites] Br J Cancer. 1996 Oct;74(7):1081-4 [8855978.001]
  • [Cites] Structure. 1996 Nov 15;4(11):1339-52 [8939757.001]
  • [Cites] Prenat Diagn. 1997 Feb;17(2):185-7 [9061770.001]
  • [Cites] Int J Cancer. 1997 May 16;71(4):539-44 [9178805.001]
  • [Cites] Tumour Biol. 1997;18(5):274-7 [9276027.001]
  • [Cites] Endocrine. 1997 Aug;7(1):15-32 [9449027.001]
  • [Cites] Prenat Diagn. 1997 Dec;17(12):1188-90 [9467819.001]
  • [Cites] J Reprod Med. 1998 Jan;43(1):3-10 [9475142.001]
  • [Cites] Clin Chem. 1999 Dec;45(12):2109-19 [10585342.001]
  • [Cites] Clin Endocrinol (Oxf). 2000 Apr;52(4):499-508 [10762294.001]
  • [Cites] J Mol Recognit. 2000 Sep-Oct;13(5):223-78 [10992290.001]
  • [Cites] Clin Chem. 2000 Nov;46(11):1796-803 [11067815.001]
  • [Cites] Int J Cancer. 2001 Jan 20;95(1):18-22 [11241305.001]
  • [Cites] Arch Med Res. 2001 Nov-Dec;32(6):635-43 [11750741.001]
  • [Cites] J Endocrinol. 2002 Mar;172(3):497-506 [11874698.001]
  • [Cites] Prenat Diagn. 2002 Aug;22(8):656-62 [12210572.001]
  • [Cites] Mol Cell Endocrinol. 2002 Aug 30;194(1-2):147-55 [12242037.001]
  • [Cites] Clin Chem. 2003 May;49(5):808-10 [12709375.001]
  • [Cites] Anticancer Res. 2003 Mar-Apr;23(2A):1087-92 [12820352.001]
  • [Cites] Mol Cell Endocrinol. 2003 Jun 30;204(1-2):21-30 [12850278.001]
  • [Cites] Clin Chim Acta. 2004 Mar;341(1-2):199-203 [14967177.001]
  • [Cites] Am J Med. 1979 Sep;67(3):414-20 [474587.001]
  • [Cites] J Clin Endocrinol Metab. 1980 Jun;50(6):1111-20 [7372790.001]
  • [Cites] Cancer. 1983 Aug 15;52(4):654-60 [6305481.001]
  • [Cites] J Biol Chem. 1983 Dec 10;258(23):14126-9 [6643471.001]
  • [Cites] Clin Chim Acta. 1987 Mar 30;163(3):339-49 [3034453.001]
  • [Cites] J Biol Chem. 1988 Jan 15;263(2):728-34 [3335522.001]
  • [Cites] J Biol Chem. 1988 Jan 25;263(3):1157-65 [3335536.001]
  • [Cites] Gynecol Oncol. 1999 Aug;74(2):302-3 [10419751.001]
  • [Cites] Endocrine. 1999 Apr;10(2):137-44 [10451222.001]
  • [Cites] Anal Biochem. 2005 Mar 15;338(2):253-62 [15745745.001]
  • [Cites] Tumour Biol. 2005 May-Jun;26(3):131-41 [15970647.001]
  • (PMID = 17081681.001).
  • [ISSN] 0303-7207
  • [Journal-full-title] Molecular and cellular endocrinology
  • [ISO-abbreviation] Mol. Cell. Endocrinol.
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK033973; United States / NIDDK NIH HHS / DK / DK33973; United States / NIDDK NIH HHS / DK / R01 DK033973-24
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Carbohydrates; 0 / Chorionic Gonadotropin; 0 / Lectins; 0 / glycosylated HCG; GZP2782OP0 / N-Acetylneuraminic Acid
  • [Other-IDs] NLM/ NIHMS14869; NLM/ PMC1847626
  •  go-up   go-down


2. Nemeth E: Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Adv Hematol; 2010;2010:750643
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias.
  • Hepcidin acts by causing the degradation of its receptor, the cellular iron exporter ferroportin.
  • The diagnosis of different forms of anemia will be facilitated by improved hepcidin assays, and the treatment will be enhanced by the development of hepcidin agonists and antagonists.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2007 Jul;117(7):1926-32 [17557118.001]
  • [Cites] J Clin Invest. 2007 Jul;117(7):1933-9 [17607365.001]
  • [Cites] Haematologica. 2007 May;92(5):583-8 [17488680.001]
  • [Cites] Blood. 2007 May 1;109(9):4038-44 [17218383.001]
  • [Cites] Clin Chem. 2007 Apr;53(4):620-8 [17272487.001]
  • [Cites] Mol Biol Cell. 2007 Mar;18(3):743-54 [17182845.001]
  • [Cites] Blood. 2007 Jan 1;109(1):353-8 [16946298.001]
  • [Cites] Physiol Res. 2006;55(6):667-74 [16497104.001]
  • [Cites] Inflamm Bowel Dis. 2006 Dec;12(12):1101-6 [17119383.001]
  • [Cites] Pediatr Blood Cancer. 2007 Jan;48(1):57-63 [16220548.001]
  • [Cites] Blood. 2006 Dec 1;108(12):3730-5 [16882706.001]
  • [Cites] J Biol Chem. 2006 Sep 29;281(39):28494-8 [16893896.001]
  • [Cites] Am J Gastroenterol. 2006 Sep;101(9):2160-2 [16817847.001]
  • [Cites] Haematologica. 2006 Jun;91(6):727-32 [16769573.001]
  • [Cites] Nat Genet. 2006 May;38(5):531-9 [16604073.001]
  • [Cites] Blood. 2006 May 1;107(9):3727-32 [16391018.001]
  • [Cites] Pediatr Blood Cancer. 2006 May 1;46(5):554-7 [16261603.001]
  • [Cites] Blood. 2005 Oct 15;106(8):2627-32 [15998837.001]
  • [Cites] Blood. 2005 Oct 15;106(8):2884-9 [15998830.001]
  • [Cites] Blood. 2005 Sep 15;106(6):2196-9 [15933050.001]
  • [Cites] J Clin Invest. 2005 Aug;115(8):2180-6 [16075058.001]
  • [Cites] Cell Metab. 2005 Mar;1(3):191-200 [16054062.001]
  • [Cites] Blood. 2005 Feb 15;105(4):1797-802 [15479721.001]
  • [Cites] Science. 2004 Dec 17;306(5704):2090-3 [15514116.001]
  • [Cites] Semin Hematol. 1966 Oct;3(4):351-75 [5341723.001]
  • [Cites] J Clin Invest. 2004 May;113(9):1271-6 [15124018.001]
  • [Cites] Blood. 2003 Apr 1;101(7):2461-3 [12433676.001]
  • [Cites] Nat Genet. 2003 Jan;33(1):21-2 [12469120.001]
  • [Cites] Blood. 2002 Nov 15;100(10):3776-81 [12393428.001]
  • [Cites] J Biol Chem. 2001 Mar 16;276(11):7806-10 [11113131.001]
  • [Cites] J Biol Chem. 2000 Jun 30;275(26):19906-12 [10747949.001]
  • [Cites] Mol Cell. 2000 Feb;5(2):299-309 [10882071.001]
  • [Cites] Nature. 2000 Feb 17;403(6771):776-81 [10693807.001]
  • [Cites] Nat Genet. 2009 Nov;41(11):1173-5 [19820699.001]
  • [Cites] Nat Genet. 2009 Nov;41(11):1170-2 [19820698.001]
  • [Cites] Br J Biomed Sci. 2009;66(3):150-7 [19839227.001]
  • [Cites] Clin J Am Soc Nephrol. 2009 Aug;4(8):1384-7 [19556376.001]
  • [Cites] Blood. 2009 Jul 2;114(1):181-6 [19414861.001]
  • [Cites] Clin J Am Soc Nephrol. 2009 Jun;4(6):1051-6 [19406957.001]
  • [Cites] Haematologica. 2009 Jun;94(6):765-72 [19454495.001]
  • [Cites] J Pharmacol Toxicol Methods. 2009 May-Jun;59(3):171-80 [19258043.001]
  • [Cites] Rapid Commun Mass Spectrom. 2009 Jun;23(11):1531-42 [19399775.001]
  • [Cites] J Hepatol. 2009 Jun;50(6):1219-25 [19398238.001]
  • [Cites] Cell Metab. 2009 May;9(5):461-73 [19416716.001]
  • [Cites] Anal Biochem. 2009 Jun 15;389(2):124-9 [19341701.001]
  • [Cites] Kidney Int. 2009 May;75(9):976-81 [19212416.001]
  • [Cites] Blood. 2009 Apr 9;113(15):3593-9 [19204324.001]
  • [Cites] Nat Genet. 2009 Apr;41(4):478-81 [19252488.001]
  • [Cites] Nat Genet. 2009 Apr;41(4):482-7 [19252486.001]
  • [Cites] J Am Diet Assoc. 2009 Feb;109(2):297-302 [19167957.001]
  • [Cites] Adv Chronic Kidney Dis. 2009 Mar;16(2):94-100 [19233068.001]
  • [Cites] Adv Chronic Kidney Dis. 2009 Mar;16(2):76-82 [19233066.001]
  • [Cites] J Hepatol. 2009 Feb;50(2):394-401 [19070914.001]
  • [Cites] Am J Clin Nutr. 2009 Feb;89(2):533-8 [19073788.001]
  • [Cites] Cell Metab. 2008 Dec;8(6):502-11 [18976966.001]
  • [Cites] Blood. 2008 Nov 15;112(10):4292-7 [18689548.001]
  • [Cites] Haematologica. 2008 Oct;93(10):1473-9 [18603562.001]
  • [Cites] Blood. 2008 Aug 15;112(4):1503-9 [18539898.001]
  • [Cites] J Biol Chem. 2008 Jun 20;283(25):17494-502 [18445598.001]
  • [Cites] Clin Cancer Res. 2008 Jun 1;14(11):3262-7 [18519751.001]
  • [Cites] Nat Genet. 2008 May;40(5):569-71 [18408718.001]
  • [Cites] Blood. 2008 May 15;111(10):5195-204 [18326817.001]
  • [Cites] Blood. 2007 Dec 1;110(12):4096-100 [17724144.001]
  • [Cites] Haematologica. 2007 Jun;92(6):857-8 [17550864.001]
  • (PMID = 20066043.001).
  • [ISSN] 1687-9112
  • [Journal-full-title] Advances in hematology
  • [ISO-abbreviation] Adv Hematol
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK082717
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2798567
  •  go-up   go-down


3. Gilch S, Schätzl HM: Aptamers against prion proteins and prions. Cell Mol Life Sci; 2009 Aug;66(15):2445-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Prion diseases are fatal neurodegenerative and infectious disorders of humans and animals, characterized by structural transition of the host-encoded cellular prion protein (PrP(c)) into the aberrantly folded pathologic isoform PrP(Sc).
  • RNA, DNA or peptide aptamers are classes of molecules which can be selected from complex combinatorial libraries for high affinity and specific binding to prion proteins and which might therefore be useful in diagnosis and therapy of prion diseases.
  • [MeSH-minor] Animals. Binding Sites. Humans. Models, Molecular. Prion Diseases / diagnosis. Prion Diseases / physiopathology. Prion Diseases / prevention & control. Prion Diseases / therapy. Protein Binding. Protein Conformation

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Annu Rev Neurosci. 2001;24:519-50 [11283320.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):906-19 [15965195.001]
  • [Cites] J Virol Methods. 2008 Jul;151(1):107-15 [18433888.001]
  • [Cites] Science. 1994 Apr 22;264(5158):530-1 [7909169.001]
  • [Cites] J Mol Recognit. 2008 Mar-Apr;21(2):122-31 [18383098.001]
  • [Cites] Nature. 1999 Jul 15;400(6741):225-6 [10421360.001]
  • [Cites] Nature. 1993 Mar 18;362(6417):213-4 [8096326.001]
  • [Cites] J Biol Chem. 2003 Oct 10;278(41):39697-705 [12902353.001]
  • [Cites] J Biol Chem. 2008 Jul 11;283(28):19616-25 [18456654.001]
  • [Cites] Biochem Biophys Res Commun. 2007 Feb 23;353(4):851-6 [17210123.001]
  • [Cites] Expert Opin Biol Ther. 2008 Jul;8(7):923-40 [18549323.001]
  • [Cites] J Clin Invest. 2006 Dec;116(12):3204-10 [17143329.001]
  • [Cites] Cancer Res. 2002 Jul 15;62(14):4029-33 [12124337.001]
  • [Cites] J Biol Chem. 2001 Jun 1;276(22):19301-9 [11278562.001]
  • [Cites] Biotechnol Prog. 2007 Sep-Oct;23(5):1239-44 [17880236.001]
  • [Cites] Science. 2000 Feb 25;287(5457):1503-6 [10688802.001]
  • [Cites] Nature. 1996 Apr 11;380(6574):548-50 [8606778.001]
  • [Cites] J Biol Chem. 1998 Feb 6;273(6):3484-9 [9452472.001]
  • [Cites] EMBO J. 1996 Dec 2;15(23):6363-73 [8978663.001]
  • [Cites] J Biol Chem. 2004 Oct 1;279(40):41918-27 [15247213.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9683-8 [15210972.001]
  • [Cites] J Cell Sci. 2003 Jul 1;116(Pt 13):2775-9 [12759373.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8567-72 [10411916.001]
  • [Cites] Autophagy. 2009 Apr;5(3):361-9 [19182537.001]
  • [Cites] EMBO J. 2002 Jul 1;21(13):3317-26 [12093733.001]
  • [Cites] Annu Rev Biochem. 1995;64:763-97 [7574500.001]
  • [Cites] Nature. 2006 Oct 19;443(7113):803-10 [17051207.001]
  • [Cites] EMBO Rep. 2003 Mar;4(3):290-5 [12634848.001]
  • [Cites] Nature. 1997 Nov 6;390(6655):74-7 [9363892.001]
  • [Cites] Science. 2006 Feb 24;311(5764):1117 [16439622.001]
  • [Cites] Nature. 2001 Jun 14;411(6839):810-3 [11459061.001]
  • [Cites] Anal Chem. 2007 Feb 1;79(3):1082-8 [17263339.001]
  • [Cites] Rev Med Virol. 2004 Nov-Dec;14(6):345-61 [15495196.001]
  • [Cites] J Virol. 1999 Aug;73(8):6245-50 [10400714.001]
  • [Cites] J Biol Chem. 2002 Mar 29;277(13):11416-22 [11756401.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6693-7 [10829072.001]
  • [Cites] Trends Biotechnol. 1995 Oct;13(10):426-30 [7546567.001]
  • [Cites] Arch Virol. 2006 Nov;151(11):2197-214 [16799875.001]
  • [Cites] Nature. 1996 Jul 11;382(6587):180-2 [8700211.001]
  • [Cites] J Biol Chem. 1991 Sep 25;266(27):18217-23 [1680859.001]
  • [Cites] Nat Med. 1998 Oct;4(10):1157-65 [9771749.001]
  • [Cites] J Virol. 1993 Feb;67(2):643-50 [7678300.001]
  • [Cites] J Neurochem. 2009 Apr;109(1):25-34 [19183256.001]
  • [Cites] J Virol. 1997 Nov;71(11):8790-7 [9343239.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83 [9811807.001]
  • [Cites] Nat Biotechnol. 1997 Aug;15(8):772-7 [9255793.001]
  • [Cites] J Biol Chem. 2007 Mar 9;282(10):7465-71 [17218310.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10404-9 [15240877.001]
  • [Cites] J Pathol. 2007 Apr;211(5):582-90 [17334982.001]
  • [Cites] J Biol Chem. 2001 May 4;276(18):15489-97 [11279046.001]
  • [Cites] Nat Rev Microbiol. 2004 Nov;2(11):861-71 [15494743.001]
  • [Cites] Lancet. 2001 Jul 21;358(9277):171-80 [11476832.001]
  • [Cites] Oncogene. 2001 Oct 4;20(45):6579-86 [11641783.001]
  • [Cites] Mol Ther. 2008 Mar;16(3):481-6 [18180775.001]
  • [Cites] Drug Discov Today. 2006 Apr;11(7-8):334-41 [16580975.001]
  • [Cites] Science. 1994 Sep 9;265(5178):1510 [8079159.001]
  • [Cites] Science. 2003 Oct 31;302(5646):814-8 [14593165.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14945-9 [8962161.001]
  • [Cites] FASEB J. 2001 Mar;15(3):592-4 [11259377.001]
  • [Cites] Exp Biol Med (Maywood). 2006 Feb;231(2):204-14 [16446497.001]
  • [Cites] Nature. 1997 Oct 2;389(6650):448-50, 526 [9333232.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3563-8 [11891310.001]
  • [Cites] Vox Sang. 2005 Aug;89(2):63-70 [16101685.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10238-43 [18632556.001]
  • [Cites] Lancet. 2004 Aug 7-13;364(9433):527-9 [15302196.001]
  • [Cites] EMBO J. 2001 Nov 1;20(21):5876-86 [11689428.001]
  • [Cites] J Mol Biol. 1999 Jun 25;289(5):1163-78 [10373359.001]
  • [Cites] Biol Chem. 1997 Dec;378(12):1521-30 [9461351.001]
  • [Cites] J Pathol. 2004 Jul;203(3):733-9 [15221931.001]
  • [Cites] Nature. 1996 Oct 24;383(6602):685-90 [8878476.001]
  • [Cites] Cell. 2004 Jan 23;116(2):313-27 [14744440.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5959-63 [8327467.001]
  • [Cites] J Protein Chem. 2001 Aug;20(6):507-19 [11760126.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10849-54 [12149459.001]
  • [Cites] Am J Pathol. 2004 Jul;165(1):227-35 [15215178.001]
  • [Cites] Nat Med. 2003 Jul;9(7):893-9 [12778138.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8342-7 [15155909.001]
  • [Cites] Clin Vaccine Immunol. 2007 Jan;14(1):36-43 [17079434.001]
  • [Cites] Science. 1977 Sep 2;197(4307):943-60 [142303.001]
  • [Cites] Nature. 2001 Aug 16;412(6848):739-43 [11507642.001]
  • [Cites] Biochim Biophys Acta. 2007 Jun;1772(6):629-44 [17451912.001]
  • [Cites] J Biol Chem. 1995 Jun 9;270(23):13581-4 [7775406.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9295-9 [11470893.001]
  • [Cites] Nature. 2005 Sep 8;437(7056):257-61 [16148934.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3606-10 [10097084.001]
  • [Cites] J Biol Chem. 2003 Sep 26;278(39):37610-21 [12842895.001]
  • [Cites] J Biochem. 2006 Mar;139(3):383-90 [16567403.001]
  • [Cites] J Biol Chem. 1992 Aug 15;267(23):16188-99 [1353761.001]
  • [Cites] J Cell Biol. 1995 Apr;129(1):121-32 [7698979.001]
  • [Cites] Chembiochem. 2002 Aug 2;3(8):717-25 [12203970.001]
  • [Cites] Nature. 1996 Aug 29;382(6594):779-88 [8752271.001]
  • [Cites] Cell. 2005 Apr 22;121(2):195-206 [15851027.001]
  • [Cites] J Biol Chem. 2004 Mar 26;279(13):13102-9 [14711834.001]
  • [Cites] J Theor Biol. 1998 Jan 21;190(2):107-19 [9538461.001]
  • [Cites] Am J Pathol. 1995 Apr;146(4):785-811 [7717447.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1898-903 [10051566.001]
  • [Cites] Mol Immunol. 2008 Jan;45(1):144-51 [17576014.001]
  • [Cites] Science. 1982 Apr 9;216(4542):136-44 [6801762.001]
  • [Cites] Curr Protein Pept Sci. 2004 Dec;5(6):507-27 [15581420.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13720-5 [11106396.001]
  • [Cites] J Mol Biol. 2007 Aug 10;371(2):362-73 [17574575.001]
  • [Cites] Protein Pept Lett. 2006;13(3):219-27 [16515449.001]
  • [Cites] Curr Biol. 1994 May 1;4(5):427-9 [7522916.001]
  • [Cites] Neuron. 2007 Feb 1;53(3):325-35 [17270731.001]
  • [Cites] Biol Chem. 2000 May-Jun;381(5-6):463-9 [10937879.001]
  • [Cites] Science. 2003 Oct 31;302(5646):871-4 [14593181.001]
  • [Cites] Nature. 1997 Oct 2;389(6650):498-501 [9333239.001]
  • [Cites] EMBO J. 2001 Aug 1;20(15):3957-66 [11483499.001]
  • [Cites] Curr Mol Med. 2004 Aug;4(5):529-38 [15267224.001]
  • [Cites] Lancet. 2004 Feb 7;363(9407):417-21 [14962520.001]
  • [Cites] Br Med Bull. 2003;66:199-212 [14522860.001]
  • (PMID = 19396399.001).
  • [ISSN] 1420-9071
  • [Journal-full-title] Cellular and molecular life sciences : CMLS
  • [ISO-abbreviation] Cell. Mol. Life Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Aptamers, Peptide; 0 / PrPC Proteins; 0 / PrPSc Proteins; 0 / Prions
  • [Number-of-references] 111
  •  go-up   go-down


Advertisement
4. Liu J, Lau SK, Varma VA, Kairdolf BA, Nie S: Multiplexed detection and characterization of rare tumor cells in Hodgkin's lymphoma with multicolor quantum dots. Anal Chem; 2010 Jul 15;82(14):6237-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The multicolor and multiplexing capabilities of semiconductor quantum dots (QDs) are most promising for improving the sensitivity and specificity of in vitro molecular and cellular diagnostics.
  • Known as the Hodgkin's and Reed-Sternberg (HRS) cells, this class of malignant cells is a pathological hallmark in clinical diagnosis, but it comprises only about 1% of the heterogeneous infiltrating cells in lymph node tissues.
  • To overcome this cellular heterogeneity and rarity problem, we have developed multicolor QD-antibody conjugates to simultaneously detect a panel of four protein biomarkers (CD15, CD30, CD45, and Pax5) directly on human tissue biopsies.

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Rev Genet. 2000 Oct;1(1):48-56 [11262874.001]
  • [Cites] ACS Nano. 2010 May 25;4(5):2755-65 [20377268.001]
  • [Cites] J Clin Pathol. 2002 Mar;55(3):162-76 [11896065.001]
  • [Cites] Clin Chem. 2002 Aug;48(8):1160-9 [12142368.001]
  • [Cites] Cancer Detect Prev. 2002;26(4):249-55 [12430629.001]
  • [Cites] Am J Clin Pathol. 2002 Jun;117 Suppl:S76-94 [14569804.001]
  • [Cites] Nat Biotechnol. 2004 Jan;22(1):47-52 [14704706.001]
  • [Cites] J Clin Pathol. 1987 Nov;40(11):1298-304 [3320093.001]
  • [Cites] Blood. 1996 Apr 1;87(7):2905-17 [8639911.001]
  • [Cites] J Pathol. 1997 Apr;181(4):462-3 [9196447.001]
  • [Cites] Mol Med Today. 1995 Apr;1(1):26-30 [9415134.001]
  • [Cites] Science. 2005 Jan 28;307(5709):538-44 [15681376.001]
  • [Cites] Curr Opin Biotechnol. 2005 Feb;16(1):63-72 [15722017.001]
  • [Cites] J Biomed Opt. 2005 Jul-Aug;10(4):41207 [16178631.001]
  • [Cites] Int J Cancer. 2006 Apr 15;118(8):1853-61 [16385563.001]
  • [Cites] Expert Rev Mol Diagn. 2006 Mar;6(2):231-44 [16512782.001]
  • [Cites] Mod Pathol. 2006 Sep;19(9):1181-91 [16778828.001]
  • [Cites] Nano Lett. 2006 Dec;6(12):2881-6 [17163724.001]
  • [Cites] Nat Protoc. 2007;2(5):1152-65 [17546006.001]
  • [Cites] Mod Pathol. 2007 Aug;20(8):871-7 [17529924.001]
  • [Cites] Annu Rev Biomed Eng. 2007;9:257-88 [17439359.001]
  • [Cites] Adv Drug Deliv Rev. 2008 Aug 17;60(11):1226-40 [18495291.001]
  • [Cites] Biochem Biophys Res Commun. 2008 Sep 19;374(2):181-6 [18621021.001]
  • [Cites] J Pathol. 2008 Nov;216(3):275-85 [18814189.001]
  • [Cites] Nat Rev Cancer. 2009 Jan;9(1):15-27 [19078975.001]
  • [Cites] Nat Methods. 2009 Feb;6(2):139-41 [19137005.001]
  • [Cites] Biomaterials. 2009 May;30(15):2912-8 [19251316.001]
  • [Cites] Annu Rev Pathol. 2009;4:151-74 [19400691.001]
  • [Cites] Trends Biotechnol. 2009 Jun;27(6):350-8 [19409634.001]
  • [Cites] Biosens Bioelectron. 2009 Aug 15;24(12):3657-62 [19540102.001]
  • [Cites] J Mol Histol. 2009 Aug;40(4):261-8 [19908148.001]
  • [Cites] ACS Nano. 2010 Jan 26;4(1):488-94 [20041634.001]
  • [Cites] N Engl J Med. 2010 Mar 11;362(10):875-85 [20220182.001]
  • [Cites] Lancet. 2002 Feb 16;359(9306):572-7 [11867112.001]
  • (PMID = 20565106.001).
  • [ISSN] 1520-6882
  • [Journal-full-title] Analytical chemistry
  • [ISO-abbreviation] Anal. Chem.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA108468; United States / NCI NIH HHS / CA / CA119338-01; United States / NCI NIH HHS / CA / U54CA119338; United States / NCI NIH HHS / CA / U54 CA119338; United States / NCI NIH HHS / CA / CA108468-01; United States / NCI NIH HHS / CA / R01 CA108468-01; United States / NCI NIH HHS / CA / R01CA108468; United States / NCI NIH HHS / CA / U54 CA119338-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies; 0 / Biomarkers
  • [Other-IDs] NLM/ NIHMS220487; NLM/ PMC2914471
  •  go-up   go-down


5. Bratasz A, Selvendiran K, Wasowicz T, Bobko A, Khramtsov VV, Ignarro LJ, Kuppusamy P: NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols. J Transl Med; 2008 Feb 26;6:9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.
  • The high mortality rate is associated with lack of early diagnosis and development of drug resistance.
  • The antitumor efficacy and mechanism of NCX-4040, a nitric oxide-releasing aspirin derivative, against ovarian cancer is studied.
  • CONCLUSION: The results suggested that NCX-4040 could resensitize drug-resistant ovarian cancer cells to cisplatin possibly by depletion of cellular thiols.

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. ACETYLSALICYLIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2000 Oct 1;89(7):1440-7 [11013356.001]
  • [Cites] Mutat Res. 2001 Jul 1;478(1-2):23-43 [11406167.001]
  • [Cites] Gynecol Oncol. 2001 Jul;82(1):172-6 [11426981.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 2001;67:93-130 [11525387.001]
  • [Cites] Cancer Res. 2002 Jan 1;62(1):307-12 [11782393.001]
  • [Cites] Gynecol Oncol. 2002 May;85(2):298-304 [11972391.001]
  • [Cites] Lancet Oncol. 2002 Sep;3(9):529-36 [12217790.001]
  • [Cites] Lancet Oncol. 2002 Sep;3(9):537-45 [12217791.001]
  • [Cites] Cancer Res. 2003 Jan 15;63(2):312-8 [12543781.001]
  • [Cites] Nat Rev Cancer. 2003 Jul;3(7):502-16 [12835670.001]
  • [Cites] Br J Cancer. 2003 Dec;89 Suppl 3:S16-22 [14661042.001]
  • [Cites] Nat Rev Cancer. 2004 Feb;4(2):97-105 [14964307.001]
  • [Cites] Magn Reson Med. 2004 Sep;52(3):650-7 [15334586.001]
  • [Cites] Chem Biol Interact. 1987 Mar;61(3):241-8 [3568194.001]
  • [Cites] Cancer Res. 1988 Jan 1;48(1):117-21 [3334986.001]
  • [Cites] Biochem Pharmacol. 1988 Aug 15;37(16):3199-201 [3401252.001]
  • [Cites] Anal Biochem. 1989 Oct;182(1):58-63 [2557778.001]
  • [Cites] Cancer Commun. 1990;2(2):93-100 [2372473.001]
  • [Cites] Trends Biochem Sci. 1992 Nov;17(11):463-8 [1455517.001]
  • [Cites] Cancer. 1993 Jan 15;71(2 Suppl):644-9 [8420689.001]
  • [Cites] Cancer Res. 1993 May 1;53(9):2066-70 [8097674.001]
  • [Cites] Cell. 1993 Oct 22;75(2):241-51 [7503812.001]
  • [Cites] Biochem Biophys Res Commun. 1993 Sep 30;195(3):1191-8 [8216248.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3680-4 [8170969.001]
  • [Cites] Crit Rev Oncol Hematol. 1995 Jul;19(3):183-232 [7612182.001]
  • [Cites] Eur J Biochem. 1995 Dec 1;234(2):472-8 [8536691.001]
  • [Cites] Magn Reson Med. 1996 Aug;36(2):212-8 [8843374.001]
  • [Cites] J Biochem Biophys Methods. 1997 Sep 25;35(2):115-28 [9350517.001]
  • [Cites] Cancer Res. 1998 Apr 1;58(7):1562-8 [9537265.001]
  • [Cites] Chem Biol Interact. 1998 Apr 24;111-112:187-98 [9679554.001]
  • [Cites] Clin Cancer Res. 1996 Nov;2(11):1859-65 [9816141.001]
  • [Cites] J Pharmacol Exp Ther. 2005 Mar;312(3):989-97 [15528452.001]
  • [Cites] J Pharmacol Exp Ther. 2005 Mar;312(3):978-88 [15528453.001]
  • [Cites] Mol Cancer Ther. 2005 Apr;4(4):650-8 [15827339.001]
  • [Cites] Cancer Cell. 2005 Jun;7(6):575-89 [15950906.001]
  • [Cites] Apoptosis. 2005 Oct;10(5):1095-103 [16151642.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3914-9 [16497833.001]
  • [Cites] Mol Cancer Ther. 2006 Apr;5(4):919-26 [16648562.001]
  • [Cites] Cancer Res. 2006 May 1;66(9):4826-34 [16651438.001]
  • [Cites] Apoptosis. 2006 Aug;11(8):1321-30 [16699954.001]
  • [Cites] Clin Cancer Res. 2006 Sep 1;12(17):5055-63 [16951221.001]
  • [Cites] Biochem Pharmacol. 2006 Oct 16;72(8):941-8 [16934227.001]
  • [Cites] Stem Cells. 2007 Jan;25(1):88-97 [16960136.001]
  • [Cites] Mol Cancer Ther. 2007 Jan;6(1):112-21 [17237271.001]
  • [Cites] Cancer Treat Rev. 2007 Feb;33(1):9-23 [17084534.001]
  • [Cites] Blood. 2007 Mar 15;109(6):2293-302 [17164350.001]
  • [Cites] Hear Res. 2007 Apr;226(1-2):157-67 [17113254.001]
  • [Cites] J Med Chem. 2007 May 17;50(10):2424-31 [17441704.001]
  • [Cites] Biochem Biophys Res Commun. 2007 Jul 13;358(4):1096-101 [17512900.001]
  • [Cites] Nat Rev Cancer. 2007 Aug;7(8):573-84 [17625587.001]
  • [Cites] Am J Med Sci. 2007 Aug;334(2):115-24 [17700201.001]
  • [Cites] Chem Res Toxicol. 2007 Dec;20(12):1903-12 [17975886.001]
  • [Cites] J Transl Med. 2007;5:52 [17971198.001]
  • [Cites] Cell Cycle. 2008 Jan 1;7(1):81-8 [18196976.001]
  • [Cites] Trends Pharmacol Sci. 1999 Aug;20(8):319-23 [10431210.001]
  • [Cites] J Inorg Biochem. 1999 Oct;77(1-2):105-10 [10626361.001]
  • [Cites] Clin Cancer Res. 1999 Dec;5(12):4097-104 [10632346.001]
  • (PMID = 18302761.001).
  • [ISSN] 1479-5876
  • [Journal-full-title] Journal of translational medicine
  • [ISO-abbreviation] J Transl Med
  • [Language] ENG
  • [Grant] United States / NIBIB NIH HHS / EB / K01 EB003519; United States / NCI NIH HHS / CA / R01 CA102264; United States / NCI NIH HHS / CA / CA102264; United States / NIBIB NIH HHS / EB / K01 EB03519
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / NCX 4040; 0 / Nitro Compounds; 0 / Sulfhydryl Compounds; 175033-36-0 / nitroaspirin; Q20Q21Q62J / Cisplatin; R16CO5Y76E / Aspirin
  • [Other-IDs] NLM/ PMC2267444
  •  go-up   go-down


6. Schwamborn K, Krieg RC, Jirak P, Ott G, Knüchel R, Rosenwald A, Wellmann A: Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma. J Cancer Res Clin Oncol; 2010 Nov;136(11):1651-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma.
  • Hodgkin lymphoma (HL) is a distinctive lymphoma subtype characterized by rareness of tumor cells [Hodgkin's and Reed-Sternberg (HRS) cells in classical HL and lymphocytic and histiocytic cells in lymphocyte predominant HL] as well as the vast majority of the surrounding inflammatory-like cellular infiltrate.
  • [MeSH-minor] Algorithms. Cell Division. Diagnosis, Differential. Gene Expression Regulation, Neoplastic. Humans. Lymph Node Excision. Lymphadenitis / diagnosis. Lymphadenitis / pathology. Lymphadenitis / surgery. Neoplasm Proteins / analysis. Neoplasm Proteins / genetics. Proteome

  • Genetic Alliance. consumer health - Hodgkin lymphoma.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Pathol. 2002 Mar;55(3):162-76 [11896065.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18126-31 [18776051.001]
  • [Cites] Nat Med. 2001 Apr;7(4):493-6 [11283679.001]
  • [Cites] Mol Cell Proteomics. 2005 Apr;4(4):394-401 [15677390.001]
  • [Cites] Am J Pathol. 2004 Oct;165(4):1057-68 [15466373.001]
  • [Cites] Blood. 2005 May 1;105(9):3722-30 [15650054.001]
  • [Cites] Blood. 2000 May 15;95(10):3020-4 [10807764.001]
  • [Cites] CA Cancer J Clin. 2004 Sep-Oct;54(5):260-72 [15371284.001]
  • [Cites] J Exp Ther Oncol. 2007;6(2):137-45 [17407972.001]
  • [Cites] Proteomics. 2005 Nov;5(16):4274-86 [16206328.001]
  • [Cites] Mod Pathol. 2004 Jun;17(6):670-8 [15098007.001]
  • [Cites] Nature. 2003 Mar 13;422(6928):226-32 [12634796.001]
  • [Cites] Int J Mol Med. 2007 Aug;20(2):155-9 [17611632.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10962-6 [7971992.001]
  • [Cites] Ann Oncol. 2002;13 Suppl 4:147-52 [12401681.001]
  • [Cites] Pathologe. 2000 Mar;21(2):113-23 [10840817.001]
  • [Cites] Blood. 2008 Feb 15;111(4):2339-46 [18070985.001]
  • [Cites] Lab Invest. 2007 Nov;87(11):1113-24 [17876297.001]
  • [Cites] Ann Oncol. 2002;13 Suppl 1:11-8 [12078890.001]
  • [Cites] Histol Histopathol. 2007 Aug;22(8):923-35 [17503349.001]
  • [Cites] J Clin Oncol. 2005 Sep 10;23(26):6379-86 [16155023.001]
  • [Cites] Anal Chem. 1999 Dec 1;71(23):5263-70 [10596208.001]
  • [Cites] Pathologe. 2002 May;23(3):207-18 [12089788.001]
  • [Cites] Cancer Cell. 2003 Jan;3(1):9-15 [12559171.001]
  • [Cites] J Biomol Tech. 2005 Dec;16(4):341-6 [16522855.001]
  • (PMID = 20865362.001).
  • [ISSN] 1432-1335
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / Proteome
  •  go-up   go-down


7. Chan JW, Taylor DS, Lane SM, Zwerdling T, Tuscano J, Huser T: Nondestructive identification of individual leukemia cells by laser trapping Raman spectroscopy. Anal Chem; 2008 Mar 15;80(6):2180-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Currently, a combination of technologies is typically required to assess the malignancy of cancer cells.
  • These methods often lack the specificity and sensitivity necessary for early, accurate diagnosis.
  • Here we demonstrate using clinical samples the application of laser trapping Raman spectroscopy as a novel approach that provides intrinsic biochemical markers for the noninvasive detection of individual cancer cells.
  • Populations of normal T and B lymphocytes from four healthy individuals and cells from three leukemia patients were analyzed, and multiple intrinsic Raman markers associated with DNA and protein vibrational modes have been identified that exhibit excellent discriminating power for cancer cell identification.
  • A combination of two multivariate statistical methods, principal component analysis (PCA) and linear discriminant analysis (LDA), was used to confirm the significance of these markers for identifying cancer cells and classifying the data.
  • We also provide evidence that these markers are unique to cancer cells and not purely a function of differences in their cellular activation.

  • MedlinePlus Health Information. consumer health - Leukemia.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18260656.001).
  • [ISSN] 0003-2700
  • [Journal-full-title] Analytical chemistry
  • [ISO-abbreviation] Anal. Chem.
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / UL1 RR024146
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


8. Schrohl AS, Würtz S, Kohn E, Banks RE, Nielsen HJ, Sweep FC, Brünner N: Banking of biological fluids for studies of disease-associated protein biomarkers. Mol Cell Proteomics; 2008 Oct;7(10):2061-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinically validated biomarkers may provide information to be used for diagnosis, screening, evaluation of risk/predisposition, assessment of prognosis, monitoring (recurrence of disease), and prediction of response to treatment and as a surrogate response marker.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Scand J Clin Lab Invest. 2002;62(3):223-30 [12088341.001]
  • [Cites] Transfusion. 1999 Oct;39(10):1078-83 [10532601.001]
  • [Cites] Int J Oncol. 2003 Dec;23(6):1715-26 [14612946.001]
  • [Cites] Dan Med Bull. 2003 Nov;50(4):368-84 [14694852.001]
  • [Cites] Am J Phys Anthropol. 2008 Jun;136(2):138-46 [18257023.001]
  • [Cites] Br J Cancer. 2002 Feb 1;86(3):417-23 [11875709.001]
  • [Cites] Clin Chem. 2002 May;48(5):691-8 [11978595.001]
  • [Cites] Transfus Med. 2004 Aug;14(4):305-12 [15285727.001]
  • [Cites] Clin Chem. 1997 Aug;43(8 Pt 1):1348-51 [9267312.001]
  • [Cites] Br J Cancer. 1998 Mar;77(6):956-64 [9528841.001]
  • [Cites] Br J Cancer. 1999 May;80(3-4):495-503 [10408859.001]
  • [Cites] Anal Biochem. 2005 Mar 15;338(2):294-8 [15745750.001]
  • [Cites] Clin Chem Lab Med. 2006;44(4):358-65 [16599826.001]
  • [Cites] Clin Chim Acta. 2007 May 1;380(1-2):128-32 [17328880.001]
  • [Cites] Clin Chem. 2007 Jul;53(7):1338-42 [17525103.001]
  • [Cites] Scand J Clin Lab Invest. 2007;67(5):545-52 [17763191.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Sep;92(9):3674-80 [17595257.001]
  • [Cites] Scand J Immunol. 2007 Oct;66(4):458-64 [17850591.001]
  • [Cites] Dis Markers. 2008;24(1):1-10 [18057530.001]
  • [Cites] Scand J Clin Lab Invest. 2007;67(8):821-35 [17852826.001]
  • [Cites] Scand J Gastroenterol. 2008;43(2):186-91 [18224564.001]
  • [Cites] Scand J Gastroenterol. 2008;43(2):242-8 [18224568.001]
  • [Cites] Int J Biol Markers. 2008 Jan-Mar;23(1):42-7 [18409150.001]
  • [Cites] Am J Hematol. 2001 Jul;67(3):157-62 [11391711.001]
  • [Cites] Int J Biol Markers. 2003 Jul-Sep;18(3):170-6 [14535586.001]
  • (PMID = 18676364.001).
  • [ISSN] 1535-9484
  • [Journal-full-title] Molecular & cellular proteomics : MCP
  • [ISO-abbreviation] Mol. Cell Proteomics
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Proteins
  • [Number-of-references] 26
  • [Other-IDs] NLM/ PMC2559931
  •  go-up   go-down


9. Abaffy T, Duncan R, Riemer DD, Tietje O, Elgart G, Milikowski C, DeFazio RA: Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process. PLoS One; 2010 Nov 04;5(11):e13813
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Discovering new melanoma biomarkers would improve early detection and diagnosis.

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Moles.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anal Chem. 2000 Feb 15;72(4):747-56 [10701259.001]
  • [Cites] J Am Chem Soc. 2010 Mar 24;132(11):3642-3 [20196537.001]
  • [Cites] Philos Trans R Soc Lond B Biol Sci. 2002 Jan 29;357(1417):17-23 [11839178.001]
  • [Cites] Breast J. 2003 May-Jun;9(3):184-91 [12752626.001]
  • [Cites] Trends Biochem Sci. 2003 Jun;28(6):329-35 [12826405.001]
  • [Cites] Cancer Treat Rev. 2003 Dec;29(6):489-99 [14585259.001]
  • [Cites] Lancet. 2004 Feb 28;363(9410):728-30 [15005091.001]
  • [Cites] Prev Med. 2004 Apr;38(4):382-7 [15020171.001]
  • [Cites] Environ Health Perspect. 2004 May;112(7):A396-7 [15159211.001]
  • [Cites] Nat Rev Cancer. 2004 Jul;4(7):551-61 [15229480.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Sep 5;808(2):269-77 [15261821.001]
  • [Cites] Nature. 1966 Nov 26;212(5065):933-5 [4306794.001]
  • [Cites] J Biol Chem. 1980 Nov 10;255(21):10493-501 [7430132.001]
  • [Cites] Anticancer Res. 1985 Jan-Feb;5(1):1-30 [3888043.001]
  • [Cites] Mutat Res. 1989 Jan;219(1):71-9 [2911273.001]
  • [Cites] Biochem Pharmacol. 1995 Dec 22;50(12):1955-62 [8849320.001]
  • [Cites] Science. 1996 Jul 5;273(5271):59-63 [8658196.001]
  • [Cites] J Biol Chem. 1997 May 2;272(18):11895-901 [9115250.001]
  • [Cites] Nucleic Acids Res. 1999 Jun 1;27(11):2291-8 [10325416.001]
  • [Cites] Cancer Res. 1999 Aug 15;59(16):3855-60 [10463569.001]
  • [Cites] J Invest Dermatol. 1964 Aug;43:111-3 [14196302.001]
  • [Cites] Biochemistry. 2004 Nov 16;43(45):14332-9 [15533037.001]
  • [Cites] Nature. 2005 Aug 4;436(7051):720-4 [16079850.001]
  • [Cites] J Invest Dermatol. 2006 Dec;126(12):2565-75 [17108903.001]
  • [Cites] Mass Spectrom Rev. 2007 Jan-Feb;26(1):51-78 [16921475.001]
  • [Cites] Nature. 2007 Feb 22;445(7130):843-50 [17314970.001]
  • [Cites] Am J Clin Nutr. 2007 Apr;85(4):946-9 [17413090.001]
  • [Cites] Cancer Biomark. 2007;3(2):95-109 [17522431.001]
  • [Cites] Int J Epidemiol. 2008 Apr;37 Suppl 1:i23-30 [18381390.001]
  • [Cites] Skin Res Technol. 2008 May;14(2):226-36 [18412567.001]
  • [Cites] PLoS Med. 2008 Jun 3;5(6):e120 [18532874.001]
  • [Cites] J Thorac Oncol. 2008 Jul;3(7):774-80 [18594325.001]
  • [Cites] Int J Cancer. 2008 Nov 15;123(10):2446-55 [18729182.001]
  • [Cites] Br J Dermatol. 2008 Sep;159(4):780-91 [18637798.001]
  • [Cites] J Am Chem Soc. 2008 Oct 29;130(43):14111-3 [18831549.001]
  • [Cites] Nature. 2008 Oct 23;455(7216):1054-6 [18948945.001]
  • [Cites] Lung Cancer. 2009 Feb;63(2):164-8 [18599152.001]
  • [Cites] Can Fam Physician. 2009 Jan;55(1):24; autor reply 24 [19155361.001]
  • [Cites] Anal Bioanal Chem. 2009 Feb;393(3):781-95 [18836706.001]
  • [Cites] Nature. 2009 Feb 12;457(7231):910-4 [19212411.001]
  • [Cites] J Am Soc Mass Spectrom. 2009 Mar;20(3):464-8 [19070510.001]
  • [Cites] Am J Pathol. 2009 Apr;174(4):1524-33 [19342374.001]
  • [Cites] Nat Rev Genet. 2009 May;10(5):295-304 [19308066.001]
  • [Cites] Cancer Control. 2009 Jul;16(3):200-18 [19556960.001]
  • [Cites] Eur Respir J. 2009 Jul;34(1):261-75 [19567608.001]
  • [Cites] BMC Cancer. 2009;9:348 [19788722.001]
  • [Cites] Pigment Cell Melanoma Res. 2009 Dec;22(6):750-60 [19735457.001]
  • [Cites] Pigment Cell Melanoma Res. 2010 Feb;23(1):64-71 [19788535.001]
  • [Cites] Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):613-20 [20143319.001]
  • [Cites] J Invest Dermatol. 2001 Apr;116(4):520-4 [11286617.001]
  • (PMID = 21079799.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA132046-02; United States / NCI NIH HHS / CA / R21 CA132046; United States / NCI NIH HHS / CA / R21CA 132046; United States / NCI NIH HHS / CA / R21 CA132046-01A1; United States / NCI NIH HHS / CA / R21 CA132046-02
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Volatile Organic Compounds
  • [Other-IDs] NLM/ PMC2973952
  •  go-up   go-down


10. Franck J, Arafah K, Elayed M, Bonnel D, Vergara D, Jacquet A, Vinatier D, Wisztorski M, Day R, Fournier I, Salzet M: MALDI imaging mass spectrometry: state of the art technology in clinical proteomics. Mol Cell Proteomics; 2009 Sep;8(9):2023-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • 1) diagnosis based on profile signatures that complement histopathology, 2) early detection of disease, 3) selection of therapeutic combinations based on the individual patient's entire disease-specific protein network, 4) real time assessment of therapeutic efficacy and toxicity, 5) rational redirection of therapy based on changes in the diseased protein network that are associated with drug resistance, and 6) combinatorial therapy in which the signaling pathway itself is viewed as the target rather than any single "node" in the pathway.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Chim Acta. 2005 Jul 24;357(2):210-8 [15913587.001]
  • [Cites] J Proteome Res. 2005 Jul-Aug;4(4):1200-12 [16083270.001]
  • [Cites] J Am Soc Mass Spectrom. 2005 Oct;16(10):1654-9 [16095912.001]
  • [Cites] Anal Chem. 2005 Oct 1;77(19):6118-24 [16194068.001]
  • [Cites] Anal Chem. 2005 Oct 15;77(20):6682-6 [16223256.001]
  • [Cites] Rapid Commun Mass Spectrom. 2006;20(2):284-90 [16345125.001]
  • [Cites] Anal Chem. 2006 Feb 1;78(3):734-42 [16448046.001]
  • [Cites] Anal Chem. 2006 Feb 1;78(3):809-19 [16448055.001]
  • [Cites] Anal Chem. 2006 Feb 1;78(3):827-34 [16448057.001]
  • [Cites] J Proteome Res. 2006 Feb;5(2):262-9 [16457591.001]
  • [Cites] Rapid Commun Mass Spectrom. 2006;20(6):965-72 [16470674.001]
  • [Cites] Mol Carcinog. 2006 Aug;45(8):613-26 [16788983.001]
  • [Cites] J Neuropathol Exp Neurol. 2006 Sep;65(9):837-45 [16957577.001]
  • [Cites] Anal Chem. 2006 Sep 15;78(18):6448-56 [16970320.001]
  • [Cites] Brain Res. 2006 Oct 3;1113(1):24-32 [16938284.001]
  • [Cites] Mol Cell Proteomics. 2006 Oct;5(10):1876-86 [16705188.001]
  • [Cites] Anal Chem. 2006 Oct 15;78(20):7145-53 [17037914.001]
  • [Cites] Methods Enzymol. 2006;412:94-106 [17046654.001]
  • [Cites] Angew Chem Int Ed Engl. 2006 Nov 6;45(43):7188-92 [17001721.001]
  • [Cites] J Am Soc Mass Spectrom. 2007 Jan;18(1):145-51 [17055739.001]
  • [Cites] Curr Opin Chem Biol. 2007 Feb;11(1):29-35 [17185024.001]
  • [Cites] J Pharmacol Toxicol Methods. 2007 Mar-Apr;55(2):193-200 [16919485.001]
  • [Cites] J Mass Spectrom. 2007 Feb;42(2):254-62 [17230433.001]
  • [Cites] Rapid Commun Mass Spectrom. 2007;21(7):1271-6 [17340571.001]
  • [Cites] Anal Chem. 2007 Mar 15;79(6):2463-71 [17305311.001]
  • [Cites] J Mass Spectrom. 2007 Apr;42(4):476-89 [17328093.001]
  • [Cites] J Proteome Res. 2007 Apr;6(4):1295-305 [17291023.001]
  • [Cites] Wien Med Wochenschr. 2007;157(5-6):122-9 [17427009.001]
  • [Cites] J Proteome Res. 2007 Jun;6(6):2057-67 [17477556.001]
  • [Cites] Nat Clin Pract Gastroenterol Hepatol. 2007 Jul;4(7):372-85 [17607293.001]
  • [Cites] Int J Mol Med. 2007 Aug;20(2):155-9 [17611632.001]
  • [Cites] J Mass Spectrom. 2007 Aug;42(8):1099-105 [17621390.001]
  • [Cites] J Am Soc Mass Spectrom. 2007 Sep;18(9):1646-52 [17659880.001]
  • [Cites] Nat Methods. 2007 Oct;4(10):828-33 [17901873.001]
  • [Cites] J Proteome Res. 2007 Nov;6(11):4127-34 [17939699.001]
  • [Cites] Pac Symp Biocomput. 2007;:458-69 [17990510.001]
  • [Cites] Curr Pharm Des. 2007;13(32):3317-24 [18045185.001]
  • [Cites] Nat Methods. 2008 Jan;5(1):57-9 [18084298.001]
  • [Cites] Nat Methods. 2008 Jan;5(1):101-8 [18165806.001]
  • [Cites] Mol Cell Proteomics. 2008 Feb;7(2):411-23 [17991918.001]
  • [Cites] J Proteome Res. 2008 Mar;7(3):969-78 [18247558.001]
  • [Cites] Anal Chem. 2008 Apr 15;80(8):2780-8 [18314967.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):237-46 [18337021.001]
  • [Cites] Rapid Commun Mass Spectrom. 2008 May;22(10):1503-9 [18421763.001]
  • [Cites] Rapid Commun Mass Spectrom. 2008 May;22(10):1615-8 [18433085.001]
  • [Cites] Expert Rev Proteomics. 2008 Jun;5(3):413-24 [18532909.001]
  • [Cites] Anal Chem. 2008 Jun 15;80(12):4761-6 [18476721.001]
  • [Cites] J Am Soc Mass Spectrom. 2008 Aug;19(8):1069-77 [18472274.001]
  • [Cites] J Proteomics. 2008 Aug 21;71(3):332-45 [18644473.001]
  • [Cites] Histochem Cell Biol. 2008 Sep;130(3):421-34 [18618129.001]
  • [Cites] Proteomics. 2008 Sep;8(18):3702-14 [18704906.001]
  • [Cites] Proteomics. 2008 Sep;8(18):3715-24 [18712763.001]
  • [Cites] Anal Chem. 2008 Nov 15;80(22):8628-34 [18847214.001]
  • [Cites] Comb Chem High Throughput Screen. 2009 Feb;12(2):156-74 [19199884.001]
  • [Cites] Rapid Commun Mass Spectrom. 2009 Mar;23(6):733-6 [19206086.001]
  • [Cites] Rapid Commun Mass Spectrom. 2009 Apr;23(8):1183-8 [19283784.001]
  • [Cites] J Proteome Res. 2008 Dec;7(12):5230-6 [19367705.001]
  • [Cites] J Exp Biol. 2000 Dec;203(Pt 23):3565-73 [11060217.001]
  • [Cites] Nat Med. 2001 Apr;7(4):493-6 [11283679.001]
  • [Cites] Curr Opin Chem Biol. 2002 Oct;6(5):676-81 [12413553.001]
  • [Cites] Neuro Endocrinol Lett. 2003 Feb-Apr;24(1-2):9-14 [12743525.001]
  • [Cites] J Mass Spectrom. 2003 Oct;38(10):1081-92 [14595858.001]
  • [Cites] Anal Chem. 2004 Feb 15;76(4):1145-55 [14961749.001]
  • [Cites] Am J Pathol. 2004 Oct;165(4):1057-68 [15466373.001]
  • [Cites] J Neurochem. 1994 Jan;62(1):404-7 [8263544.001]
  • [Cites] Endocrinology. 1994 Apr;134(4):1812-9 [8137747.001]
  • [Cites] J Biol Chem. 1994 Dec 2;269(48):30288-92 [7982940.001]
  • [Cites] Brain Res Mol Brain Res. 1994 Sep;25(3-4):355-8 [7808235.001]
  • [Cites] Anal Chem. 1997 Dec 1;69(23):4751-60 [9406525.001]
  • [Cites] Biochemistry. 1998 Feb 17;37(7):2070-6 [9485334.001]
  • [Cites] Anal Chem. 1998 May 1;70(9):1805-11 [9599581.001]
  • [Cites] Exp Nephrol. 1998 Sep-Oct;6(5):421-8 [9730658.001]
  • [Cites] J Neurophysiol. 1999 Mar;81(3):1251-60 [10085352.001]
  • [Cites] Cancer Res. 2004 Dec 15;64(24):9093-100 [15604278.001]
  • [Cites] Mol Cell Proteomics. 2005 Apr;4(4):394-401 [15677390.001]
  • [Cites] Drug Discov Today. 2005 Jun 15;10(12):823-37 [15970265.001]
  • (PMID = 19451175.001).
  • [ISSN] 1535-9484
  • [Journal-full-title] Molecular & cellular proteomics : MCP
  • [ISO-abbreviation] Mol. Cell Proteomics
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proteins
  • [Number-of-references] 84
  • [Other-IDs] NLM/ PMC2742436
  •  go-up   go-down


11. Wicker CA, Sahu RP, Kulkarni-Datar K, Srivastava SK, Brown TL: BITC Sensitizes Pancreatic Adenocarcinomas to TRAIL-induced Apoptosis. Cancer Growth Metastasis; 2010 Jan 20;2009(2):45-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pancreatic adenocarcinoma is an aggressive cancer with a greater than 95% mortality rate and short survival after diagnosis.
  • Codon 12 mutations maintain Ras in a constitutively active state leading to continuous cellular proliferation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20559452.001).
  • [Journal-full-title] Cancer growth and metastasis
  • [ISO-abbreviation] Cancer Growth Metastasis
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA106953; United States / NCI NIH HHS / CA / CA106953-03; United States / NCI NIH HHS / CA / CA106953-05; United States / NCI NIH HHS / CA / CA106953-06; United States / NCI NIH HHS / CA / R01 CA129038
  • [Publication-type] JOURNAL ARTICLE
  • [Publication-country] United States
  •  go-up   go-down


12. Provenzano PP, Eliceiri KW, Keely PJ: Shining new light on 3D cell motility and the metastatic process. Trends Cell Biol; 2009 Nov;19(11):638-48
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Understanding tissue architecture and physical and chemical reciprocity between cells and their microenvironment provides vital insights into key events in cancer metastasis, such as cell migration through three-dimensional (3D) extracellular matrices.
  • Yet, many mechanistic details associated with metastasis remain elusive due to the difficulty of studying cancer cells in relevant 3D microenvironments.
  • Optical imaging is also providing novel 'optical biomarkers' with diagnostic potential that are linked to cell-motility pathways associated with metastasis, and these can to help guide new approaches to cancer diagnosis and therapy.
  • Here we present recent advances in one subclass of optical imaging of particular promise for cellular imaging - multiphoton microscopy - that can be used to improve the detection of malignant cells as well as advance our understanding of the cell biology of cancer metastasis.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neoplasia. 2000 Jan-Apr;2(1-2):89-117 [10933071.001]
  • [Cites] Nat Rev Mol Cell Biol. 2001 Jun;2(6):444-56 [11389468.001]
  • [Cites] Nat Med. 2001 Jul;7(7):864-8 [11433354.001]
  • [Cites] Biophys J. 2002 Jan;82(1 Pt 1):493-508 [11751336.001]
  • [Cites] Nature. 2002 Jan 31;415(6871):530-6 [11823860.001]
  • [Cites] Cancer Res. 2002 Feb 1;62(3):682-7 [11830520.001]
  • [Cites] Nat Rev Cancer. 2002 Jan;2(1):11-8 [11902581.001]
  • [Cites] Cancer Res. 2002 Apr 1;62(7):2125-30 [11929834.001]
  • [Cites] Biophys J. 2002 May;82(5):2811-25 [11964266.001]
  • [Cites] J Biomed Opt. 2002 Apr;7(2):205-14 [11966305.001]
  • [Cites] J Microsc. 2002 Apr;206(Pt 1):65-71 [12000564.001]
  • [Cites] Nat Rev Cancer. 2002 Apr;2(4):266-76 [12001988.001]
  • [Cites] J Cell Biol. 2003 Jan 20;160(2):267-77 [12527751.001]
  • [Cites] Methods. 2003 Jan;29(1):97-109 [12543075.001]
  • [Cites] J Struct Biol. 2003 Jan;141(1):53-62 [12576020.001]
  • [Cites] Genes Dev. 2003 Mar 1;17(5):545-80 [12629038.001]
  • [Cites] Science. 2003 Apr 4;300(5616):87-91 [12677058.001]
  • [Cites] Gynecol Oncol. 1997 Jul;66(1):122-32 [9234932.001]
  • [Cites] Biophys J. 1998 Oct;75(4):2015-24 [9746543.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 May 25;96(11):6255-60 [10339574.001]
  • [Cites] Nat Biotechnol. 1999 Aug;17(8):763-7 [10429240.001]
  • [Cites] Science. 1962 Aug 17;137(3529):499-508 [13878016.001]
  • [Cites] Nature. 2004 Nov 18;432(7015):332-7 [15549095.001]
  • [Cites] J Cell Biol. 2004 Nov 22;167(4):769-81 [15557125.001]
  • [Cites] Genes Dev. 2004 Dec 15;18(24):2998-3003 [15601818.001]
  • [Cites] FEBS Lett. 2005 Feb 7;579(4):927-32 [15680976.001]
  • [Cites] Nat Rev Mol Cell Biol. 2005 Jan;6(1):56-68 [15688067.001]
  • [Cites] Biophys J. 2005 Feb;88(2):1224-37 [15531633.001]
  • [Cites] Biophys J. 2005 Feb;88(2):1377-86 [15533922.001]
  • [Cites] Trends Cell Biol. 2005 Mar;15(3):138-45 [15752977.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3738-43 [15701700.001]
  • [Cites] Cancer Res. 2005 Jun 15;65(12):5278-83 [15958574.001]
  • [Cites] BMC Biotechnol. 2005;5:14 [15910685.001]
  • [Cites] Cancer Res. 2005 Jul 1;65(13):5674-82 [15994941.001]
  • [Cites] Adv Biochem Eng Biotechnol. 2005;95:17-56 [16080264.001]
  • [Cites] Adv Biochem Eng Biotechnol. 2005;95:57-75 [16080265.001]
  • [Cites] Adv Biochem Eng Biotechnol. 2005;95:143-75 [16080268.001]
  • [Cites] J Biomed Opt. 2005 Sep-Oct;10(5):051601 [16292949.001]
  • [Cites] Nat Methods. 2005 Dec;2(12):905-9 [16299475.001]
  • [Cites] Nat Methods. 2005 Dec;2(12):932-40 [16299478.001]
  • [Cites] Nat Methods. 2005 Dec;2(12):941-50 [16299479.001]
  • [Cites] Biophys J. 2006 Jan 15;90(2):693-703 [16258040.001]
  • [Cites] Cell. 2006 Jan 27;124(2):263-6 [16439202.001]
  • [Cites] Science. 2006 Apr 14;312(5771):217-24 [16614209.001]
  • [Cites] J Biomed Opt. 2006 Mar-Apr;11(2):020502 [16674173.001]
  • [Cites] J Cell Biol. 2006 May 8;173(3):395-404 [16651380.001]
  • [Cites] Nat Biotechnol. 2006 Jul;24(7):848-51 [16823374.001]
  • [Cites] Oncogene. 2006 Jul 27;25(32):4429-40 [16547501.001]
  • [Cites] Curr Biol. 2006 Aug 8;16(15):1515-23 [16890527.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17137-42 [17088565.001]
  • [Cites] Cell. 2006 Nov 17;127(4):679-95 [17110329.001]
  • [Cites] J Cell Biol. 2007 Jan 1;176(1):35-42 [17190792.001]
  • [Cites] BMC Med. 2006;4(1):38 [17190588.001]
  • [Cites] Biophys J. 2007 Mar 15;92(6):2212-22 [17172303.001]
  • [Cites] Neuro Oncol. 2007 Apr;9(2):103-12 [17325340.001]
  • [Cites] Cancer Res. 2007 Apr 15;67(8):3505-11 [17440055.001]
  • [Cites] J Biomed Opt. 2007 Mar-Apr;12(2):024014 [17477729.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11760-5 [17601776.001]
  • [Cites] Dev Cell. 2008 Dec;15(6):813-28 [19081071.001]
  • [Cites] Exp Cell Res. 2009 Feb 1;315(3):396-410 [19041305.001]
  • [Cites] Med Phys. 2008 Dec;35(12):5758-67 [19175133.001]
  • [Cites] J Clin Invest. 2009 Feb;119(2):252-66 [19147981.001]
  • [Cites] Histol Histopathol. 2009 Apr;24(4):503-10 [19224453.001]
  • [Cites] Clin Exp Metastasis. 2009;26(4):357-70 [18766302.001]
  • [Cites] J Biophotonics. 2008 Mar;1(1):13-23 [19343631.001]
  • [Cites] J Cell Biol. 2009 Apr 6;185(1):11-9 [19332889.001]
  • [Cites] Cell Biochem Biophys. 2009;53(3):145-57 [19259625.001]
  • [Cites] Opt Lett. 2003 Jun 1;28(11):902-4 [12816240.001]
  • [Cites] Cell. 2003 Jul 11;114(1):33-45 [12859896.001]
  • [Cites] Nat Cell Biol. 2003 Aug;5(8):711-9 [12844144.001]
  • [Cites] Opt Lett. 2003 Sep 1;28(17):1552-4 [12956376.001]
  • [Cites] Nat Biotechnol. 2003 Nov;21(11):1369-77 [14595365.001]
  • [Cites] Photochem Photobiol. 2003 Nov;78(5):462-9 [14653577.001]
  • [Cites] Microsc Res Tech. 2004 Jan 1;63(1):18-22 [14677129.001]
  • [Cites] Microsc Res Tech. 2004 Jan 1;63(1):58-66 [14677134.001]
  • [Cites] Nat Rev Cancer. 2003 Dec;3(12):921-30 [14737122.001]
  • [Cites] J Neurophysiol. 2004 Apr;91(4):1908-12 [14668300.001]
  • [Cites] Science. 2004 Apr 30;304(5671):743-6 [15118165.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Oct;5(10):816-26 [15459662.001]
  • [Cites] Cancer Res. 2004 Oct 1;64(19):7022-9 [15466195.001]
  • [Cites] Biosens Bioelectron. 2004 Oct 15;20(3):643-50 [15494250.001]
  • [Cites] Nature. 1985 Oct 24-30;317(6039):748-9 [4058582.001]
  • [Cites] J Cell Biol. 1987 Jul;105(1):41-8 [3112165.001]
  • [Cites] Science. 1990 Apr 6;248(4951):73-6 [2321027.001]
  • [Cites] Anal Biochem. 1992 May 1;202(2):316-30 [1519759.001]
  • [Cites] J Cell Sci. 1993 Jun;105 ( Pt 2):317-31 [8408268.001]
  • [Cites] Ann Biomed Eng. 1994 Jul-Aug;22(4):342-56 [7998680.001]
  • [Cites] J Cell Biochem. 2007 Aug 15;101(6):1338-54 [17471532.001]
  • [Cites] Nat Cell Biol. 2007 Aug;9(8):893-904 [17618273.001]
  • [Cites] Cell. 2007 Sep 7;130(5):784-95 [17803903.001]
  • [Cites] Nat Rev Cancer. 2007 Oct;7(10):737-49 [17891189.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2048-57 [17932352.001]
  • [Cites] Curr Opin Gastroenterol. 2008 Jan;24(1):64-9 [18043235.001]
  • [Cites] Nat Cell Biol. 2007 Dec;9(12):1392-400 [18037882.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19494-9 [18042710.001]
  • [Cites] Clin Gastroenterol Hepatol. 2008 Jan;6(1):95-101 [18065276.001]
  • [Cites] Cell Metab. 2008 Jan;7(1):11-20 [18177721.001]
  • [Cites] Lasers Surg Med. 2008 Apr;40(4):273-81 [18412229.001]
  • [Cites] Biophys J. 2008 Jun;94(11):4504-14 [18281387.001]
  • [Cites] BMC Med. 2008;6:11 [18442412.001]
  • [Cites] Adv Drug Deliv Rev. 2008 Aug 17;60(11):1226-40 [18495291.001]
  • [Cites] Curr Opin Cell Biol. 2008 Oct;20(5):541-50 [18586481.001]
  • [Cites] Oncogene. 2008 Sep 18;27(41):5497-510 [18794884.001]
  • [Cites] Opt Express. 2008 Oct 13;16(21):16431-41 [18852749.001]
  • [Cites] Am J Pathol. 2008 Nov;173(5):1551-65 [18845837.001]
  • [Cites] Trends Cell Biol. 2008 Nov;18(11):560-74 [18848450.001]
  • [Cites] Phys Med Biol. 2008 Dec 7;53(23):6641-52 [18997272.001]
  • [Cites] Biophys J. 2008 Dec;95(11):5374-84 [18775961.001]
  • [Cites] J Biomed Opt. 2008 Sep-Oct;13(5):054050 [19021430.001]
  • [Cites] Dis Model Mech. 2008 Sep-Oct;1(2-3):155-67; discussion 165 [19048079.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11014-9 [12177437.001]
  • [Cites] Nat Rev Cancer. 2002 Sep;2(9):683-93 [12209157.001]
  • [Cites] Curr Opin Neurobiol. 2002 Oct;12(5):593-601 [12367641.001]
  • [Cites] J Microsc. 2002 Oct;208(Pt 1):35-48 [12366596.001]
  • [Cites] Cancer Res. 2002 Nov 1;62(21):6278-88 [12414658.001]
  • [Cites] N Engl J Med. 2002 Dec 19;347(25):1999-2009 [12490681.001]
  • [Cites] Cancer Res. 2002 Dec 15;62(24):7166-9 [12499251.001]
  • [Cites] Nat Genet. 2003 Jan;33(1):49-54 [12469122.001]
  • [Cites] Nat Med. 2003 Jan;9(1):123-8 [12514725.001]
  • [Cites] Science. 2009 May 22;324(5930):1029-33 [19460998.001]
  • [Cites] J Invest Dermatol. 2009 Jul;129(7):1752-8 [19177136.001]
  • [Cites] Anticancer Res. 2009 Jun;29(6):1909-19 [19528447.001]
  • [Cites] Nat Rev Mol Cell Biol. 2009 Jul;10(7):445-57 [19546857.001]
  • [Cites] Nat Methods. 2009 Jul;6(7):511-2 [19525959.001]
  • [Cites] Mol Cell Biol. 2005 Mar;25(5):1680-95 [15713627.001]
  • [Cites] Nat Rev Cancer. 2003 May;3(5):362-74 [12724734.001]
  • [Cites] Nat Med. 2003 Jun;9(6):796-800 [12754503.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7075-80 [12756303.001]
  • (PMID = 19819146.001).
  • [ISSN] 1879-3088
  • [Journal-full-title] Trends in cell biology
  • [ISO-abbreviation] Trends Cell Biol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA076537; United States / NIBIB NIH HHS / EB / EB000184; United States / NCI NIH HHS / CA / R01 CA114462; United States / NIBIB NIH HHS / EB / R21 EB008811; United States / NCI NIH HHS / CA / R21 CA126635; United States / NCI NIH HHS / CA / R01 CA076537-11; United States / NIBIB NIH HHS / EB / EB008811-01A1; United States / NCI NIH HHS / CA / R01 CA142833; United States / NCI NIH HHS / CA / T32CA009681; United States / NCI NIH HHS / CA / R01 CA076537; United States / NCI NIH HHS / CA / CA076537-11; United States / NCI NIH HHS / CA / CA126635-01A1; United States / NIBIB NIH HHS / EB / R01 EB000184; United States / NIBIB NIH HHS / EB / R21 EB008811-01A1; United States / NCI NIH HHS / CA / R29 CA076537; United States / NCI NIH HHS / CA / R21 CA126635-01A1; United States / NCI NIH HHS / CA / T32 CA009681
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 137
  • [Other-IDs] NLM/ NIHMS142781; NLM/ PMC2783928
  •  go-up   go-down


13. Lu W, Singh AK, Khan SA, Senapati D, Yu H, Ray PC: Gold nano-popcorn-based targeted diagnosis, nanotherapy treatment, and in situ monitoring of photothermal therapy response of prostate cancer cells using surface-enhanced Raman spectroscopy. J Am Chem Soc; 2010 Dec 29;132(51):18103-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gold nano-popcorn-based targeted diagnosis, nanotherapy treatment, and in situ monitoring of photothermal therapy response of prostate cancer cells using surface-enhanced Raman spectroscopy.
  • Prostate cancer is the second leading cause of cancer-related death among the American male population, and the cost of treating prostate cancer patients is about $10 billion/year in the United States.
  • Current treatments are mostly ineffective against advanced-stage prostate cancer and are often associated with severe side effects.
  • Our experimental data show that, in the presence of LNCaP human prostate cancer cells, multifunctional popcorn-shaped gold nanoparticles form several hot spots and provide a significant enhancement of the Raman signal intensity by several orders of magnitude (2.5 × 10(9)).
  • As a result, it can recognize human prostate cancer cells at the 50-cells level.
  • Our results indicate that the localized heating that occurs during near-infrared irradiation can cause irreparable cellular damage to the prostate cancer cells.
  • Ultimately, this nanotechnology-driven assay could have enormous potential applications in rapid, on-site targeted sensing, nanotherapy treatment, and monitoring of the nanotherapy process, which are critical to providing effective treatment of cancer.

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GOLD, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anal Chem. 2008 Feb 1;80(3):567-72 [18166023.001]
  • [Cites] ACS Nano. 2010 Nov 23;4(11):6395-403 [20958080.001]
  • [Cites] Nat Rev Cancer. 2008 Apr;8(4):268-78 [18337732.001]
  • [Cites] J Am Chem Soc. 2008 Apr 23;130(16):5523-9 [18373341.001]
  • [Cites] Bioconjug Chem. 2008 Jun;19(6):1309-12 [18512972.001]
  • [Cites] Nat Nanotechnol. 2007 Dec;2(12):751-60 [18654426.001]
  • [Cites] J Proteome Res. 2008 Aug;7(8):3329-38 [18578523.001]
  • [Cites] J Phys Chem B. 2008 Sep 11;112(36):11198-201 [18702540.001]
  • [Cites] J Am Chem Soc. 2008 Nov 12;130(45):14934-5 [18937463.001]
  • [Cites] Mod Pathol. 2008 Dec;21(12):1421-7 [18839017.001]
  • [Cites] Acc Chem Res. 2008 Dec;41(12):1842-51 [19053240.001]
  • [Cites] J Am Chem Soc. 2008 Dec 24;130(51):17214-5 [19053187.001]
  • [Cites] Chemistry. 2009;15(2):342-51 [19035615.001]
  • [Cites] J Am Chem Soc. 2009 Jan 14;131(1):162-9 [19063599.001]
  • [Cites] ACS Nano. 2007 Oct;1(3):208-14 [19206651.001]
  • [Cites] ACS Nano. 2008 Nov 25;2(11):2306-14 [19206397.001]
  • [Cites] ACS Nano. 2009 Jan 27;3(1):80-6 [19206252.001]
  • [Cites] Acc Chem Res. 2008 Dec;41(12):1578-86 [18447366.001]
  • [Cites] Acc Chem Res. 2008 Dec;41(12):1630-40 [18698851.001]
  • [Cites] Nano Lett. 2009 Mar;9(3):1139-46 [19193041.001]
  • [Cites] J Am Chem Soc. 2009 Apr 29;131(16):5728-9 [19351115.001]
  • [Cites] J Am Chem Soc. 2009 Jun 17;131(23):7937-9 [19507897.001]
  • [Cites] Chem Rev. 2009 Jul;109(7):3200-8 [19522504.001]
  • [Cites] Chem Rev. 2009 Jul;109(7):2859-61 [19583428.001]
  • [Cites] ACS Nano. 2009 Sep 22;3(9):2834-40 [19691350.001]
  • [Cites] J Am Chem Soc. 2009 Sep 30;131(38):13639-45 [19772360.001]
  • [Cites] J Am Chem Soc. 2009 Dec 2;131(47):17328-34 [19929020.001]
  • [Cites] J Am Chem Soc. 2010 Feb 17;132(6):1929-38 [20092330.001]
  • [Cites] ACS Nano. 2010 Mar 23;4(3):1739-49 [20155973.001]
  • [Cites] J Am Chem Soc. 2010 Apr 7;132(13):4678-84 [20225865.001]
  • [Cites] Nat Rev Clin Oncol. 2010 May;7(5):266-76 [20351700.001]
  • [Cites] Chem Rev. 2010 May 12;110(5):3196-211 [20170129.001]
  • [Cites] Chem Rev. 2010 May 12;110(5):3146-95 [20225900.001]
  • [Cites] Angew Chem Int Ed Engl. 2010 May 17;49(22):3777-81 [20391446.001]
  • [Cites] Chemistry. 2010 May 17;16(19):5600-6 [20397252.001]
  • [Cites] Nat Rev Cancer. 2005 Mar;5(3):161-71 [15738981.001]
  • [Cites] J Am Chem Soc. 2005 Mar 9;127(9):3115-9 [15740151.001]
  • [Cites] Nat Rev Cancer. 2006 Jan;6(1):63-74 [16372017.001]
  • [Cites] J Am Chem Soc. 2006 Feb 15;128(6):2115-20 [16464114.001]
  • [Cites] J Am Chem Soc. 2006 Feb 22;128(7):2426-33 [16478198.001]
  • [Cites] J Am Chem Soc. 2006 Jul 5;128(26):8378-9 [16802785.001]
  • [Cites] Cancer Lett. 2006 Jul 28;239(1):36-45 [16202512.001]
  • [Cites] J Am Chem Soc. 2007 Nov 28;129(47):14572-3 [17985912.001]
  • [Cites] Nano Lett. 2008 Jan;8(1):214-20 [18052230.001]
  • [Cites] J Am Chem Soc. 2008 Mar 5;130(9):2780-2 [18257576.001]
  • (PMID = 21128627.001).
  • [ISSN] 1520-5126
  • [Journal-full-title] Journal of the American Chemical Society
  • [ISO-abbreviation] J. Am. Chem. Soc.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / GM008047-35; United States / NIGMS NIH HHS / GM / S06 GM008047; United States / NIGMS NIH HHS / GM / S06 GM008047-35; United States / NIGMS NIH HHS / GM / S06GM008047
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 7440-57-5 / Gold
  • [Other-IDs] NLM/ NIHMS256741; NLM/ PMC3074586
  •  go-up   go-down


14. Gromov P, Celis JE, Gromova I, Rank F, Timmermans-Wielenga V, Moreira JM: A single lysis solution for the analysis of tissue samples by different proteomic technologies. Mol Oncol; 2008 Dec;2(4):368-79
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cancer, being a major healthcare concern worldwide, is one of the main targets for the application of emerging proteomic technologies and these tools promise to revolutionize the way cancer will be diagnosed and treated in the near future.
  • This need, compounded by mounting evidence that cellular model systems are unable to fully recapitulate all biological aspects of human dissease, is driving scientists to increasingly use clinically relevant samples for biomarker and target discovery.
  • [MeSH-minor] Electrophoresis, Gel, Two-Dimensional. Humans. Neoplasms / diagnosis. Solutions. Tissue Array Analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] OMICS. 2006 Fall;10(3):411-27 [17069517.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 15;849(1-2):1-31 [17113834.001]
  • [Cites] Cancer Cell. 2003 Apr;3(4):317-25 [12726858.001]
  • [Cites] Nat Biotechnol. 2006 Aug;24(8):971-83 [16900146.001]
  • [Cites] Biotechniques. 2008 Apr;44(5):697-8, 700 [18474047.001]
  • [Cites] Cold Spring Harb Symp Quant Biol. 2005;70:517-24 [16869790.001]
  • [Cites] Mol Cell Proteomics. 2008 Oct;7(10):1887-901 [18676365.001]
  • [Cites] Methods Mol Biol. 2008;424:35-42 [18369850.001]
  • [Cites] Proteomics. 2004 Dec;4(12):3665-85 [15543535.001]
  • [Cites] Nature. 2001 May 17;411(6835):355-65 [11357143.001]
  • [Cites] Mol Cell Proteomics. 2004 Nov;3(11):1102-18 [15358805.001]
  • [Cites] Genome Biol. 2001;2(2):RESEARCH0004 [11182887.001]
  • [Cites] Anal Chem. 2007 Aug 1;79(15):5817-25 [17605470.001]
  • [Cites] Electrophoresis. 1999 Feb;20(2):355-61 [10197443.001]
  • [Cites] Curr Opin Chem Biol. 2008 Feb;12(1):72-7 [18295612.001]
  • [Cites] Mol Oncol. 2008 Dec;2(4):368-79 [19383358.001]
  • [Cites] Anal Chem. 1996 Mar 1;68(5):850-8 [8779443.001]
  • [Cites] Proteomics. 2006 Mar;6(5):1427-36 [16440370.001]
  • [Cites] Clin Lab Sci. 2007 Fall;20(4):245-8 [18069451.001]
  • [Cites] Mol Oncol. 2008 Oct;2(3):213-22 [19383342.001]
  • [Cites] Mol Cell Proteomics. 2008 Oct;7(10):1795-809 [18632593.001]
  • [Cites] Adv Clin Chem. 2007;44:103-42 [17682341.001]
  • [Cites] Clin Chem. 2004 Nov;50(11):1994-2002 [15364885.001]
  • [Cites] Nat Protoc. 2006;1(2):812-23 [17406312.001]
  • [Cites] FEBS J. 2005 Jan;272(1):2-15 [15634327.001]
  • [Cites] Nature. 2007 Dec 13;450(7172):991-1000 [18075578.001]
  • [Cites] Cancer. 2007 Jun 25;111(3):173-84 [17487852.001]
  • [Cites] Mol Oncol. 2007 Sep;1(2):172-80 [19383293.001]
  • [Cites] Proteomics. 2003 Nov;3(11):2085-90 [14595806.001]
  • [Cites] Mol Cell Proteomics. 2003 Jun;2(6):369-77 [12832461.001]
  • [Cites] Mol Cell Proteomics. 2008 Oct;7(10):1780-94 [18664563.001]
  • [Cites] Curr Opin Mol Ther. 2003 Jun;5(3):302-9 [12870441.001]
  • [Cites] Curr Opin Biotechnol. 2008 Feb;19(1):30-5 [18187316.001]
  • [Cites] Mol Oncol. 2007 Dec;1(3):321-49 [19383306.001]
  • [Cites] Mol Oncol. 2007 Jun;1(1):97-119 [19383289.001]
  • [Cites] Nature. 2003 Mar 13;422(6928):198-207 [12634793.001]
  • [Cites] Mol Oncol. 2007 Dec;1(3):313-20 [19383305.001]
  • [Cites] Electrophoresis. 2000 Jun;21(11):2235-42 [10892734.001]
  • [Cites] Cancer Cell. 2003 Jan;3(1):9-15 [12559171.001]
  • [Cites] Mol Oncol. 2007 Jun;1(1):42-54 [19383286.001]
  • [Cites] J Biol Chem. 1975 May 25;250(10):4007-21 [236308.001]
  • [Cites] Mol Oncol. 2008 Aug;2(2):153-60 [19383334.001]
  • [Cites] Mol Oncol. 2007 Sep;1(2):216-25 [19305640.001]
  • [Cites] AJR Am J Roentgenol. 1998 Jul;171(1):59-63 [9648764.001]
  • [Cites] Proteomics. 2008 Dec;8(23-24):5038-52 [19003862.001]
  • [Cites] Methods Mol Biol. 2007;355:111-9 [17093307.001]
  • [Cites] Mol Cell Proteomics. 2005 Apr;4(4):492-522 [15695426.001]
  • [Cites] Mol Cell Proteomics. 2004 Apr;3(4):327-44 [14754989.001]
  • [Cites] Mol Oncol. 2007 Sep;1(2):144-59 [18443658.001]
  • [Cites] Proc Natl Acad Sci U S A. 1980 Mar;77(3):1311-5 [6246487.001]
  • [Cites] Mol Oncol. 2007 Jun;1(1):84-96 [18516279.001]
  • (PMID = 19383358.001).
  • [ISSN] 1878-0261
  • [Journal-full-title] Molecular oncology
  • [ISO-abbreviation] Mol Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Buffers; 0 / Solutions
  •  go-up   go-down


15. Skala MC, Riching KM, Bird DK, Gendron-Fitzpatrick A, Eickhoff J, Eliceiri KW, Keely PJ, Ramanujam N: In vivo multiphoton fluorescence lifetime imaging of protein-bound and free nicotinamide adenine dinucleotide in normal and precancerous epithelia. J Biomed Opt; 2007 Mar-Apr;12(2):024014
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Multiphoton fluorescence lifetime imaging microscopy (FLIM) is a noninvasive, cellular resolution, 3-D functional imaging technique.
  • We investigate the potential for in vivo precancer diagnosis with metabolic imaging via multiphoton FLIM of the endogenous metabolic cofactor nicotinamide adenine dinucleotide (NADH).
  • Inhibition of cellular glycolysis and oxidative phosphorylation in cell monolayers produces an increase and decrease, respectively, in the protein-bound NADH lifetime (p<0.05).

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11715-20 [9751731.001]
  • [Cites] Anticancer Res. 1996 Mar-Apr;16(2):741-9 [8687123.001]
  • [Cites] Anal Biochem. 1995 Jul 1;228(2):312-7 [8572312.001]
  • [Cites] J Oral Pathol Med. 1998 Nov;27(10):470-4 [9831958.001]
  • [Cites] Nat Biotechnol. 1999 Aug;17(8):763-7 [10429240.001]
  • [Cites] Photochem Photobiol Sci. 2005 Jan;4(1):13-22 [15616687.001]
  • [Cites] J Fluoresc. 2004 Sep;14(5):649-54 [15617271.001]
  • [Cites] Cancer Res. 2005 Feb 15;65(4):1180-6 [15735001.001]
  • [Cites] Cancer Res. 2005 Jun 15;65(12):5163-71 [15958560.001]
  • [Cites] J Biol Chem. 2005 Jul 1;280(26):25119-26 [15863500.001]
  • [Cites] J Photochem Photobiol B. 2005 Aug 1;80(2):122-9 [15908228.001]
  • [Cites] Cancer Res. 2005 Oct 1;65(19):8766-73 [16204046.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Jun 16;344(4):1086-93 [16643849.001]
  • [Cites] Cell Death Differ. 2006 Nov;13(11):1900-14 [16514418.001]
  • [Cites] Biophys J. 1998 Oct;75(4):2015-24 [9746543.001]
  • [Cites] Int J Exp Pathol. 1996 Feb;77(1):7-14 [8664146.001]
  • [Cites] N Engl J Med. 2001 May 24;344(21):1603-7 [11372013.001]
  • [Cites] Annu Rev Biomed Eng. 2000;2:399-429 [11701518.001]
  • [Cites] Biophys J. 2002 May;82(5):2811-25 [11964266.001]
  • [Cites] Photochem Photobiol. 2003 May;77(5):550-5 [12812299.001]
  • [Cites] J Biomed Opt. 2003 Jul;8(3):432-9 [12880349.001]
  • [Cites] Nat Biotechnol. 2003 Nov;21(11):1356-60 [14595363.001]
  • [Cites] Lasers Surg Med. 2004;34(1):25-38 [14755422.001]
  • [Cites] Appl Opt. 2004 Sep 20;43(27):5173-82 [15473237.001]
  • [Cites] Biochim Biophys Acta. 1976 Sep 28;446(1):192-205 [974111.001]
  • [Cites] J Biol Chem. 1979 Jun 10;254(11):4764-71 [220260.001]
  • [Cites] Diagn Histopathol. 1981 Oct-Dec;4(4):307-33 [6802623.001]
  • [Cites] Biochemistry. 1989 May 16;28(10):4259-62 [2569889.001]
  • [Cites] Indian J Cancer. 1989 Mar;26(1):21-30 [2777329.001]
  • [Cites] Science. 1990 Apr 6;248(4951):73-6 [2321027.001]
  • [Cites] Zhonghua Zhong Liu Za Zhi. 1990 Mar;12(2):92-4 [2401184.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1271-5 [1741380.001]
  • [Cites] J Cell Sci. 1995 Feb;108 ( Pt 2):595-607 [7769004.001]
  • [Cites] Contraception. 1995 Nov;52(5):317-20 [8585890.001]
  • (PMID = 17477729.001).
  • [ISSN] 1083-3668
  • [Journal-full-title] Journal of biomedical optics
  • [ISO-abbreviation] J Biomed Opt
  • [Language] eng
  • [Grant] United States / NIBIB NIH HHS / EB / R01 EB000184; United States / NIBIB NIH HHS / EB / R01 EB000184-03
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0U46U6E8UK / NAD
  • [Other-IDs] NLM/ NIHMS122928; NLM/ PMC2743958
  •  go-up   go-down


16. Chen WT, Thirumalai D, Shih TT, Chen RC, Tu SY, Lin CI, Yang PC: Dynamic contrast-enhanced folate-receptor-targeted MR imaging using a Gd-loaded PEG-dendrimer-folate conjugate in a mouse xenograft tumor model. Mol Imaging Biol; 2010 Apr;12(2):145-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PROCEDURES: KB cells, FR siRNA knockdown KB cells, and FR negative HT-1080 cells, were incubated with fluorescein-labeled dendrimer and their cellular uptake was observed.
  • RESULTS: Green fluorescence was found in the KB cells in the cellular uptake experiment, but was not seen in other settings.
  • A 17% cut-off point for a 30-min washout percentage can be a useful parameter for the diagnosis of FR-positive tumors.

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • Hazardous Substances Data Bank. FOLIC ACID .
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Magn Reson Imaging. 2000 Mar;11(3):233-43 [10739554.001]
  • [Cites] Magn Reson Med. 1991 Dec;22(2):282-7; discussion 300-3 [1725917.001]
  • [Cites] J Cell Mol Med. 2008 Jan-Feb;12(1):174-86 [18194445.001]
  • [Cites] Zhonghua Yi Xue Za Zhi. 2007 Mar 13;87(10):673-8 [17553304.001]
  • [Cites] MAGMA. 2001 May;12(2-3):104-13 [11390265.001]
  • [Cites] Cancer Res. 2003 Jun 1;63(11):2723-7 [12782573.001]
  • [Cites] Anal Biochem. 2005 Mar 15;338(2):284-93 [15745749.001]
  • [Cites] Radiology. 2001 May;219(2):316-33 [11323453.001]
  • [Cites] J Biol Chem. 1979 Nov 25;254(22):11312-8 [500647.001]
  • [Cites] J Cell Mol Med. 2008 Jan-Feb;12(1):187-8 [18208557.001]
  • [Cites] Curr Opin Mol Ther. 2003 Dec;5(6):625-30 [14755889.001]
  • [Cites] J Magn Reson Imaging. 2002 Mar;15(3):308-14 [11891976.001]
  • [Cites] Int J Nanomedicine. 2008;3(2):201-10 [18686779.001]
  • [Cites] J Biomed Mater Res A. 2008 Oct;87(1):165-75 [18085650.001]
  • [Cites] Ann Surg Oncol. 2008 Mar;15(3):889-99 [18181001.001]
  • [Cites] J Am Chem Soc. 2001 Jun 27;123(25):5908-17 [11414823.001]
  • [Cites] Contrast Media Mol Imaging. 2007 Mar-Apr;2(2):72-81 [17385788.001]
  • [Cites] PLoS One. 2009;4(2):e4343 [19183814.001]
  • [Cites] J Nucl Med. 2006 Jul;47(7):1153-60 [16818950.001]
  • [Cites] Arch Biochem Biophys. 1999 Jun 15;366(2):183-91 [10356282.001]
  • [Cites] Eur J Radiol. 2002 Oct;44(1):52-8 [12350413.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):775-82 [10498396.001]
  • [Cites] Adv Drug Deliv Rev. 2004 Apr 29;56(8):1127-41 [15094211.001]
  • [Cites] J Control Release. 1998 Apr 30;53(1-3):39-48 [9741912.001]
  • [Cites] J Biomed Mater Res A. 2006 Sep 1;78(3):550-7 [16736484.001]
  • [Cites] Drug Discov Today. 2001 Jan 1;6(1):44-51 [11165172.001]
  • [Cites] Blood. 1992 Jun 1;79(11):2807-20 [1586732.001]
  • [Cites] Cancer Res. 1991 Oct 1;51(19):5329-38 [1717147.001]
  • [Cites] Z Med Labortech. 1967;8(6):318-21 [4878525.001]
  • [Cites] J Nucl Med. 1996 Jun;37(6):1003-8 [8683292.001]
  • [Cites] J Biol Chem. 1994 Feb 4;269(5):3198-204 [8106354.001]
  • (PMID = 19636639.001).
  • [ISSN] 1860-2002
  • [Journal-full-title] Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging
  • [ISO-abbreviation] Mol Imaging Biol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carrier Proteins; 0 / Contrast Media; 0 / Dendrimers; 0 / Folate Receptors, GPI-Anchored; 0 / RNA, Small Interfering; 0 / Receptors, Cell Surface; 30IQX730WE / Polyethylene Glycols; 935E97BOY8 / Folic Acid; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


17. Iorio E, Ricci A, Bagnoli M, Pisanu ME, Castellano G, Di Vito M, Venturini E, Glunde K, Bhujwalla ZM, Mezzanzanica D, Canevari S, Podo F: Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res; 2010 Mar 1;70(5):2126-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
  • Altered phosphatidylcholine (PC) metabolism in epithelial ovarian cancer (EOC) could provide choline-based imaging approaches as powerful tools to improve diagnosis and identify new therapeutic targets.
  • PC-plc inhibition by tricyclodecan-9-yl-potassium xanthate (D609) in OVCAR3 and SKOV3 cancer cells induced a 30% to 40% reduction of PCho content and blocked cell proliferation.

  • Genetic Alliance. consumer health - Ovarian cancer.
  • Genetic Alliance. consumer health - Ovarian epithelial cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • SciCrunch. ArrayExpress: Data: Microarray .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] NMR Biomed. 1999 Nov;12(7):413-39 [10654290.001]
  • [Cites] Cancer Res. 2007 Dec 1;67(23):11284-90 [18056454.001]
  • [Cites] Cancer Res. 2001 May 1;61(9):3599-603 [11325827.001]
  • [Cites] Cancer Res. 2002 Apr 1;62(7):1966-70 [11929812.001]
  • [Cites] Oncogene. 2002 Jun 20;21(27):4317-22 [12082619.001]
  • [Cites] Methods Mol Biol. 2003;218:155-76 [12616720.001]
  • [Cites] J Nucl Med. 2003 Jul;44(7):1051-6 [12843219.001]
  • [Cites] J Cell Biochem. 2003 Oct 15;90(3):525-33 [14523987.001]
  • [Cites] J Lipid Res. 2003 Oct;44(10):1963-75 [12837850.001]
  • [Cites] Prog Lipid Res. 2004 May;43(3):266-81 [15003397.001]
  • [Cites] Cancer Res. 2004 Jun 15;64(12):4270-6 [15205341.001]
  • [Cites] Radiology. 2004 Aug;232(2):599-605 [15286325.001]
  • [Cites] Clin Cancer Res. 2004 Aug 1;10(15):5202-14 [15297424.001]
  • [Cites] Exp Cell Res. 2004 Oct 1;299(2):370-82 [15350536.001]
  • [Cites] Cancer Res. 2004 Sep 15;64(18):6732-9 [15374991.001]
  • [Cites] Nucl Med Biol. 2004 Oct;31(7):859-65 [15464387.001]
  • [Cites] NMR Biomed. 1992 Sep-Oct;5(5):303-24 [1333263.001]
  • [Cites] EMBO J. 1995 Dec 1;14(23):5859-68 [8846779.001]
  • [Cites] Anticancer Res. 1996 May-Jun;16(3B):1399-412 [8694508.001]
  • [Cites] J Biol Chem. 1997 Apr 25;272(17):11011-6 [9110992.001]
  • [Cites] Anal Biochem. 1997 Aug 15;251(1):45-9 [9300081.001]
  • [Cites] Anal Biochem. 1997 Oct 1;252(1):1-9 [9324933.001]
  • [Cites] Int J Cancer. 1997 Sep 26;73(1):143-50 [9334822.001]
  • [Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11026-31 [18667693.001]
  • [Cites] Cancer Res. 2008 Aug 15;68(16):6541-9 [18701477.001]
  • [Cites] NMR Biomed. 2009 Jan;22(1):114-27 [19016452.001]
  • [Cites] Arch Biochem Biophys. 2009 Mar 1;483(1):90-8 [19135976.001]
  • [Cites] Cancer Res. 2009 Apr 15;69(8):3464-71 [19336572.001]
  • [Cites] Neoplasia. 2009 May;11(5):477-84 [19412432.001]
  • [Cites] Oncogene. 2009 Jul 2;28(26):2425-35 [19448670.001]
  • [Cites] Cancer Res. 1999 Jan 1;59(1):80-4 [9892190.001]
  • [Cites] Mol Imaging. 2004 Oct;3(4):319-23 [15802048.001]
  • [Cites] Annu Rev Biomed Eng. 2005;7:287-326 [16004573.001]
  • [Cites] Cancer Res. 2005 Oct 15;65(20):9369-76 [16230400.001]
  • [Cites] Cancer Res. 2005 Dec 1;65(23):11034-43 [16322253.001]
  • [Cites] Cancer Res. 2006 Jan 1;66(1):427-34 [16397258.001]
  • [Cites] Biochem J. 2006 Feb 15;394(Pt 1):299-308 [16255717.001]
  • [Cites] Radiology. 2006 Mar;238(3):958-69 [16424238.001]
  • [Cites] Curr Med Chem. 2006;13(10):1169-86 [16719778.001]
  • [Cites] Mol Pharm. 2006 Sep-Oct;3(5):496-506 [17009848.001]
  • [Cites] Pharmacogenomics. 2006 Oct;7(7):1109-23 [17054420.001]
  • [Cites] Mol Imaging. 2006 Oct-Dec;5(4):498-509 [17150162.001]
  • [Cites] Int J Cancer. 2007 Apr 15;120(8):1721-30 [17236204.001]
  • [Cites] J Cell Biochem. 2007 Oct 1;102(2):421-8 [17393430.001]
  • [Cites] Lancet Oncol. 2007 Oct;8(10):889-97 [17851129.001]
  • [Cites] Clin Cancer Res. 2000 Jun;6(6):2482-91 [10873103.001]
  • (PMID = 20179205.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA103175-05; United States / NCI NIH HHS / CA / P50 CA103175; United States / NCI NIH HHS / CA / P50 CA103175-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Membrane Transport Proteins; 0 / Phosphatidylcholines; 0 / choline transporter; EC 2.7.1.32 / Choline Kinase; EC 3.1.4.- / Phosphoric Diester Hydrolases; EC 3.1.4.- / Type C Phospholipases; EC 3.1.4.2 / glycerophosphocholine phosphodiesterase; EC 3.1.4.3 / phosphatidylcholine-specific phospholipase C; EC 3.1.4.4 / Phospholipase D
  • [Other-IDs] NLM/ NIHMS167358; NLM/ PMC2831129
  •  go-up   go-down


18. Laiakis EC, Morris GA, Fornace AJ, Howie SR: Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PLoS One; 2010 Sep 09;5(9)
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The objective of this pilot study is to apply metabolomic analysis to childhood pneumonia to explore its potential to improve pneumonia diagnosis in a high-burden setting.

  • MedlinePlus Health Information. consumer health - Pneumonia.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Free Radic Biol Med. 1993 Jun;14(6):615-31 [8325534.001]
  • [Cites] Nature. 2009 Feb 12;457(7231):910-4 [19212411.001]
  • [Cites] J Surg Res. 1997 Jul 15;71(1):61-6 [9271279.001]
  • [Cites] Nat Med. 1999 Oct;5(10):1199-202 [10502826.001]
  • [Cites] Expert Rev Proteomics. 2007 Jun;4(3):389-400 [17552923.001]
  • [Cites] J Proteome Res. 2009 Dec;8(12):5550-8 [19817432.001]
  • [Cites] J Proteome Res. 2009 Jun;8(6):3029-36 [19368345.001]
  • [Cites] Pediatr Infect Dis J. 1994 Nov;13(11):975-82 [7845751.001]
  • [Cites] Pediatr Pulmonol. 2003 Dec;36(6):469-74 [14618637.001]
  • [Cites] Bull World Health Organ. 2008 May;86(5):322-2A [18545727.001]
  • [Cites] Shock. 2010 Mar;33(3):258-62 [19543152.001]
  • [Cites] Curr Pharm Des. 2009;15(13):1415-27 [19442166.001]
  • [Cites] Eur J Surg. 1995 Mar;161(3):147-55 [7599292.001]
  • [Cites] Trop Med Int Health. 1997 Jan;2(1):28-37 [9018300.001]
  • [Cites] PLoS One. 2008;3(3):e1773 [18335047.001]
  • [Cites] Radiat Res. 2009 Aug;172(2):198-212 [19630524.001]
  • [Cites] PLoS One. 2009;4(4):e5328 [19390697.001]
  • [Cites] Anal Chem. 2008 Feb 1;80(3):665-74 [18173289.001]
  • [Cites] PLoS Med. 2008 Apr 22;5(4):e86 [19226734.001]
  • [Cites] Methods Mol Biol. 2009;520:273-95 [19381962.001]
  • [Cites] Crit Care Med. 2009 Sep;37(9):2506-11 [19602974.001]
  • [Cites] Acta Paediatr. 1993 Oct;82(10):849-52 [8241644.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L152-61 [18441091.001]
  • [Cites] PLoS One. 2009;4(7):e6386 [19636438.001]
  • [Cites] BMC Ear Nose Throat Disord. 2006 May 10;6:10 [16686940.001]
  • [Cites] Anal Chem. 2008 Oct 1;80(19):7562-70 [18767870.001]
  • [Cites] Radiat Res. 2009 Jul;172(1):42-57 [19580506.001]
  • [Cites] World Health Stat Q. 1992;45(2-3):180-91 [1462653.001]
  • [Cites] J Proteome Res. 2009 Dec;8(12):5409-10 [19899780.001]
  • [Cites] Front Biosci. 2006;11:1977-86 [16368572.001]
  • [Cites] Crit Care Med. 2009 May;37(5):1655-62 [19325487.001]
  • [Cites] J Cell Mol Med. 2009 Jun;13(6):1125-35 [19602041.001]
  • [Cites] Blood. 2001 Feb 15;97(4):937-45 [11159520.001]
  • [Cites] J Proteome Res. 2007 Feb;6(2):498-505 [17269706.001]
  • [Cites] Lancet. 2006 Nov 11;368(9548):1646 [17098074.001]
  • [Cites] J Proteome Res. 2009 May;8(5):2361-75 [19275195.001]
  • [Cites] J Hypertens. 2008 Nov;26(11):2085-92 [18854744.001]
  • [Cites] Infect Immun. 2008 Mar;76(3):1230-8 [18174343.001]
  • [Cites] Nat Rev Microbiol. 2007 Jun;5(6):464-70 [17487146.001]
  • [Cites] Lancet. 2007 Jul 21;370(9583):285-9 [17658399.001]
  • [Cites] J Exp Med. 2006 Dec 25;203(13):2907-17 [17158962.001]
  • [Cites] Mass Spectrom Rev. 2010 May-Jun;29(3):503-21 [19890938.001]
  • [Cites] Ann Trop Paediatr. 1987 Jun;7(2):91-9 [2441658.001]
  • [Cites] Curr Pharm Des. 2009;15(13):1537-45 [19442171.001]
  • [Cites] Immunol Lett. 2003 Oct 31;89(2-3):229-36 [14556983.001]
  • [Cites] Hunan Yi Ke Da Xue Xue Bao. 1999;24(3):287-9 [12016810.001]
  • [Cites] Radiat Res. 2008 Jul;170(1):1-14 [18582157.001]
  • [Cites] Lancet. 2003 Jun 28;361(9376):2226-34 [12842379.001]
  • [Cites] Bull World Health Organ. 2008 May;86(5):408-16 [18545744.001]
  • [Cites] PLoS Pathog. 2009 Feb;5(2):e1000305 [19229321.001]
  • [Cites] Am J Respir Crit Care Med. 2009 May 15;179(10):903-13 [19218193.001]
  • (PMID = 20844590.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / MC/ U190088478; United Kingdom / Medical Research Council / / MC/ UP/ A900/ 1124; United Kingdom / Medical Research Council / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers
  • [Other-IDs] NLM/ PMC2936566
  •  go-up   go-down


19. Fang Y: PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS. Expert Opin Drug Discov; 2010 Dec;5(12):1237-1248
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS.
  • IMPORTANCE OF THE FIELD: Cancer is a collection of diseases that arise from the progressive accumulation of genetic alterations in somatic cells.
  • It is acknowledged that it is proteins, rather than genes, to fulfill most cellular functions; and signaling proteins largely operate through a large and complex network.
  • To this end, cancer is mostly a pathway dysregulated disease - a small number of core pathways are dominate in aberrant cell growth leading to cancer.
  • Thus, understanding the functional consequences of dysregulated and/or mutant signaling proteins in the context of native signaling networks is the frontier in cancer research.
  • AREAS COVERED IN THIS REVIEW: This article reviews why resonant waveguide grating (RWG) biosensor cellular assays are considered to be integrative in nature, and how RWG biosensor can be used for mining the surface markers of cancer cells, and discovering core pathway(s) of cancer receptor signaling.
  • WHAT THE READER WILL GAIN: The reader will gain an overview of cancer biology from pathway perspective, and have a glimpse of potential implications of integrative cellular assays, as promised by RWG biosensor, in cancer research and diagnosis.
  • TAKE HOME MESSAGE: Successful approaches for developing next-generation anti-cancer therapies and diagnostic protocols should take into account that the dysregulation of oncogenic pathways is central to tumorigenesis.
  • The biosensor cellular assays offer unprecedented advantage in characterizing cancer biology.
  • However, significant challenges are also presented in deconvoluting and validating cellular mechanisms identified in cancer receptor signaling using these assays.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21113317.001).
  • [ISSN] 1746-045X
  • [Journal-full-title] Expert opinion on drug discovery
  • [ISO-abbreviation] Expert Opin Drug Discov
  • [Language] ENG
  • [Grant] United States / NIMH NIH HHS / MH / MH084691-01; United States / NIMH NIH HHS / MH / U54 MH084691
  • [Publication-type] JOURNAL ARTICLE
  • [Publication-country] England
  •  go-up   go-down


20. Jaffer FA, Libby P, Weissleder R: Optical and multimodality molecular imaging: insights into atherosclerosis. Arterioscler Thromb Vasc Biol; 2009 Jul;29(7):1017-24
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Imaging approaches that visualize molecular targets rather than anatomic structures aim to illuminate vital molecular and cellular aspects of atherosclerosis biology in vivo.

  • MedlinePlus Health Information. consumer health - Atherosclerosis.
  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Circulation. 2002 Jun 11;105(23):2766-71 [12057992.001]
  • [Cites] Nature. 2008 Feb 21;451(7181):953-7 [18288186.001]
  • [Cites] Nat Med. 2003 Jan;9(1):123-8 [12514725.001]
  • [Cites] Circulation. 2003 May 20;107(19):2453-8 [12719280.001]
  • [Cites] N Engl J Med. 2003 Jun 19;348(25):2491-9 [12815134.001]
  • [Cites] Circulation. 2003 Oct 7;108(14):1664-72 [14530185.001]
  • [Cites] Nat Med. 2008 Apr;14(4):459-65 [18376410.001]
  • [Cites] Bioconjug Chem. 2008 May;19(5):1001-8 [18396900.001]
  • [Cites] J Nucl Cardiol. 2008 May-Jun;15(3):417-28 [18513648.001]
  • [Cites] NMR Biomed. 2008 Jun;21(5):453-63 [17918777.001]
  • [Cites] Nat Med. 2001 Jun;7(6):743-8 [11385514.001]
  • [Cites] Circulation. 2003 Nov 4;108(18):2270-4 [14557370.001]
  • [Cites] Cancer Res. 2003 Dec 1;63(23):8122-5 [14678964.001]
  • [Cites] Stroke. 2004 Jul;35(7):1631-5 [15166394.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12294-9 [15304657.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12634-9 [15304647.001]
  • [Cites] J Am Coll Cardiol. 1986 Mar;7(3):472-8 [3950227.001]
  • [Cites] AJR Am J Roentgenol. 1998 Jul;171(1):137-43 [9648777.001]
  • [Cites] Circulation. 1999 Apr 6;99(13):1726-32 [10190883.001]
  • [Cites] Nat Biotechnol. 1999 Apr;17(4):375-8 [10207887.001]
  • [Cites] Circ Res. 2004 Dec 10;95(12):1225-33 [15539632.001]
  • [Cites] Circ Res. 2005 Feb 18;96(3):327-36 [15653572.001]
  • [Cites] Nat Biotechnol. 2005 Mar;23(3):313-20 [15765087.001]
  • [Cites] Magn Reson Med. 2005 May;53(5):999-1005 [15844142.001]
  • [Cites] NeuroRx. 2005 Apr;2(2):215-25 [15897946.001]
  • [Cites] Magn Reson Med. 2005 Sep;54(3):718-24 [16086367.001]
  • [Cites] Magn Reson Med. 2006 Jan;55(1):126-35 [16342148.001]
  • [Cites] Cardiovasc Res. 2006 Feb 15;69(3):625-35 [16376322.001]
  • [Cites] J Control Release. 2008 Jun 24;128(3):217-23 [18457896.001]
  • [Cites] Stroke. 2008 Jul;39(7):2144-7 [18451355.001]
  • [Cites] Adv Drug Deliv Rev. 2008 Aug 17;60(11):1241-51 [18508157.001]
  • [Cites] J Am Coll Cardiol. 2008 Aug 5;52(6):483-91 [18672170.001]
  • [Cites] Mol Imaging. 2008 Mar-Apr;7(2):68-76 [18706289.001]
  • [Cites] Circulation. 2008 Oct 28;118(18):1802-9 [18852366.001]
  • [Cites] J Nucl Med. 2008 Nov;49(11):1845-51 [18927332.001]
  • [Cites] Anal Biochem. 2009 Jan 15;384(2):254-62 [18938129.001]
  • [Cites] FASEB J. 2008 Dec;22(12):4179-89 [18697838.001]
  • [Cites] JACC Cardiovasc Imaging. 2008 Sep;1(5):624-34 [19356492.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):992-1000 [19057023.001]
  • [Cites] J Biomed Opt. 2006 Mar-Apr;11(2):021009 [16674184.001]
  • [Cites] Bioconjug Chem. 2006 May-Jun;17(3):662-9 [16704203.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1601-6 [16627809.001]
  • [Cites] Nat Rev Immunol. 2006 Jul;6(7):508-19 [16778830.001]
  • [Cites] Circulation. 2006 Jul 4;114(1):55-62 [16801460.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2103-9 [16825592.001]
  • [Cites] Stroke. 2006 Sep;37(9):2266-70 [16917091.001]
  • [Cites] Mol Imaging. 2006 Apr-Jun;5(2):85-92 [16954022.001]
  • [Cites] Circulation. 2006 Oct 3;114(14):1504-11 [17000904.001]
  • [Cites] Small. 2006 Aug;2(8-9):983-7 [17193154.001]
  • [Cites] Nat Med. 2007 Mar;13(3):372-7 [17322898.001]
  • [Cites] Circulation. 2007 May 1;115(17):2292-8 [17420353.001]
  • [Cites] Nat Clin Pract Cardiovasc Med. 2007 Sep;4(9):491-502 [17712362.001]
  • [Cites] Circulation. 2007 Aug 28;116(9):1052-61 [17724271.001]
  • [Cites] Nat Chem Biol. 2007 Oct;3(10):668-77 [17828252.001]
  • [Cites] Chem Biol. 2007 Nov;14(11):1221-31 [18022561.001]
  • [Cites] Circulation. 2007 Dec 11;116(24):2841-50 [18040026.001]
  • [Cites] Photochem Photobiol Sci. 2008 Jan;7(1):33-9 [18167594.001]
  • [Cites] Circulation. 2008 Jan 22;117(3):379-87 [18158358.001]
  • [Cites] Nat Med. 2002 Jul;8(7):757-60 [12091907.001]
  • (PMID = 19359659.001).
  • [ISSN] 1524-4636
  • [Journal-full-title] Arteriosclerosis, thrombosis, and vascular biology
  • [ISO-abbreviation] Arterioscler. Thromb. Vasc. Biol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R24 CA092782; United States / NHLBI NIH HHS / HL / U01 HL080731; United States / NHLBI NIH HHS / HL / UO1-HL080731; United States / NHLBI NIH HHS / HL / R01-HL078641; United States / NHLBI NIH HHS / HL / R01 HL078641; United States / NCI NIH HHS / CA / R24-CA92782; United States / Howard Hughes Medical Institute / / ; United States / NHLBI NIH HHS / HL / HL078641-04; United States / NCI NIH HHS / CA / R24 CA092782-05; United States / NHLBI NIH HHS / HL / R01 HL078641-04; United States / NHLBI NIH HHS / HL / U01 HL080731-04
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Photosensitizing Agents
  • [Number-of-references] 61
  • [Other-IDs] NLM/ NIHMS130290; NLM/ PMC2733228
  •  go-up   go-down


21. Ozben B, Dursun E, Monari E, Cuoghi A, Bergamini S, Tomasi A, Ozben T: Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment. Mol Cell Biochem; 2009 Nov;331(1-2):9-17
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There is a great need for the identification of biomarkers for the early diagnosis of atherosclerosis and the agents to prevent its progression.

  • MedlinePlus Health Information. consumer health - Atherosclerosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Cardiol. 2008 Mar 28;125(1):4-10 [17467819.001]
  • [Cites] Clin Chem. 2002 Aug;48(8):1296-304 [12142387.001]
  • [Cites] Anal Biochem. 2003 Oct 1;321(1):116-24 [12963062.001]
  • [Cites] Eur Heart J. 2005 Feb;26(3):215-25 [15642700.001]
  • [Cites] Acta Histochem. 2006;108(6):415-24 [17007910.001]
  • [Cites] Mol Med. 2001 Jun;7(6):383-92 [11474131.001]
  • [Cites] Kidney Int Suppl. 2005 Dec;(99):S103-7 [16336560.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Apr 5;292(3):587-92 [11922607.001]
  • [Cites] Clin Exp Pharmacol Physiol. 2006 Apr;33(4):305-9 [16620292.001]
  • [Cites] BMC Bioinformatics. 2005 Jul 15;6 Suppl 2:S5 [16026602.001]
  • [Cites] J Nutr. 2005 Apr;135(4):722-8 [15795424.001]
  • [Cites] J Agric Food Chem. 2008 Feb 13;56(3):1148-57 [18173244.001]
  • [Cites] Cardiovasc Res. 2001 Feb 1;49(2):430-9 [11164853.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2135-42 [16123314.001]
  • [Cites] Nutr Metab Cardiovasc Dis. 2000 Aug;10(4):209-15 [11079259.001]
  • [Cites] Prostate Cancer Prostatic Dis. 1999 Dec;2(5/6):264-276 [12497173.001]
  • [Cites] Proteomics. 2004 Dec;4(12):3751-61 [15540213.001]
  • [Cites] J Agric Food Chem. 2006 Mar 8;54(5):1928-35 [16506855.001]
  • [Cites] J Cardiovasc Pharmacol. 2004 Jan;43(1):148-53 [14668581.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2003 Apr 1;23 (4):615-21 [12692005.001]
  • [Cites] Atherosclerosis. 2005 Nov;183(1):25-33 [16216589.001]
  • [Cites] Cardiovasc Res. 2006 Oct 1;72(1):18-29 [16814757.001]
  • [Cites] Physiol Genomics. 2006 Apr 13;25(2):194-202 [16418319.001]
  • [Cites] Circulation. 2001 Jul 31;104(5):511-4 [11479245.001]
  • [Cites] Nitric Oxide. 2002 Sep;7(2):83-90 [12223177.001]
  • [Cites] J Proteome Res. 2005 Jul-Aug;4(4):1181-91 [16083268.001]
  • [Cites] J Am Coll Cardiol. 2003 Nov 19;42(10):1838-44 [14642697.001]
  • [Cites] Trends Cardiovasc Med. 2007 Feb;17(2):43-8 [17292045.001]
  • [Cites] Expert Opin Pharmacother. 2004 Apr;5(4):893-9 [15102571.001]
  • [Cites] Circ Res. 2001 Apr 27;88(8):763-73 [11325867.001]
  • [Cites] Acta Histochem. 2007;109(1):45-51 [17046051.001]
  • (PMID = 19421716.001).
  • [ISSN] 1573-4919
  • [Journal-full-title] Molecular and cellular biochemistry
  • [ISO-abbreviation] Mol. Cell. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Benzopyrans; 0 / Ethanolamines; 030Y90569U / Nebivolol
  •  go-up   go-down


22. Boustany NN, Boppart SA, Backman V: Microscopic imaging and spectroscopy with scattered light. Annu Rev Biomed Eng; 2010 Aug 15;12:285-314
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Optical contrast based on elastic scattering interactions between light and matter can be used to probe cellular structure, cellular dynamics, and image tissue architecture.
  • Cellular and tissue data enabled by current advances in optical scatter spectroscopy and imaging stand to impact a variety of biomedical applications including clinical tissue diagnosis, in vivo imaging, drug discovery, and basic cell biology.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biomed Opt. 2005 Nov-Dec;10(6):060503 [16409066.001]
  • [Cites] Int J Cancer. 2008 Jan 15;122(2):363-71 [17935126.001]
  • [Cites] Biophys J. 2008 Jan 1;94(1):286-97 [17766334.001]
  • [Cites] Opt Lett. 2008 Apr 1;33(7):714-6 [18382527.001]
  • [Cites] J Biomed Opt. 2008 Mar-Apr;13(2):024015 [18465978.001]
  • [Cites] Opt Express. 2008 Feb 18;16(4):2555-69 [18542337.001]
  • [Cites] Opt Express. 2008 Jul 21;16(15):11525-39 [18648474.001]
  • [Cites] Opt Lett. 2008 Oct 1;33(19):2209-11 [18830354.001]
  • [Cites] Nature. 1948 May 15;161(4098):777 [18860291.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20118-23 [19073935.001]
  • [Cites] J Opt Soc Am A Opt Image Sci Vis. 2007 Apr;24(4):1034-41 [17361289.001]
  • [Cites] Opt Lett. 2007 Mar 1;32(5):503-5 [17392902.001]
  • [Cites] Microsc Res Tech. 2007 Apr;70(4):361-71 [17262787.001]
  • [Cites] Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Mar;75(3 Pt 2):037601 [17500837.001]
  • [Cites] J Biomed Opt. 2007 May-Jun;12(3):030503 [17614706.001]
  • [Cites] Opt Lett. 2007 Aug 15;32(16):2348-50 [17700781.001]
  • [Cites] Nat Methods. 2007 Sep;4(9):717-9 [17694065.001]
  • [Cites] J Opt Soc Am A Opt Image Sci Vis. 2007 Sep;24(9):2527-42 [17767224.001]
  • [Cites] Opt Lett. 2007 Sep 1;32(17):2517-9 [17767290.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17255-60 [17956980.001]
  • [Cites] J Biol Chem. 2002 Nov 8;277(45):42802-7 [12207028.001]
  • [Cites] J Biomed Opt. 2003 Jan;8(1):7-16 [12542374.001]
  • [Cites] Cancer Res. 2003 May 1;63(9):1999-2004 [12727808.001]
  • [Cites] Opt Lett. 2003 Jul 15;28(14):1218-20 [12885026.001]
  • [Cites] Opt Lett. 2003 Sep 1;28(17):1546-8 [12956374.001]
  • [Cites] Opt Lett. 2003 Nov 1;28(21):2067-9 [14587817.001]
  • [Cites] Nat Biotechnol. 2003 Nov;21(11):1361-7 [14595364.001]
  • [Cites] Technol Cancer Res Treat. 2004 Feb;3(1):33-40 [14750891.001]
  • [Cites] Opt Lett. 2004 Jun 1;29(11):1239-41 [15209259.001]
  • [Cites] Opt Lett. 2004 Jun 15;29(12):1393-5 [15233446.001]
  • [Cites] Opt Lett. 2004 Jul 15;29(14):1647-9 [15309847.001]
  • [Cites] Opt Lett. 2004 Aug 15;29(16):1906-8 [15357355.001]
  • [Cites] Opt Lett. 2004 Sep 1;29(17):2028-30 [15455769.001]
  • [Cites] J Cell Biol. 1966 Aug;30(2):269-97 [5968972.001]
  • [Cites] J Histochem Cytochem. 1974 Jul;22(7):598-604 [4137305.001]
  • [Cites] Cancer Res. 2009 Feb 1;69(3):1199-204 [19141640.001]
  • [Cites] Biosens Bioelectron. 2009 Feb 15;24(6):1685-92 [18945607.001]
  • [Cites] J Opt Soc Am A Opt Image Sci Vis. 2009 Feb;26(2):376-86 [19183692.001]
  • [Cites] Dis Markers. 2008;25(6):291-301 [19208947.001]
  • [Cites] Opt Lett. 2009 Mar 1;34(5):653-5 [19252582.001]
  • [Cites] J Biomed Opt. 2009 Jan-Feb;14(1):014004 [19256692.001]
  • [Cites] Appl Opt. 2009 Apr 1;48(10):D109-20 [19340098.001]
  • [Cites] Appl Opt. 2009 Apr 1;48(10):D20-5 [19340110.001]
  • [Cites] Appl Opt. 2009 Apr 1;48(10):D45-51 [19340123.001]
  • [Cites] J Biomed Opt. 2009 Mar-Apr;14(2):024033 [19405762.001]
  • [Cites] Cancer Res. 2009 May 15;69(10):4476-83 [19417131.001]
  • [Cites] Opt Lett. 2009 Jun 15;34(12):1891-3 [19529738.001]
  • [Cites] J Biomed Opt. 2009 May-Jun;14(3):034034 [19566327.001]
  • [Cites] Cancer Res. 2009 Jul 1;69(13):5357-63 [19549915.001]
  • [Cites] Opt Express. 2009 Jul 6;17(14):12001-12 [19582115.001]
  • [Cites] Opt Express. 2009 Aug 3;17(16):13447-57 [19654752.001]
  • [Cites] Opt Lett. 2009 Sep 1;34(17):2679-81 [19724530.001]
  • [Cites] J Biomed Opt. 2009 Jul-Aug;14(4):044022 [19725733.001]
  • [Cites] Anal Quant Cytol Histol. 2009 Aug;31(4):197-207 [19736867.001]
  • [Cites] Opt Lett. 2009 Oct 15;34(20):3235-7 [19838284.001]
  • [Cites] Opt Express. 2009 Oct 26;17(22):20401-14 [19997269.001]
  • [Cites] Opt Express. 2009 Dec 7;17(25):23114-22 [20052238.001]
  • [Cites] Gastroenterology. 2001 Jun;120(7):1620-9 [11375944.001]
  • [Cites] Biophys J. 2001 Nov;81(5):2964-71 [11606306.001]
  • [Cites] Acad Radiol. 2002 May;9 Suppl 1:S52-5 [12019894.001]
  • [Cites] Biophys J. 2002 Sep;83(3):1691-700 [12202392.001]
  • [Cites] Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):961-8 [16467111.001]
  • [Cites] Opt Lett. 2006 Mar 15;31(6):775-7 [16544620.001]
  • [Cites] Opt Lett. 2006 Apr 15;31(8):1079-81 [16625909.001]
  • [Cites] J Opt Soc Am A Opt Image Sci Vis. 2006 May;23(5):1027-37 [16642179.001]
  • [Cites] Opt Lett. 2006 May 15;31(10):1459-61 [16642138.001]
  • [Cites] J Biomed Opt. 2006 Jul-Aug;11(4):041125 [16965153.001]
  • [Cites] J Opt Soc Am A Opt Image Sci Vis. 2006 Oct;23(10):2433-9 [16985528.001]
  • [Cites] Nature. 2006 Oct 12;443(7112):658-62 [17035996.001]
  • [Cites] Opt Lett. 2006 Dec 15;31(24):3585-7 [17130911.001]
  • [Cites] J Biomed Opt. 2006 Nov-Dec;11(6):064007 [17212530.001]
  • [Cites] Opt Lett. 2007 Mar 15;32(6):626-8 [17308582.001]
  • [Cites] J Biomed Opt. 2007 Jan-Feb;12(1):014010 [17343485.001]
  • [Cites] Appl Opt. 2007 Apr 1;46(10):1760-9 [17356619.001]
  • [Cites] Arch Biochem Biophys. 1979 Jul;195(2):453-9 [383019.001]
  • [Cites] Scan Electron Microsc. 1981;(Pt 2):9-31 [7034182.001]
  • [Cites] J Opt Soc Am A. 1985 Jul;2(7):1160-9 [4020513.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9382-6 [1946349.001]
  • [Cites] Science. 1991 Nov 22;254(5035):1178-81 [1957169.001]
  • [Cites] J Biol Chem. 1992 May 5;267(13):8834-9 [1374381.001]
  • [Cites] J Biol Chem. 1994 Jun 17;269(24):16638-42 [7515881.001]
  • [Cites] J Exp Med. 1996 Apr 1;183(4):1533-44 [8666911.001]
  • [Cites] Nature. 1996 Jun 27;381(6585):811-2 [8657288.001]
  • [Cites] Cell. 1997 Nov 28;91(5):627-37 [9393856.001]
  • [Cites] Biophys J. 1998 Jan;74(1):645-54 [9449366.001]
  • [Cites] Mol Biol Cell. 1999 Jan;10(1):197-210 [9880336.001]
  • [Cites] J Invest Dermatol. 1999 Sep;113(3):293-303 [10469324.001]
  • [Cites] Nature. 1954 May 1;173(4409):821-2 [13165653.001]
  • [Cites] Biophys J. 2004 Dec;87(6):4163-71 [15377529.001]
  • [Cites] Appl Opt. 2005 Jan 20;44(3):366-77 [15717826.001]
  • [Cites] Nano Lett. 2005 Mar;5(3):473-7 [15755097.001]
  • [Cites] Opt Lett. 2005 Apr 1;30(7):741-3 [15832924.001]
  • [Cites] Opt Lett. 2005 Apr 1;30(7):747-9 [15832926.001]
  • [Cites] J Biomed Opt. 2005 Mar-Apr;10(2):024005 [15910079.001]
  • [Cites] Photochem Photobiol. 2005 Mar-Apr;81(2):215-37 [15588122.001]
  • [Cites] Biophys J. 2005 Jun;88(6):4170-7 [15805175.001]
  • [Cites] J Biomed Opt. 2005 Jul-Aug;10(4):41208 [16178632.001]
  • [Cites] Opt Lett. 2005 Sep 15;30(18):2445-7 [16196347.001]
  • [Cites] Biomed Microdevices. 2005 Dec;7(4):331-9 [16404511.001]
  • (PMID = 20617940.001).
  • [ISSN] 1545-4274
  • [Journal-full-title] Annual review of biomedical engineering
  • [ISO-abbreviation] Annu Rev Biomed Eng
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA128641; United States / NCI NIH HHS / CA / R01 CA128641; United States / NIBIB NIH HHS / EB / R01 EB003682; United States / NIBIB NIH HHS / EB / R01 EB003682; United States / NIBIB NIH HHS / EB / R01 EB005221; United States / NIBIB NIH HHS / EB / R01 EB005221; United States / NIBIB NIH HHS / EB / R21 EB005321; United States / NIBIB NIH HHS / EB / R21 EB005321
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS376319; NLM/ PMC3357207
  •  go-up   go-down


23. Czaja AJ: Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly. Drugs Aging; 2008;25(3):219-39
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.
  • Diagnostic criteria have been codified, and a scoring system allows systemic assessment of all clinical features and quantifies the strength of the diagnosis.
  • Treatment failure is uncommon in the elderly, and age-related changes in the cellular immune response may attenuate the disease and enhance its response to therapy.
  • [MeSH-major] Azathioprine / therapeutic use. Glucocorticoids / therapeutic use. Hepatitis, Autoimmune / diagnosis. Hepatitis, Autoimmune / therapy. Immunosuppressive Agents / therapeutic use. Prednisone / therapeutic use
  • [MeSH-minor] Aged. Diagnosis, Differential. Drug Therapy, Combination. Humans. Liver Transplantation. Prognosis

  • Genetic Alliance. consumer health - Hepatitis.
  • Genetic Alliance. consumer health - Autoimmune Hepatitis.
  • MedlinePlus Health Information. consumer health - Steroids.
  • Hazardous Substances Data Bank. AZATHIOPRINE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Gastroenterol Hepatol. 2005 Apr;17(4):457-61 [15756101.001]
  • [Cites] Rev Esp Enferm Dig. 1999 Sep;91(9):630-8 [10502711.001]
  • [Cites] Liver Int. 2006 Dec;26(10):1201-8 [17105585.001]
  • [Cites] Gut. 1975 Nov;16(11):876-83 [1104411.001]
  • [Cites] N Engl J Med. 1999 Jun 3;340(22):1704-14 [10352162.001]
  • [Cites] Hepatology. 2002 Mar;35(3):658-64 [11870381.001]
  • [Cites] Clin Immunol Immunopathol. 1988 Sep;48(3):290-6 [2456868.001]
  • [Cites] Lancet. 1968 Jul 6;2(7558):24-6 [4172688.001]
  • [Cites] Gastroenterology. 1987 Jan;92(1):215-9 [3781190.001]
  • [Cites] Dig Dis Sci. 2006 May;51(5):968-75 [16773433.001]
  • [Cites] Hepatology. 1997 Feb;25(2):317-23 [9021941.001]
  • [Cites] Gastroenterology. 1992 Oct;103(4):1290-5 [1397887.001]
  • [Cites] Liver Int. 2006 Jun;26(5):552-8 [16761999.001]
  • [Cites] Hepatology. 1989 Jul;10(1):39-43 [2737603.001]
  • [Cites] Compr Ther. 1992 Nov;18(11):26-34 [1478056.001]
  • [Cites] Liver Int. 2006 Jun;26(5):625-9 [16762009.001]
  • [Cites] Am J Gastroenterol. 2001 Dec;96(12):3390-4 [11774954.001]
  • [Cites] Hepatology. 1984 Jul-Aug;4(4):622-7 [6745850.001]
  • [Cites] Gastroenterology. 1996 Mar;110(3):848-57 [8608895.001]
  • [Cites] Hepatology. 2006 Aug;44(2):489-501 [16871565.001]
  • [Cites] Gastroenterology. 1993 Nov;105(5):1502-7 [8224654.001]
  • [Cites] Clin Exp Immunol. 1992 Nov;90(2):351-4 [1424294.001]
  • [Cites] J Hepatol. 2002 Oct;37(4):441-7 [12217596.001]
  • [Cites] Immunol Invest. 1988 Jul;17(5):389-424 [3058585.001]
  • [Cites] J Hepatol. 1999 Jan;30(1):131-41 [9927160.001]
  • [Cites] J Hepatol. 1999 Nov;31(5):929-38 [10580593.001]
  • [Cites] Cancer Invest. 1992;10(6):525-31 [1422890.001]
  • [Cites] Clin Gastroenterol Hepatol. 2004 Jul;2(7):625-31 [15224287.001]
  • [Cites] J Gastroenterol Hepatol. 2003 Jan;18(1):63-7 [12519226.001]
  • [Cites] Liver Transpl. 2001 Apr;7(4):302-10 [11303289.001]
  • [Cites] Gastroenterology. 1993 Dec;105(6):1824-32 [8253358.001]
  • [Cites] J Immunol. 1998 Oct 1;161(7):3527-35 [9759873.001]
  • [Cites] Am J Gastroenterol. 2002 Oct;97(10):2670-3 [12385459.001]
  • [Cites] Hepatology. 2000 Jun;31(6):1231-8 [10827147.001]
  • [Cites] Ann Clin Res. 1976 Jun;8(3):221-7 [793499.001]
  • [Cites] Aliment Pharmacol Ther. 2005 May 15;21(10):1273-7 [15882249.001]
  • [Cites] Age Ageing. 1997 Nov;26(6):441-4 [9466294.001]
  • [Cites] Hepatology. 1989 Feb;9(2):193-7 [2783576.001]
  • [Cites] Hepatology. 1991 Apr;13(4):701-6 [2010165.001]
  • [Cites] J Hepatol. 2005 Apr;42(4):578-84 [15763345.001]
  • [Cites] Am J Gastroenterol. 2002 Sep;97(9):2402-7 [12358264.001]
  • [Cites] Gastroenterology. 1997 Jun;112(6):2028-35 [9178696.001]
  • [Cites] Dig Dis Sci. 1996 Sep;41(9):1733-40 [8794787.001]
  • [Cites] Gastroenterology. 1993 Nov;105(5):1522-8 [8224657.001]
  • [Cites] J Hepatol. 2002 Sep;37(3):302-8 [12175624.001]
  • [Cites] Dig Dis Sci. 1985 Sep;30(9):824-8 [3875463.001]
  • [Cites] Adv Clin Chem. 2005;40:127-64 [16355922.001]
  • [Cites] Hum Immunol. 2000 Jul;61(7):640-50 [10880734.001]
  • [Cites] J Hepatol. 2004 Apr;40(4):646-52 [15030981.001]
  • [Cites] Liver Int. 2005 Aug;25(4):723-7 [15998421.001]
  • [Cites] Clin Liver Dis. 2002 Aug;6(3):799-824 [12362582.001]
  • [Cites] Aliment Pharmacol Ther. 1994 Dec;8(6):585-90 [7696446.001]
  • [Cites] Autoimmunity. 1991;8(3):245-9 [1822969.001]
  • [Cites] Minerva Gastroenterol Dietol. 2005 Dec;51(4):313-33 [16282960.001]
  • [Cites] Hepatology. 1996 Nov;24(5):1068-73 [8903377.001]
  • [Cites] Ann Rheum Dis. 2004 Feb;63(2):123-9 [14722198.001]
  • [Cites] Liver Transpl. 2007 Oct;13(10):1382-8 [17902123.001]
  • [Cites] Ann Hepatol. 2005 Jan-Mar;4(1):6-24 [15798657.001]
  • [Cites] Dig Dis Sci. 1986 Jul;31(7):705-11 [3720467.001]
  • [Cites] Hepatology. 1990 Jun;11(6):1044-9 [2365282.001]
  • [Cites] Am J Dig Dis. 1977 Nov;22(11):973-80 [920708.001]
  • [Cites] Am J Gastroenterol. 1999 Jan;94(1):241-8 [9934764.001]
  • [Cites] Hepatology. 2002 Feb;35(2):349-56 [11826408.001]
  • [Cites] N Engl J Med. 1995 Oct 12;333(15):958-63 [7666914.001]
  • [Cites] Am J Gastroenterol. 2002 Feb;97(2):413-9 [11866281.001]
  • [Cites] Hepatology. 2006 Mar;43(3):532-8 [16496338.001]
  • [Cites] Hepatol Res. 2003 Mar;25(3):263-270 [12697247.001]
  • [Cites] Am J Gastroenterol. 1995 May;90(5):771-6 [7537444.001]
  • [Cites] J Hepatol. 1998 Dec;29(6):990-3 [9875647.001]
  • [Cites] Hepatol Res. 2006 Oct;36(2):139-42 [16872893.001]
  • [Cites] Am J Med. 1976 Jun;60(7):941-8 [937354.001]
  • [Cites] Am J Gastroenterol. 1997 Dec;92(12):2197-200 [9399751.001]
  • [Cites] Clin Transpl. 1998;:17-37 [10503083.001]
  • [Cites] Gastroenterology. 1999 Oct;117(4):761-9 [10500056.001]
  • [Cites] Am J Gastroenterol. 2001 May;96(5):1587-91 [11374704.001]
  • [Cites] J Gastroenterol Hepatol. 1998 May;13(5):490-5 [9641646.001]
  • [Cites] Can J Gastroenterol. 2004 May;18(5):321-6 [15152283.001]
  • [Cites] Dig Dis Sci. 1998 Oct;43(10):2190-5 [9790453.001]
  • [Cites] Hepatology. 1993 Oct;18(4):816-22 [8406354.001]
  • [Cites] Ann Rheum Dis. 2005 Oct;64(10):1519-20 [16162908.001]
  • [Cites] Liver Int. 2005 Apr;25(2):325-30 [15780057.001]
  • [Cites] J Hepatol. 2006 Oct;45(4):575-83 [16899323.001]
  • [Cites] Hepatology. 1998 Aug;28(2):360-5 [9695997.001]
  • [Cites] QJM. 1997 Apr;90(4):289-96 [9307764.001]
  • [Cites] World J Gastroenterol. 2006 Mar 7;12(9):1362-6 [16552802.001]
  • [Cites] Hepatogastroenterology. 2005 Jul-Aug;52(64):1233-5 [16001669.001]
  • [Cites] Hepatology. 2005 Jul;42(1):53-62 [15954109.001]
  • [Cites] Am J Surg Pathol. 1995 Jun;19(6):699-708 [7755156.001]
  • [Cites] Am J Gastroenterol. 2007 May;102(5):1005-12 [17319926.001]
  • [Cites] JAMA. 1990 Nov 28;264(20):2660-2 [2232043.001]
  • [Cites] Gastroenterology. 2000 Apr;118(4):655-60 [10734016.001]
  • [Cites] N Engl J Med. 2002 Sep 19;347(12):911-20 [12239261.001]
  • [Cites] Hum Immunol. 2001 Aug;62(8):826-49 [11476907.001]
  • [Cites] Hepatology. 1987 Nov-Dec;7(6):1333-9 [3679093.001]
  • [Cites] Dig Dis Sci. 1997 May;42(5):1100-3 [9149070.001]
  • [Cites] J Hepatol. 2000 Sep;33(3):371-5 [11019991.001]
  • [Cites] J Hepatol. 1998 Jun;28(6):985-90 [9672174.001]
  • [Cites] J Hepatol. 2006 Oct;45(4):480-2 [16901573.001]
  • [Cites] Hepatology. 2002 Apr;35(4):890-7 [11915036.001]
  • [Cites] Hepatology. 2002 Aug;36(2):479-97 [12143059.001]
  • [Cites] Gut. 2002 May;50(5):713-7 [11950822.001]
  • [Cites] J Clin Lab Anal. 2005;19(1):6-10 [15645466.001]
  • [Cites] J Hepatol. 2006 Dec;45(6):844-50 [17050030.001]
  • [Cites] Q J Med. 1971 Apr;40(158):159-85 [4933363.001]
  • [Cites] Hepatology. 1986 May-Jun;6(3):345-8 [3710424.001]
  • [Cites] J Clin Pathol. 2006 Mar;59(3):280-4 [16505279.001]
  • [Cites] Liver Int. 2005 Oct;25(5):927-34 [16162148.001]
  • [Cites] Hum Immunol. 1994 Oct;41(2):146-50 [7860360.001]
  • [Cites] Q J Med. 1987 Jan;62(237):59-66 [3423206.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;210:167-79 [8565555.001]
  • [Cites] Lancet. 1984 Oct 27;2(8409):954-6 [6149344.001]
  • [Cites] J Clin Gastroenterol. 2005 Oct;39(9):819-25 [16145346.001]
  • [Cites] Z Gastroenterol. 1997 Jul;35(7):571-8 [9273991.001]
  • [Cites] Hepatology. 2001 Sep;34(3):464-70 [11526530.001]
  • [Cites] Hepatology. 1998 Jun;27(6):1536-43 [9620324.001]
  • [Cites] Hepatology. 2001 Oct;34(4 Pt 1):659-65 [11584360.001]
  • [Cites] Autoimmunity. 2002 Dec;35(8):475-83 [12765472.001]
  • [Cites] Clin Exp Immunol. 1972 Sep;12(1):79-87 [4563336.001]
  • [Cites] J Hepatol. 2006 Oct;45(4):584-91 [16876902.001]
  • [Cites] Ann N Y Acad Sci. 1992 Nov 21;663:36-42 [1482065.001]
  • [Cites] Am J Gastroenterol. 1995 Aug;90(8):1206-11 [7639216.001]
  • [Cites] J Clin Gastroenterol. 2002 Jul;35(1):75-81 [12080231.001]
  • [Cites] Gastroenterology. 1975 Aug;69(2):289-302 [1150039.001]
  • [Cites] Dig Dis Sci. 2001 Jun;46(6):1321-7 [11414311.001]
  • [Cites] Arch Intern Med. 1975 Feb;135(2):319-21 [1147734.001]
  • [Cites] Ann Intern Med. 1980 Jan;92 (1):14-9 [7350868.001]
  • [Cites] J Clin Invest. 1991 Oct;88(4):1370-8 [1717511.001]
  • [Cites] J Gastroenterol. 1997 Oct;32(5):689-95 [9349999.001]
  • [Cites] Clin Liver Dis. 2002 Aug;6(3):727-37 [12362577.001]
  • [Cites] J Clin Gastroenterol. 2004 Oct;38(9):805-9 [15365410.001]
  • [Cites] Gastroenterology. 2000 Nov;119(5):1312-6 [11054389.001]
  • [Cites] Liver Transpl Surg. 1998 May;4(3):208-14 [9563959.001]
  • [Cites] Science. 1999 Jul 2;285(5424):113-6 [10390361.001]
  • [Cites] Am J Surg Pathol. 2004 Apr;28(4):471-8 [15087666.001]
  • [Cites] Clin Exp Rheumatol. 1992 Jan-Feb;10(1):13-7 [1551275.001]
  • [Cites] Hepatology. 1990 Dec;12(6):1300-4 [2175292.001]
  • [Cites] Minerva Gastroenterol Dietol. 2007 Mar;53(1):43-78 [17415344.001]
  • [Cites] Annu Rev Gerontol Geriatr. 1990;10:71-96 [2102713.001]
  • [Cites] Gastroenterology. 1989 Nov;97(5):1288-93 [2792661.001]
  • [Cites] J Hepatol. 1994 Nov;21(5):866-71 [7890904.001]
  • [Cites] Am J Gastroenterol. 2004 Aug;99(8):1510-6 [15307869.001]
  • [Cites] Inflamm Res. 1999 Mar;48(3):106-19 [10219652.001]
  • [Cites] Dig Dis Sci. 1998 Sep;43(9):2149-55 [9753285.001]
  • [Cites] Gastroenterology. 1980 Mar;78(3):518-23 [7351290.001]
  • [Cites] Aliment Pharmacol Ther. 2005 Mar 15;21(6):695-9 [15771755.001]
  • [Cites] Gastroenterology. 1992 Sep;103(3):1041-7 [1354193.001]
  • [Cites] Am J Gastroenterol. 1999 Jul;94(7):1906-13 [10406258.001]
  • [Cites] World J Gastroenterol. 2003 Dec;9(12):2681-5 [14669312.001]
  • [Cites] Lancet. 1973 Apr 7;1(7806):735-7 [4121073.001]
  • [Cites] Liver. 1984 Apr;4(2):105-16 [6727581.001]
  • [Cites] Hepatology. 1983 Sep-Oct;3(5):685-9 [6618435.001]
  • [Cites] J Hepatol. 2005 Dec;43(6):951-7 [16143423.001]
  • [Cites] J Clin Gastroenterol. 1984 Aug;6(4):331-5 [6481116.001]
  • [Cites] World J Gastroenterol. 2005 Mar 28;11(12):1862-6 [15793882.001]
  • [Cites] Am J Gastroenterol. 2001 Apr;96(4):1224-31 [11316174.001]
  • [Cites] Gastroenterology. 1972 Nov;63(5):820-33 [4538724.001]
  • [Cites] Eur J Immunol. 1992 Nov;22(11):2989-93 [1425923.001]
  • [Cites] Clin Liver Dis. 2002 Aug;6(3):825-50, ix [12362583.001]
  • [Cites] Semin Liver Dis. 2002 Nov;22(4):365-78 [12447708.001]
  • [Cites] Am J Gastroenterol. 2002 Aug;97(8):2051-7 [12190176.001]
  • (PMID = 18331074.001).
  • [ISSN] 1170-229X
  • [Journal-full-title] Drugs & aging
  • [ISO-abbreviation] Drugs Aging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] New Zealand
  • [Chemical-registry-number] 0 / Glucocorticoids; 0 / Immunosuppressive Agents; MRK240IY2L / Azathioprine; VB0R961HZT / Prednisone
  • [Number-of-references] 161
  •  go-up   go-down


24. Maiese K, Hou J, Chong ZZ, Shang YC: Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology. ScientificWorldJournal; 2009 Oct 02;9:1072-104
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Oxidative stress significantly impacts multiple cellular pathways that can lead to the initiation and progression of varied disorders throughout the body.
  • It therefore becomes imperative to elucidate the components and function of novel therapeutic strategies against oxidative stress to further clinical diagnosis and care.
  • In particular, both the growth factor and cytokine erythropoietin (EPO), and members of the mammalian forkhead transcription factors of the O class (FoxOs), may offer the greatest promise for new treatment regimens, since these agents and the cellular pathways they oversee cover a range of critical functions that directly influence progenitor cell development, cell survival and degeneration, metabolism, immune function, and cancer cell invasion.
  • Furthermore, both EPO and FoxOs function not only as therapeutic targets, but also as biomarkers of disease onset and progression, since their cellular pathways are closely linked and overlap with several unique signal transduction pathways.
  • Here we present the exciting as well as the complex role that EPO and FoxOs possess to uncover the benefits as well as the risks of these agents for cell biology and clinical care in processes that range from stem cell development to uncontrolled cellular proliferation.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Exp Med. 2004 Oct 18;200(8):1051-62 [15492127.001]
  • [Cites] Trends Pharmacol Sci. 2004 Nov;25(11):577-83 [15491780.001]
  • [Cites] Blood. 1974 Jul;44(1):77-85 [4834517.001]
  • [Cites] Nature. 1985 Feb 28-Mar 6;313(6005):806-10 [3838366.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Nov;82(22):7580-4 [3865178.001]
  • [Cites] Biochemistry. 1988 Jul 26;27(15):5646-54 [3179269.001]
  • [Cites] Cell. 1989 May 19;57(4):645-58 [2566386.001]
  • [Cites] Eur J Biochem. 1990 Mar 10;188(2):405-11 [2156701.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Aug;87(15):5978-82 [2165612.001]
  • [Cites] Kidney Int. 1990 Nov;38(5):969-75 [2266682.001]
  • [Cites] Blood. 1991 Feb 1;77(3):419-34 [1991159.001]
  • [Cites] Neurobiol Aging. 1999 Nov-Dec;20(6):581-9 [10674423.001]
  • [Cites] J Neurosci Res. 2000 Feb 15;59(4):568-80 [10679797.001]
  • [Cites] Genes Dev. 2000 Jan 15;14(2):142-6 [10702024.001]
  • [Cites] J Neurosci Res. 1999 Feb 15;55(4):472-85 [10723057.001]
  • [Cites] J Autoimmun. 2000 May;14(3):221-9 [10756084.001]
  • [Cites] Cell Mol Neurobiol. 2000 Jun;20(3):383-400 [10789835.001]
  • [Cites] Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):423-31 [10817926.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E1038-44 [10827006.001]
  • [Cites] J Cereb Blood Flow Metab. 2000 Sep;20(9):1380-91 [10994860.001]
  • [Cites] J Neurosci Res. 2000 Oct 15;62(2):257-72 [11020218.001]
  • [Cites] J Biochem. 2000 Nov;128(5):731-7 [11056384.001]
  • [Cites] J Biol Chem. 2000 Dec 15;275(50):39754-61 [10995753.001]
  • [Cites] Biochem J. 2000 Jul 15;349(Pt 2):629-34 [10880363.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2000 Dec;279(6):E1242-8 [11093910.001]
  • [Cites] ScientificWorldJournal. 2008;8:270-4 [18661049.001]
  • [Cites] Oncogene. 2008 Aug 7;27(34):4733-44 [18408765.001]
  • [Cites] Curr Neurovasc Res. 2008 Aug;5(3):159-70 [18691073.001]
  • [Cites] J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1125-31 [18086112.001]
  • [Cites] J Mol Cell Cardiol. 2008 Aug;45(2):250-60 [18586265.001]
  • [Cites] J Immunol. 2008 Sep 1;181(5):2980-9 [18713968.001]
  • [Cites] Mol Cancer Ther. 2008 Aug;7(8):2263-71 [18687658.001]
  • [Cites] Arch Immunol Ther Exp (Warsz). 2008 Jul-Aug;56(4):257-66 [18726147.001]
  • [Cites] Hear Res. 2008 Sep;243(1-2):121-6 [18672044.001]
  • [Cites] Carcinogenesis. 2008 Sep;29(9):1837-44 [18390843.001]
  • [Cites] J Neurosci Res. 2008 Oct;86(13):3018-27 [18512763.001]
  • [Cites] J Cereb Blood Flow Metab. 2001 Mar;21(3):262-75 [11295881.001]
  • [Cites] J Neuropathol Exp Neurol. 2001 Apr;60(4):386-92 [11305874.001]
  • [Cites] Mamm Genome. 2001 Jun;12(6):416-25 [11353388.001]
  • [Cites] J Biol Chem. 2001 Jan 26;276(4):2571-5 [11073947.001]
  • [Cites] J Am Coll Cardiol. 2001 Jun 1;37(7):1775-80 [11401110.001]
  • [Cites] Pediatr Res. 2002 Apr;51(4):472-8 [11919332.001]
  • [Cites] J Cereb Blood Flow Metab. 2002 May;22(5):503-14 [11973422.001]
  • [Cites] J Cell Mol Med. 2002 Jan-Mar;6(1):82-92 [12003671.001]
  • [Cites] J Vasc Res. 2002 Mar-Apr;39(2):131-47 [12011585.001]
  • [Cites] J Biol Chem. 2002 Jul 26;277(30):26729-32 [12048180.001]
  • [Cites] Eur J Neurosci. 2002 Aug;16(4):584-92 [12270034.001]
  • [Cites] Microsc Res Tech. 2002 Nov 15;59(4):331-4 [12424797.001]
  • [Cites] J Biol Chem. 2002 Dec 6;277(49):47928-37 [12351634.001]
  • [Cites] Circulation. 2002 Dec 3;106(23):2973-9 [12460881.001]
  • [Cites] Histol Histopathol. 2003 Jan;18(1):173-89 [12507297.001]
  • [Cites] Exp Biol Med (Maywood). 2003 Jan;228(1):1-14 [12524467.001]
  • [Cites] Circulation. 2003 Jan 21;107(2):294-9 [12538431.001]
  • [Cites] J Neurosci Res. 2003 Mar 1;71(5):659-69 [12584724.001]
  • [Cites] J Biol Chem. 2003 Feb 21;278(8):5871-82 [12488318.001]
  • [Cites] J Hematother Stem Cell Res. 2002 Dec;11(6):863-71 [12590701.001]
  • [Cites] J Cereb Blood Flow Metab. 2003 Mar;23(3):320-30 [12621307.001]
  • [Cites] J Biol Chem. 2003 Apr 4;278(14):12361-6 [12517744.001]
  • [Cites] Br J Pharmacol. 2003 Mar;138(6):1107-18 [12684267.001]
  • [Cites] J Biol Chem. 2003 Apr 18;278(16):13898-904 [12578834.001]
  • [Cites] Transplantation. 2003 Apr 27;75(8):1356-60 [12717230.001]
  • [Cites] Arch Toxicol. 2003 May;77(5):267-73 [12734640.001]
  • [Cites] Trends Pharmacol Sci. 2003 May;24(5):228-32 [12767721.001]
  • [Cites] Science. 2003 Jul 11;301(5630):215-8 [12855809.001]
  • [Cites] Blood. 2003 Aug 15;102(4):1340-6 [12702503.001]
  • [Cites] Circulation. 2003 Aug 5;108(5):616-22 [12835226.001]
  • [Cites] Mol Pharmacol. 2003 Sep;64(3):557-69 [12920191.001]
  • [Cites] J Neurosci Res. 2003 Oct 1;74(1):37-51 [13130504.001]
  • [Cites] Cell Mol Neurobiol. 2003 Oct;23(4-5):561-78 [14514016.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11285-90 [13679577.001]
  • [Cites] Am J Obstet Gynecol. 2003 Dec;189(6):1764-70 [14710111.001]
  • [Cites] Arch Intern Med. 2004 Feb 9;164(3):262-76 [14769622.001]
  • [Cites] Clin Nephrol. 2004 Feb;61(2):127-9 [14989632.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2975-80 [14978268.001]
  • [Cites] Antioxid Redox Signal. 2004 Apr;6(2):277-87 [15025929.001]
  • [Cites] Science. 2004 Mar 26;303(5666):2011-5 [14976264.001]
  • [Cites] Cell. 2004 Apr 16;117(2):225-37 [15084260.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2004 May;31(5):733-9 [14985868.001]
  • [Cites] Exp Cell Res. 2004 Jun 10;296(2):196-207 [15149850.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9855-60 [15210945.001]
  • [Cites] J Am Coll Cardiol. 2004 Jul 7;44(1):63-7 [15234408.001]
  • [Cites] J Cereb Blood Flow Metab. 2004 Jul;24(7):728-43 [15241181.001]
  • [Cites] Restor Neurol Neurosci. 2004;22(2):87-104 [15272144.001]
  • [Cites] Restor Neurol Neurosci. 2004;22(2):105-19 [15272145.001]
  • [Cites] J Biol Chem. 2004 Aug 13;279(33):34741-9 [15184386.001]
  • [Cites] Immunity. 2004 Aug;21(2):203-13 [15308101.001]
  • [Cites] Front Biosci. 2004 Sep 1;9:2500-20 [15353303.001]
  • [Cites] Cancer Lett. 2004 Oct 28;214(2):171-9 [15363543.001]
  • [Cites] J Biol Chem. 2004 Sep 24;279(39):41114-23 [15272020.001]
  • [Cites] J Neuroimmunol. 2009 Jun 25;211(1-2):92-100 [19428125.001]
  • [Cites] Clin Transl Oncol. 2009 Jul;11(7):411-27 [19574199.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2009;16(4):530-7 [19333535.001]
  • [Cites] Neurobiol Dis. 2009 Aug;35(2):278-85 [19481149.001]
  • [Cites] Glia. 2009 Sep;57(12):1351-61 [19229997.001]
  • [Cites] Clin Pharmacol Ther. 2009 Aug;86(2):154-9 [19458615.001]
  • [Cites] Eur J Heart Fail. 2009 Aug;11(8):732-8 [19633100.001]
  • [Cites] ScientificWorldJournal. 2009;9:781-91 [19705038.001]
  • [Cites] Am J Nephrol. 2009;30(3):253-60 [19494484.001]
  • [Cites] Molecules. 2009;14(9):3446-85 [19783937.001]
  • [Cites] J Alzheimers Dis. 2009;17(2):267-76 [19221404.001]
  • [Cites] Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):14-9 [1928074.001]
  • [Cites] Am Heart J. 1992 Aug;124(2):424-7 [1386184.001]
  • [Cites] Nature. 1993 Jul 29;364(6436):412-20 [8332212.001]
  • [Cites] J Neurosci Res. 1993 Sep 1;36(1):77-87 [8230323.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3974-8 [8171022.001]
  • [Cites] Genes Chromosomes Cancer. 1994 Oct;11(2):79-84 [7529552.001]
  • [Cites] J Cereb Blood Flow Metab. 1995 May;15(3):440-9 [7714002.001]
  • [Cites] Eur J Biochem. 1996 Jul 15;239(2):494-500 [8706759.001]
  • [Cites] J Neurochem. 1997 Feb;68(2):710-4 [9003060.001]
  • [Cites] Circulation. 1997 May 6;95(9):2303-11 [9142009.001]
  • [Cites] J Cereb Blood Flow Metab. 1997 May;17(5):560-6 [9183294.001]
  • [Cites] Blood. 1997 Nov 1;90(9):3714-9 [9345057.001]
  • [Cites] Free Radic Res. 1997 Sep;27(3):311-23 [9350435.001]
  • [Cites] Nature. 1997 Oct 30;389(6654):994-9 [9353126.001]
  • [Cites] Science. 1997 Nov 14;278(5341):1319-22 [9360933.001]
  • [Cites] Biochemistry. 1998 Apr 28;37(17):6179-87 [9558357.001]
  • [Cites] Arch Biochem Biophys. 1998 May 15;353(2):312-21 [9606965.001]
  • [Cites] J Biol Chem. 1998 Sep 25;273(39):25381-7 [9738005.001]
  • [Cites] Exp Neurol. 1999 Jan;155(1):79-94 [9918707.001]
  • [Cites] Exp Cell Res. 1999 Feb 1;246(2):290-300 [9925743.001]
  • [Cites] Cell Biochem Biophys. 1999;30(1):153-66 [10099826.001]
  • [Cites] J Histochem Cytochem. 1999 May;47(5):661-72 [10219058.001]
  • [Cites] J Biol Chem. 1999 Jun 4;274(23):15982-5 [10347145.001]
  • [Cites] J Biol Chem. 1999 Jun 11;274(24):17184-92 [10358076.001]
  • [Cites] J Neurobiol. 1999 Aug;40(2):171-84 [10413448.001]
  • [Cites] Blood. 1950 Apr;5(4):372-80 [15411424.001]
  • [Cites] Science. 2004 Nov 12;306(5699):1190-4 [15498972.001]
  • [Cites] Acta Med Okayama. 2004 Aug;58(4):197-205 [15551757.001]
  • [Cites] Diabetologia. 2004 Oct;47(10):1695-703 [15502930.001]
  • [Cites] Circ Res. 2008 Mar 28;102(6):686-94 [18218983.001]
  • [Cites] J Biol Chem. 2008 Apr 4;283(14):9224-30 [18250171.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):152-9 [17967510.001]
  • [Cites] Cancer Res. 2008 Apr 15;68(8):3001-9 [18413770.001]
  • [Cites] Breast Cancer Res. 2008;10(1):R21 [18312651.001]
  • [Cites] Adv Exp Med Biol. 2008;615:13-23 [18437889.001]
  • [Cites] Pharmacol Ther. 2008 Apr;118(1):58-81 [18313758.001]
  • [Cites] Acta Trop. 2008 May;106(2):104-8 [18359468.001]
  • [Cites] BJU Int. 2008 Jun;101(11):1454-60 [18336616.001]
  • [Cites] Biomed Pharmacother. 2008 Apr-May;62(4):218-32 [18342481.001]
  • [Cites] Trends Mol Med. 2008 May;14(5):219-27 [18403263.001]
  • [Cites] Curr Neurovasc Res. 2008 May;5(2):125-42 [18473829.001]
  • [Cites] N Engl J Med. 2008 May 15;358(20):2107-16 [18480203.001]
  • [Cites] Prog Neurobiol. 2008 Jun;85(2):194-213 [18396368.001]
  • [Cites] Brain Res Bull. 2008 Jul 1;76(4):424-38 [18502319.001]
  • [Cites] Neuropsychopharmacology. 2008 Jul;33(8):1942-51 [17805306.001]
  • [Cites] Eur J Pharmacol. 2008 Jul 7;588(2-3):178-88 [18502414.001]
  • [Cites] Expert Opin Ther Targets. 2008 Jul;12(7):905-16 [18554157.001]
  • [Cites] Brain Res. 2008 Jul 7;1218:224-9 [18533137.001]
  • [Cites] Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):834-46 [18452700.001]
  • [Cites] Neurochem Res. 2008 Aug;33(8):1599-609 [18461448.001]
  • [Cites] Neuroscience. 2008 Jul 17;154(4):1458-66 [18555616.001]
  • [Cites] J Nephrol. 2008 Jul-Aug;21(4):543-9 [18651544.001]
  • [Cites] Oncogene. 2008 Jul 24;27(32):4422-33 [18391984.001]
  • [Cites] J Pharmacol Exp Ther. 2006 Apr;317(1):68-75 [16377761.001]
  • [Cites] J Am Soc Nephrol. 2006 Apr;17(4):932-42 [16481411.001]
  • [Cites] Obesity (Silver Spring). 2006 Feb;14(2):188-93 [16571842.001]
  • [Cites] Curr Med Chem. 2006;13(8):883-95 [16611073.001]
  • [Cites] Neurosci Lett. 2006 May 1;398(1-2):39-43 [16423457.001]
  • [Cites] PLoS Med. 2006 Apr;3(4):e101 [16478293.001]
  • [Cites] Eur J Cardiothorac Surg. 2006 Jun;29(6):902-7 [16675226.001]
  • [Cites] Cancer Immunol Immunother. 2006 Sep;55(9):1064-71 [16328385.001]
  • [Cites] Curr Neurovasc Res. 2006 May;3(2):107-17 [16719794.001]
  • [Cites] J Am Soc Nephrol. 2006 Jun;17(6):1576-84 [16672321.001]
  • [Cites] Nature. 2006 May 25;441(7092):523-7 [16680151.001]
  • [Cites] Blood. 2008 Oct 1;112(7):2787-94 [18628488.001]
  • [Cites] J Ocul Pharmacol Ther. 2008 Oct;24(5):453-9 [18788995.001]
  • [Cites] J Biol Chem. 2008 Oct 10;283(41):27810-9 [18678867.001]
  • [Cites] J Neurochem. 2008 Oct;107(1):127-40 [18665912.001]
  • [Cites] Biochem Biophys Res Commun. 2008 Nov 14;376(2):251-5 [18774777.001]
  • [Cites] Cell Cycle. 2008 Oct;7(20):3162-70 [18927507.001]
  • [Cites] Epilepsia. 2008 Oct;49(10):1723-32 [18479396.001]
  • [Cites] Neurosci Lett. 2008 Dec 31;448(3):245-9 [18973793.001]
  • [Cites] Perfusion. 2008 May;23(3):187-92 [19029270.001]
  • [Cites] J Physiol. 2008 Dec 1;586(Pt 23):5757-69 [18845609.001]
  • [Cites] Crit Care. 2008;12(5):227 [18983707.001]
  • [Cites] Neuroepidemiology. 2009;32(1):40-6 [19001795.001]
  • [Cites] Ann Neurol. 2008 Nov;64(5):523-34 [19067366.001]
  • [Cites] J Neurosci Res. 2009 Jan;87(1):150-63 [18711747.001]
  • [Cites] Cell Mol Life Sci. 2008 Dec;65(24):4000-18 [18820996.001]
  • [Cites] Clin Sci (Lond). 2009 Feb;116(3):191-203 [19118491.001]
  • [Cites] J Ren Nutr. 2009 Jan;19(1):20-4 [19121765.001]
  • [Cites] Brain Res. 2009 Jan 16;1249:212-21 [18977207.001]
  • [Cites] Eur J Pharmacol. 2009 Jan 14;602(2-3):406-12 [19061883.001]
  • [Cites] Trends Parasitol. 2009 Jan;25(1):30-6 [19008152.001]
  • [Cites] Cell Cycle. 2008 Dec 15;7(24):3829-39 [19066462.001]
  • [Cites] J Biol Chem. 2009 Jan 23;284(4):2001-11 [19047055.001]
  • [Cites] Exp Cell Res. 2009 Feb 1;315(3):419-31 [19056379.001]
  • [Cites] Life Sci. 2009 Feb 13;84(7-8):205-10 [19101571.001]
  • [Cites] Brain Behav Immun. 2009 Feb;23(2):193-203 [18835350.001]
  • [Cites] FASEB J. 2009 Feb;23(2):351-61 [18827024.001]
  • [Cites] Acta Pharmacol Sin. 2009 Feb;30(2):202-8 [19122671.001]
  • [Cites] Pharmacol Biochem Behav. 2009 Apr;92(2):251-9 [19138703.001]
  • [Cites] Neonatology. 2009;95(2):105-16 [18776724.001]
  • [Cites] Placenta. 2009 Mar;30(3):256-62 [19150739.001]
  • [Cites] Crit Care Med. 2009 Mar;37(3):889-98 [19237893.001]
  • [Cites] Adv Exp Med Biol. 2009;643:359-68 [19239167.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1329-35 [18952918.001]
  • [Cites] J Urol. 2009 Mar;181(3):1434-43 [19157461.001]
  • [Cites] Mech Ageing Dev. 2009 Apr;130(4):253-61 [19162061.001]
  • [Cites] Trends Cell Biol. 2009 Mar;19(3):119-29 [19208479.001]
  • [Cites] Immunol Rev. 2009 Mar;228(1):149-69 [19290926.001]
  • [Cites] Cell Calcium. 2009 Apr;45(4):358-68 [19201465.001]
  • [Cites] Chin Med J (Engl). 2009 Mar 5;122(5):566-70 [19323909.001]
  • [Cites] Biochem Biophys Res Commun. 2009 Apr 17;381(4):491-5 [19233143.001]
  • [Cites] Hellenic J Cardiol. 2009 Mar-Apr;50(2):127-32 [19329414.001]
  • [Cites] J Neurochem. 2009 Apr;109(2):360-70 [19220704.001]
  • [Cites] Free Radic Biol Med. 2009 Apr 15;46(8):1032-41 [19136057.001]
  • [Cites] Med Res Rev. 2009 May;29(3):395-418 [18985696.001]
  • [Cites] Glia. 2009 May;57(7):734-43 [18985732.001]
  • [Cites] Curr Neurovasc Res. 2009 Feb;6(1):20-31 [19355923.001]
  • [Cites] J Comp Neurol. 2009 Jun 1;514(4):403-14 [19330822.001]
  • [Cites] Brain. 2009 Apr;132(Pt 4):879-88 [19244253.001]
  • [Cites] Brain Res. 2009 Mar 31;1263:23-32 [19368821.001]
  • [Cites] Stem Cells Dev. 2009 Apr;18(3):411-21 [18590375.001]
  • [Cites] J Neurochem. 2009 May;109(4):1157-67 [19302476.001]
  • [Cites] Neuropharmacology. 2009 May-Jun;56(6-7):1027-34 [19268480.001]
  • [Cites] J Cell Mol Med. 2009 Apr;13(4):701-11 [18410524.001]
  • [Cites] Cell Signal. 2007 Jun;19(6):1150-62 [17289346.001]
  • [Cites] Eur Surg Res. 2007;39(3):189-97 [17377393.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 May;27(5):1043-54 [17077815.001]
  • [Cites] J Neuropathol Exp Neurol. 2007 May;66(5):389-98 [17483696.001]
  • [Cites] Biochim Biophys Acta. 2007 Apr;1769(4):244-52 [17482685.001]
  • [Cites] Mol Cell Biol. 2007 May;27(10):3839-3854 [17353275.001]
  • [Cites] Nat Rev Mol Cell Biol. 2007 Jun;8(6):440-50 [17522590.001]
  • [Cites] Adv Ther. 2007 Mar-Apr;24(2):346-52 [17565925.001]
  • [Cites] Clin Cancer Res. 2007 Jun 15;13(12):3536-44 [17575216.001]
  • [Cites] Mol Cell Biol. 2007 Jul;27(13):4917-30 [17452451.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 Jul;27(7):1369-76 [17264861.001]
  • [Cites] Biochim Biophys Acta. 2010 Jan;1802(1):167-85 [19751830.001]
  • [Cites] Oxid Med Cell Longev. 2009 Jan-Mar;2(1):1 [20046637.001]
  • [Cites] Oxid Med Cell Longev. 2009 Jan-Mar;2(1):19-25 [20046641.001]
  • [Cites] Oxid Med Cell Longev. 2009 Jan-Mar;2(1):43-51 [20046644.001]
  • [Cites] Adv Exp Med Biol. 2009;665:242-60 [20429429.001]
  • [Cites] Oxid Med Cell Longev. 2008 Oct-Dec;1(1):1-14 [19750024.001]
  • [Cites] BMC Neurosci. 2004 Nov 29;5:48 [15569384.001]
  • [Cites] Neurosignals. 2004 Nov-Dec;13(6):265-89 [15627815.001]
  • [Cites] JAMA. 2005 Jan 5;293(1):90-5 [15632341.001]
  • [Cites] Cancer Res. 2005 Jan 1;65(1):284-90 [15665305.001]
  • [Cites] Curr Opin Neurobiol. 2005 Feb;15(1):101-7 [15721751.001]
  • [Cites] Arch Intern Med. 2005 Feb 28;165(4):466-9 [15738380.001]
  • [Cites] Arthritis Rheum. 2005 Mar;52(3):940-50 [15751086.001]
  • [Cites] J Mol Neurosci. 2005;25(2):183-9 [15784966.001]
  • [Cites] Mol Cancer Res. 2005 Mar;3(3):163-9 [15798096.001]
  • [Cites] J Cell Biol. 2005 Apr 25;169(2):331-9 [15837797.001]
  • [Cites] J Am Coll Cardiol. 2005 May 3;45(9):1406-12 [15862410.001]
  • [Cites] Prog Neurobiol. 2005 Feb;75(3):207-46 [15882775.001]
  • [Cites] Nat Med. 2005 Jun;11(6):666-71 [15895074.001]
  • [Cites] Brain Res Brain Res Rev. 2005 Jul;49(1):1-21 [15960984.001]
  • [Cites] Brain Res. 2005 Jul 19;1050(1-2):15-26 [15979589.001]
  • [Cites] Mol Ther. 2005 Aug;12(2):283-9 [15935736.001]
  • [Cites] Dev Cell. 2005 Aug;9(2):261-70 [16054032.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11278-83 [16076959.001]
  • [Cites] J Biol Chem. 2005 Aug 19;280(33):29864-73 [15961397.001]
  • [Cites] Neurosci Lett. 2005 Oct 14;387(1):5-10 [16054296.001]
  • [Cites] Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1223-33 [16115027.001]
  • [Cites] Endocrinology. 2005 Oct;146(10):4370-6 [16020479.001]
  • [Cites] Curr Neurovasc Res. 2005 Jan;2(1):55-72 [16181100.001]
  • [Cites] Curr Neurovasc Res. 2005 Jul;2(3):197-211 [16181114.001]
  • [Cites] Curr Neurovasc Res. 2005 Oct;2(4):271-85 [16181120.001]
  • [Cites] Curr Neurovasc Res. 2005 Oct;2(4):331-40 [16181124.001]
  • [Cites] J Biol Chem. 2005 Sep 30;280(39):33558-65 [16061480.001]
  • [Cites] Sports Med. 2005;35(10):831-40 [16180943.001]
  • [Cites] Genes Dev. 2005 Oct 15;19(20):2435-46 [16230533.001]
  • [Cites] Biochem J. 2005 Nov 1;391(Pt 3):623-9 [15987244.001]
  • [Cites] Histol Histopathol. 2006 Jan;21(1):103-24 [16267791.001]
  • [Cites] Curr Neurovasc Res. 2005 Dec;2(5):387-99 [16375720.001]
  • [Cites] Curr Neurovasc Res. 2005 Dec;2(5):425-46 [16375723.001]
  • [Cites] Ann Hematol. 2006 Feb;85(2):79-85 [16132904.001]
  • [Cites] Cancer Res. 2006 Jan 1;66(1):212-20 [16397234.001]
  • [Cites] Gene Expr Patterns. 2006 Jan;6(2):134-40 [16326148.001]
  • [Cites] J Neurochem. 2006 Feb;96(4):1101-10 [16417583.001]
  • [Cites] J Clin Invest. 2006 Feb;116(2):344-56 [16453021.001]
  • [Cites] Curr Neurovasc Res. 2006 Feb;3(1):25-39 [16472123.001]
  • [Cites] Mutat Res. 2006 Feb 22;594(1-2):155-61 [16289600.001]
  • [Cites] J Pharmacol Exp Ther. 2006 Mar;316(3):999-1005 [16306273.001]
  • [Cites] Nat Genet. 2006 Mar;38(3):320-3 [16415884.001]
  • [Cites] Mol Cancer Ther. 2006 Feb;5(2):356-61 [16505109.001]
  • [Cites] J Neurosci Res. 2006 Mar;83(4):584-93 [16435392.001]
  • [Cites] J Infect Dis. 2006 Apr 1;193(7):987-95 [16518761.001]
  • [Cites] Brain Res Bull. 2006 Mar 31;69(2):117-22 [16533659.001]
  • [Cites] J Pharmacol Exp Ther. 2006 Apr;317(1):109-16 [16357210.001]
  • [Cites] Mol Cell Endocrinol. 2008 Jan 16;281(1-2):47-55 [18035477.001]
  • [Cites] Mol Cell. 2007 Dec 28;28(6):941-53 [18158893.001]
  • [Cites] Cell Death Differ. 2008 Feb;15(2):299-311 [17992191.001]
  • [Cites] Resuscitation. 2008 Mar;76(3):397-404 [18037223.001]
  • [Cites] Rejuvenation Res. 2008 Feb;11(1):139-50 [18069916.001]
  • [Cites] Gynecol Oncol. 2008 Mar;108(3):609-18 [18234299.001]
  • [Cites] Diabetes. 2008 Mar;57(3):563-76 [18162510.001]
  • [Cites] Clin Dev Immunol. 2007;2007:89195 [18317534.001]
  • [Cites] Br J Haematol. 2008 Apr;141(1):14-31 [18324962.001]
  • [Cites] Cell Signal. 2008 May;20(5):892-906 [18276109.001]
  • [Cites] Expert Rev Cardiovasc Ther. 2008 Mar;6(3):281-4 [18327989.001]
  • [Cites] Cell. 2006 Jun 2;125(5):987-1001 [16751106.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9051-6 [16757565.001]
  • [Cites] Biochem J. 2006 Jul 15;397(2):233-46 [16792526.001]
  • [Cites] J Cardiovasc Pharmacol. 2006 Jun;47(6):736-41 [16810073.001]
  • [Cites] Diabetes. 2006 Aug;55(8):2231-7 [16873685.001]
  • [Cites] Clin Sci (Lond). 2006 Sep;111(3):171-83 [16901264.001]
  • [Cites] Eur J Neurosci. 2006 Jul;24(2):361-70 [16903847.001]
  • [Cites] Diabet Med. 2006 Aug;23(8):839-44 [16911620.001]
  • [Cites] Acta Biomed. 2005;76 Suppl 3:49-54 [16915797.001]
  • [Cites] Curr Neurovasc Res. 2006 Aug;3(3):187-201 [16918383.001]
  • [Cites] Cancer Biol Ther. 2006 Jul;5(7):875-83 [16861905.001]
  • [Cites] Nat Clin Pract Nephrol. 2005 Dec;1(2):87-97 [16932374.001]
  • [Cites] Diabetes. 2006 Sep;55(9):2649-53 [16936217.001]
  • [Cites] Pediatrics. 2006 Sep;118(3):e635-40 [16908620.001]
  • [Cites] Semin Nephrol. 2006 Jul;26(4):296-306 [16949468.001]
  • [Cites] Circulation. 2006 Sep 19;114(12):1269-76 [16952980.001]
  • [Cites] Eur J Endocrinol. 2006 Oct;155(4):609-14 [16990661.001]
  • [Cites] Int J Cardiol. 2006 Oct 10;112(3):341-7 [16309765.001]
  • [Cites] Diabetes. 2006 Oct;55(10):2863-70 [17003354.001]
  • [Cites] J Am Soc Nephrol. 2006 Oct;17(10):2812-20 [16943306.001]
  • [Cites] J Clin Oncol. 2006 Oct 10;24(29):4675-6 [17028292.001]
  • [Cites] J Med Genet. 2006 Oct;43(10):798-803 [16723389.001]
  • [Cites] Nephron Exp Nephrol. 2006;104(3):e83-8 [16837817.001]
  • [Cites] Fertil Steril. 2006 Nov;86(5):1518-21 [16979636.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16260-5 [17053067.001]
  • [Cites] Eur J Immunol. 2006 Nov;36(11):2971-80 [17051618.001]
  • [Cites] J Thromb Haemost. 2006 Dec;4(12):2656-63 [16961585.001]
  • [Cites] J Control Release. 2006 Nov10;116(1):28-34 [17081643.001]
  • [Cites] Am Heart J. 2006 Dec;152(6):1096.e9-15 [17161060.001]
  • [Cites] Development. 2007 Jan;134(1):199-209 [17164425.001]
  • [Cites] Prog Retin Eye Res. 2007 Jan;26(1):1-37 [17074526.001]
  • [Cites] J Neurooncol. 2007 Jan;81(1):81-91 [16858513.001]
  • [Cites] Int J Mol Med. 2007 Feb;19(2):263-72 [17203200.001]
  • [Cites] J Virol. 2007 Feb;81(3):1511-6 [17108038.001]
  • [Cites] Cell Signal. 2007 Mar;19(3):634-45 [17045782.001]
  • [Cites] Epilepsia. 2007 Jan;48(1):175-81 [17241225.001]
  • [Cites] Cell. 2007 Jan 26;128(2):309-23 [17254969.001]
  • [Cites] Cell. 2007 Jan 26;128(2):325-39 [17254970.001]
  • [Cites] Neurobiol Dis. 2007 Feb;25(2):412-26 [17166730.001]
  • [Cites] Diabetes. 2007 Feb;56(2):295-303 [17259372.001]
  • [Cites] Diabetes. 2007 Feb;56(2):389-93 [17259383.001]
  • [Cites] Blood. 2007 Feb 15;109(4):1627-35 [17062728.001]
  • [Cites] Cell Death Differ. 2007 Mar;14(3):534-47 [16888645.001]
  • [Cites] Curr Neurovasc Res. 2007 Feb;4(1):63-71 [17311546.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 Mar;27(3):469-76 [16804549.001]
  • [Cites] J Clin Neurosci. 2007 Apr;14(4):364-8 [17236773.001]
  • [Cites] Br J Cancer. 2007 Mar 12;96(5):692-700 [17299396.001]
  • [Cites] Exp Neurol. 2007 Mar;204(1):106-17 [17157835.001]
  • [Cites] Mol Cell Biol. 2007 Apr;27(7):2676-86 [17242183.001]
  • [Cites] Mediators Inflamm. 2006;2006(5):18061 [17392570.001]
  • [Cites] Br J Pharmacol. 2007 Apr;150(7):839-50 [17339844.001]
  • [Cites] Clin Exp Dermatol. 2007 May;32(3):287-90 [17397351.001]
  • [Cites] J Biol Chem. 2007 Apr 13;282(15):11590-601 [17308309.001]
  • [Cites] Apoptosis. 2007 Aug;12(8):1365-75 [17508273.001]
  • [Cites] FASEB J. 2007 Jul;21(9):2226-36 [17369508.001]
  • [Cites] Eur J Neurosci. 2007 Jul;26(1):90-100 [17614942.001]
  • [Cites] Anal Bioanal Chem. 2007 Aug;388(7):1521-9 [17516052.001]
  • [Cites] Cancer Lett. 2007 Aug 18;253(2):170-9 [17462819.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H274-83 [17337594.001]
  • [Cites] Curr Med Chem. 2007;14(16):1729-38 [17627510.001]
  • [Cites] J Biol Chem. 2007 Jul 20;282(29):21542-50 [17522055.001]
  • [Cites] Semin Hematol. 2007 Jul;44(3):212-7 [17631185.001]
  • [Cites] Mod Pathol. 2007 Aug;20(8):835-42 [17491598.001]
  • [Cites] Antioxid Redox Signal. 2007 Aug;9(8):1059-96 [17571960.001]
  • [Cites] Free Radic Biol Med. 2007 Aug 15;43(4):477-503 [17640558.001]
  • [Cites] J Pharmacol Exp Ther. 2007 Aug;322(2):789-94 [17470644.001]
  • [Cites] Histol Histopathol. 2007 Nov;22(11):1251-67 [17647198.001]
  • [Cites] BMC Genet. 2007;8:43 [17601350.001]
  • [Cites] Arthritis Rheum. 2007 Jul;56(7):2180-91 [17599731.001]
  • [Cites] Curr Neurovasc Res. 2007 Aug;4(3):194-204 [17691973.001]
  • [Cites] JAMA. 2007 Aug 15;298(7):765-75 [17699010.001]
  • [Cites] N Engl J Med. 2007 Aug 16;357(7):673-81 [17699817.001]
  • [Cites] Biomed Pharmacother. 2007 Aug;61(7):390-9 [17178208.001]
  • [Cites] J Biol Chem. 2007 Aug 24;282(34):24574-82 [17604275.001]
  • [Cites] Dev Neurosci. 2007;29(4-5):321-30 [17762200.001]
  • [Cites] J Cell Physiol. 2007 Nov;213(2):434-9 [17520690.001]
  • [Cites] N Engl J Med. 2007 Sep 6;357(10):965-76 [17804841.001]
  • [Cites] Br J Pharmacol. 2007 Sep;152(2):230-9 [17641676.001]
  • [Cites] J Glaucoma. 2007 Sep;16(6):567-71 [17873720.001]
  • [Cites] J Cardiovasc Pharmacol Ther. 2007 Sep;12(3):237-47 [17875952.001]
  • [Cites] Mol Ther. 2007 Oct;15(10):1751-66 [17680029.001]
  • [Cites] Am Heart J. 2007 Oct;154(4):645.e9-15 [17892986.001]
  • [Cites] Curr Med Chem. 2007;14(21):2278-87 [17896976.001]
  • [Cites] Pharmacol Rep. 2007 Jul-Aug;59(4):393-401 [17901567.001]
  • [Cites] Cancer Res. 2007 Oct 1;67(19):9018-23 [17909003.001]
  • [Cites] Antioxid Redox Signal. 2007 Oct;9(10):1659-75 [17867931.001]
  • [Cites] Cancer Sci. 2007 Dec;98(12):1949-58 [17900262.001]
  • [Cites] Neurol Clin. 2007 Nov;25(4):891-924, vii [17964020.001]
  • [Cites] Oncogene. 2007 Nov 1;26(50):7081-91 [17496928.001]
  • [Cites] Genes Dev. 2007 Nov 1;21(21):2775-87 [17974917.001]
  • [Cites] J Clin Invest. 2007 Nov;117(11):3211-23 [17965779.001]
  • [Cites] Virology. 2007 Nov 25;368(2):249-61 [17669459.001]
  • [Cites] Cancer Gene Ther. 2007 Dec;14(12):945-52 [17885675.001]
  • [Cites] Cardiology. 2007;108(4):228-36 [17106196.001]
  • [Cites] J Pharmacol Exp Ther. 2007 Dec;323(3):759-62 [17717190.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1859-67 [17828550.001]
  • [Cites] J Cell Physiol. 2008 Feb;214(2):491-503 [17960565.001]
  • [Cites] Mol Med. 2007 Nov-Dec;13(11-12):561-6 [17873969.001]
  • [Cites] Curr Neurovasc Res. 2007 Nov;4(4):295-302 [18045156.001]
  • [Cites] Nucleic Acids Res. 2007;35(20):6984-94 [17940099.001]
  • [Cites] Brain Res. 2007 Dec 14;1185:321-7 [17961521.001]
  • [Cites] Oncogene. 2007 Dec 6;26(55):7647-55 [17563745.001]
  • [Cites] Biochim Biophys Acta. 2008 Jan;1785(1):63-84 [17980712.001]
  • [Cites] World J Gastroenterol. 2007 Dec 14;13(46):6172-82 [18069756.001]
  • [Cites] J Pharmacol Exp Ther. 2008 Jan;324(1):160-9 [17928571.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20517-22 [18077353.001]
  • [Cites] Proteomics. 2008 Mar;8(6):1237-47 [18338825.001]
  • [Cites] Cytokine Growth Factor Rev. 2008 Apr;19(2):145-55 [18299246.001]
  • [Cites] Endocrinology. 2008 Apr;149(4):1942-50 [18096667.001]
  • [Cites] Cell Stem Cell. 2007 Jun 7;1(1):101-12 [18371339.001]
  • [Cites] Histol Histopathol. 2005 Jan;20(1):299-315 [15578447.001]
  • (PMID = 19802503.001).
  • [ISSN] 1537-744X
  • [Journal-full-title] TheScientificWorldJournal
  • [ISO-abbreviation] ScientificWorldJournal
  • [Language] ENG
  • [Grant] United States / NIEHS NIH HHS / ES / P30 ES06639; United States / NINDS NIH HHS / NS / R01 NS053946-01A2; United States / NINDS NIH HHS / NS / R01 NS053946-03S1; United States / NINDS NIH HHS / NS / R01 NS053946-03; United States / NIEHS NIH HHS / ES / P30 ES006639; United States / NINDS NIH HHS / NS / R01 NS053946-02; United States / NINDS NIH HHS / NS / R01 NS053946
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Forkhead Transcription Factors; 0 / Receptors, Erythropoietin; 11096-26-7 / Erythropoietin
  • [Number-of-references] 409
  • [Other-IDs] NLM/ NIHMS150105; NLM/ PMC2762199
  •  go-up   go-down


25. Ozekes S, Osman O, Ucan ON: Nodule detection in a lung region that's segmented with using genetic cellular neural networks and 3D template matching with fuzzy rule based thresholding. Korean J Radiol; 2008 Jan-Feb;9(1):1-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nodule detection in a lung region that's segmented with using genetic cellular neural networks and 3D template matching with fuzzy rule based thresholding.
  • First, to reduce the number of region of interests (ROIs) and the computation time, the lung regions of the CTs were segmented using Genetic Cellular Neural Networks (G-CNN).
  • RESULTS: The computer aided diagnosis (CAD) system achieved 100% sensitivity with 13.375 FPs per case when the nodule thickness was greater than or equal to 5.625 mm.
  • [MeSH-major] Diagnosis, Computer-Assisted. Lung Neoplasms / radiography. Neural Networks (Computer). Tomography, X-Ray Computed


26. Bindukumar B, Schwartz SA, Nair MP, Aalinkeel R, Kawinski E, Chadha KC: Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth. Neoplasia; 2005 Mar;7(3):241-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Prostate-specific antigen (PSA) is a serine protease that is widely used as a surrogate marker in the early diagnosis and management of prostate cancer.
  • Confluent monolayers of prostate cancer cell lines, PC-3M and LNCaP, were treated with f-PSA in a series of in vitro experiments to determine the changes in expression of various genes that are known to regulate tumor growth and metastasis.
  • Gene array, quantitative polymerase chain reaction (QPCR), and enzyme-linked immunosorbent assay (ELISA) results show significant changes in the expression of various cancer-related genes in PC-3M and LNCaP cells treated with f-PSA.

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer Screening.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Biochem. 2004 Jan 1;91(1):125-50 [14689586.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):113-20 [15556523.001]
  • [Cites] Cancer Res. 2004 Mar 15;64(6):1987-96 [15026334.001]
  • [Cites] Int J Biol Markers. 2004 Apr-Jun;19(2):164-7 [15255551.001]
  • [Cites] Cancer Res. 2004 Aug 1;64(15):5311-21 [15289337.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Sep;89(9):4391-6 [15356036.001]
  • [Cites] Cancer Res. 1983 Apr;43(4):1809-18 [6831420.001]
  • [Cites] Cancer Res. 2004 Mar 1;64(5):1722-9 [14996732.001]
  • [Cites] Prostate. 1999 Dec 1;41(4):275-80 [10544301.001]
  • [Cites] Br J Cancer. 1999 Dec;81(8):1269-73 [10604721.001]
  • [Cites] Clin Cancer Res. 2000 Jan;6(1):160-5 [10656445.001]
  • [Cites] Clin Chem. 2000 Jul;46(7):896-900 [10894830.001]
  • [Cites] Anticancer Res. 2000 May-Jun;20(3B):2151-4 [10928169.001]
  • [Cites] Urology. 2000 Sep 1;56(3):527-32 [10962338.001]
  • [Cites] Ann N Y Acad Sci. 2000;926:192-203 [11193035.001]
  • [Cites] J Chromatogr B Biomed Sci Appl. 2001 Apr 25;754(2):521-5 [11339296.001]
  • [Cites] Br J Cancer. 2001 Jun 1;84(11):1512-9 [11384102.001]
  • [Cites] Cancer Res. 2001 Jun 15;61(12):4683-8 [11406537.001]
  • [Cites] Clin Cancer Res. 2001 Jun;7(6):1533-8 [11410487.001]
  • [Cites] Nature. 2001 Aug 23;412(6849):822-6 [11518967.001]
  • [Cites] Carcinogenesis. 2001 Nov;22(11):1775-80 [11698338.001]
  • [Cites] Prostate. 2002 Feb 15;50(3):145-53 [11813206.001]
  • [Cites] J Urol. 2002 Nov;168(5):2001-5 [12394695.001]
  • [Cites] Cancer Res. 2003 May 15;63(10):2477-82 [12750269.001]
  • [Cites] Prostate. 2003 Aug 1;56(3):212-9 [12772191.001]
  • [Cites] Cancer Res. 1997 Nov 1;57(21):4924-30 [9354459.001]
  • [Cites] FASEB J. 2003 Jun;17(9):1081-8 [12773490.001]
  • [Cites] Angiogenesis. 2002;5(3):153-65 [12831056.001]
  • [Cites] Oncogene. 2003 Jul 31;22(31):4831-40 [12894224.001]
  • [Cites] J Cell Physiol. 2003 Oct;197(1):131-8 [12942549.001]
  • [Cites] Oncogene. 2003 Nov 27;22(54):8758-73 [14647471.001]
  • [Cites] Proc Natl Acad Sci U S A. 1986 May;83(10):3166-70 [2422647.001]
  • [Cites] Anal Biochem. 1987 Apr;162(1):156-9 [2440339.001]
  • [Cites] J Clin Invest. 1987 Aug;80(2):281-5 [3611349.001]
  • [Cites] Nature. 1989 May 4;339(6219):58-61 [2469964.001]
  • [Cites] J Urol. 1990 Dec;144(6):1523-6 [1700162.001]
  • [Cites] Mol Cell Biol. 1990 Dec;10(12):6316-24 [2174105.001]
  • [Cites] J Clin Endocrinol Metab. 1991 Aug;73(2):401-7 [1713219.001]
  • [Cites] Int J Cancer. 1991 Nov 11;49(5):645-9 [1718912.001]
  • [Cites] J Biol Chem. 1992 Jun 5;267(16):10931-4 [1375931.001]
  • [Cites] J Urol. 1992 Jul;148(1):21-3 [1377289.001]
  • [Cites] J Natl Cancer Inst. 1992 Jun 17;84(12):951-7 [1378502.001]
  • [Cites] Clin Chem. 1993 Feb;39(2):181-95 [7679336.001]
  • [Cites] Thromb Haemost. 1992 Dec 7;68(6):662-6 [1337629.001]
  • [Cites] Annu Rev Immunol. 1993;11:571-611 [8476573.001]
  • [Cites] J Clin Endocrinol Metab. 1994 Jun;78(6):1536-9 [7515392.001]
  • [Cites] J Biol Chem. 1994 Jun 17;269(24):16766-73 [8207000.001]
  • [Cites] Nature. 1994 Jul 7;370(6484):14-5 [8015594.001]
  • [Cites] Immunity. 1994 Sep;1(6):447-56 [7895156.001]
  • [Cites] Scand J Clin Lab Invest Suppl. 1995;221:105-12 [7544479.001]
  • [Cites] EMBO J. 1996 Apr 15;15(8):2030 [8617250.001]
  • [Cites] Mol Cell Endocrinol. 1996 Mar 1;117(1):53-8 [8734473.001]
  • [Cites] Nature. 1997 Sep 18;389(6648):300-5 [9305847.001]
  • [Cites] Clin Chem. 1997 Oct;43(10):1862-7 [9342005.001]
  • [Cites] Am J Physiol. 1997 Oct;273(4 Pt 1):G824-32 [9357823.001]
  • [Cites] Crit Rev Oncog. 1996;7(5-6):343-432 [9467665.001]
  • [Cites] Anticancer Res. 1997 Nov-Dec;17(6D):4735-7 [9494598.001]
  • [Cites] Clin Cancer Res. 1998 Jun;4(6):1489-97 [9626467.001]
  • [Cites] Clin Cancer Res. 1996 Sep;2(9):1627-36 [9816342.001]
  • [Cites] Clin Chem. 1999 Jun;45(6 Pt 1):814-21 [10351990.001]
  • [Cites] Cancer Chemother Pharmacol. 1999;43 Suppl:S78-84 [10357564.001]
  • [Cites] J Natl Cancer Inst. 1999 Oct 6;91(19):1635-40 [10511590.001]
  • [ErratumIn] Neoplasia. 2005 May;7(5):544
  • (PMID = 15799824.001).
  • [ISSN] 1522-8002
  • [Journal-full-title] Neoplasia (New York, N.Y.)
  • [ISO-abbreviation] Neoplasia
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proto-Oncogene Proteins; 0 / Vascular Endothelial Growth Factor A; 63231-63-0 / RNA; 82115-62-6 / Interferon-gamma; EC 2.7.11.1 / PIM1 protein, human; EC 2.7.11.1 / Pim1 protein, mouse; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.1 / Proto-Oncogene Proteins c-pim-1; EC 3.4.21.73 / Urokinase-Type Plasminogen Activator; EC 3.4.21.77 / Prostate-Specific Antigen
  • [Other-IDs] NLM/ PMC1501136
  •  go-up   go-down


27. Kam Y, Guess C, Estrada L, Weidow B, Quaranta V: A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro. BMC Cancer; 2008 Jul 14;8:198
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro.
  • We examined 3 cancer cell lines (MCF-7, SCOV-3, and MDA-MB-231), each with a different established degree of aggressiveness, to test our assay's ability to detect diverse levels of invasiveness.
  • We also applied the CIA technique to DLD-1 cells in the presence of lysophosphatidic acid (LPA), a bioactive lipid that was recently shown to stimulate cancer cell colony dispersal into single migratory cells, in order to validate our method's ability to detect collective and individual motility.
  • CONCLUSION: Given its ability to both determine pseudo-realistic invasive cell behavior in vitro and capture subtle differences in cell motility, we propose that our CIA method may shed some light on the cellular mechanisms underlying cancer invasion and deserves inclusion in further studies.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann N Y Acad Sci. 1997 Dec 29;833:137-46 [9616746.001]
  • [Cites] Cancer. 1997 Oct 15;80(8 Suppl):1529-37 [9362419.001]
  • [Cites] Methods Mol Biol. 2005;294:97-105 [15576908.001]
  • [Cites] Trends Cell Biol. 2005 Mar;15(3):138-45 [15752977.001]
  • [Cites] Physiology (Bethesda). 2005 Jun;20:194-200 [15888576.001]
  • [Cites] J Cell Physiol. 2006 Feb;206(2):337-46 [16110477.001]
  • [Cites] Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42 [16493418.001]
  • [Cites] Trends Cell Biol. 2006 May;16(5):250-6 [16580836.001]
  • [Cites] Am J Physiol Cell Physiol. 2006 Jul;291(1):C68-75 [16495370.001]
  • [Cites] Cell. 2006 Nov 17;127(4):679-95 [17110329.001]
  • [Cites] Mol Cancer Res. 2006 Dec;4(12):905-13 [17189381.001]
  • [Cites] Nat Protoc. 2007;2(2):329-33 [17406593.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):15988-93 [17905871.001]
  • [Cites] Gynecol Oncol. 2007 Nov;107(2):298-309 [17716713.001]
  • [Cites] Cell Mol Life Sci. 2007 Dec;64(24):3201-18 [17957337.001]
  • [Cites] J Biochem Mol Biol. 2003 Jan 31;36(1):128-37 [12542983.001]
  • [Cites] Cell Mol Life Sci. 2000 Jan 20;57(1):41-64 [10949580.001]
  • [Cites] Anal Biochem. 2001 May 15;292(2):287-95 [11355863.001]
  • [Cites] Science. 2001 Nov 23;294(5547):1708-12 [11721053.001]
  • [Cites] Cancer Res. 2002 Sep 15;62(18):5301-7 [12235000.001]
  • [Cites] Nat Rev Cancer. 2003 May;3(5):362-74 [12724734.001]
  • [Cites] Nat Rev Cancer. 2003 Dec;3(12):921-30 [14737122.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1554-9 [14747654.001]
  • [Cites] Curr Opin Cell Biol. 2004 Feb;16(1):14-23 [15037300.001]
  • [Cites] J Biol Chem. 2004 Apr 23;279(17):17634-9 [14744855.001]
  • [Cites] Histochem Cell Biol. 2004 Sep;122(3):183-90 [15258769.001]
  • [Cites] J Natl Cancer Inst. 1977 Jul;59(1):221-6 [327080.001]
  • [Cites] In Vitro. 1978 Nov;14(11):911-5 [730202.001]
  • [Cites] Cancer Res. 1979 Mar;39(3):1020-5 [427742.001]
  • [Cites] Nature. 1980 Mar 6;284(5751):67-8 [6243750.001]
  • [Cites] Cancer Res. 1987 Jun 15;47(12):3239-45 [2438036.001]
  • [Cites] Cancer Res. 1992 Apr 15;52(8):2353-6 [1313744.001]
  • [Cites] Int J Cancer. 1992 Sep 9;52(2):234-40 [1521911.001]
  • [Cites] Cancer. 1993 Jan 15;71(2):315-21 [8422623.001]
  • [Cites] Biochem Biophys Res Commun. 1993 Jun 15;193(2):497-503 [8390242.001]
  • [Cites] J Clin Gastroenterol. 1995;21 Suppl 1:S40-4 [8774989.001]
  • [Cites] Gan To Kagaku Ryoho. 1997 Jan;24(2):187-95 [9030229.001]
  • [Cites] Science. 1997 Apr 4;276(5309):75-81 [9082989.001]
  • [Cites] Clin Exp Metastasis. 1997 May;15(3):272-306 [9174129.001]
  • [Cites] Cancer Res. 1999 Sep 15;59(18):4574-7 [10493510.001]
  • (PMID = 18625060.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA047858; United States / NCI NIH HHS / CA / U54 CA113007; United States / NCI NIH HHS / CA / CA47858-17A2; United States / NCI NIH HHS / CA / U54CA113007-04
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2491634
  •  go-up   go-down


28. Maiese K, Chong ZZ, Hou J, Shang YC: Oxidative stress: Biomarkers and novel therapeutic pathways. Exp Gerontol; 2010 Mar;45(3):217-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Oxidative stress significantly impacts multiple cellular pathways that can lead to the initiation and progression of varied disorders throughout the body.
  • It therefore becomes imperative to elucidate the components and function of novel therapeutic strategies against oxidative stress to further clinical diagnosis and care.
  • In particular, both the growth factor and cytokine erythropoietin (EPO) and members of the mammalian forkhead transcription factors of the O class (FoxOs) may offer the greatest promise for new treatment regimens since these agents and the cellular pathways they oversee cover a range of critical functions that directly influence progenitor cell development, cell survival and degeneration, metabolism, immune function, and cancer cell invasion.
  • Furthermore, both EPO and FoxOs function not only as therapeutic targets, but also as biomarkers of disease onset and progression, since their cellular pathways are closely linked and overlap with several unique signal transduction pathways.
  • Here we present the exciting as well as complicated role EPO and FoxOs possess to uncover the benefits as well as the risks of these agents for cell biology and clinical care in processes that range from stem cell development to uncontrolled cellular proliferation.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • [Cites] Pediatrics. 2006 Sep;118(3):e635-40 [16908620.001]
  • [Cites] Semin Nephrol. 2006 Jul;26(4):296-306 [16949468.001]
  • [Cites] Circulation. 2006 Sep 19;114(12):1269-76 [16952980.001]
  • [Cites] Eur J Endocrinol. 2006 Oct;155(4):609-14 [16990661.001]
  • [Cites] Int J Cardiol. 2006 Oct 10;112(3):341-7 [16309765.001]
  • [Cites] Diabetes. 2006 Oct;55(10):2863-70 [17003354.001]
  • [Cites] J Am Soc Nephrol. 2006 Oct;17(10):2812-20 [16943306.001]
  • [Cites] J Clin Oncol. 2006 Oct 10;24(29):4675-6 [17028292.001]
  • [Cites] J Med Genet. 2006 Oct;43(10):798-803 [16723389.001]
  • [Cites] Nephron Exp Nephrol. 2006;104(3):e83-8 [16837817.001]
  • [Cites] Fertil Steril. 2006 Nov;86(5):1518-21 [16979636.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16260-5 [17053067.001]
  • [Cites] Eur J Immunol. 2006 Nov;36(11):2971-80 [17051618.001]
  • [Cites] J Thromb Haemost. 2006 Dec;4(12):2656-63 [16961585.001]
  • [Cites] J Control Release. 2006 Nov10;116(1):28-34 [17081643.001]
  • [Cites] Am Heart J. 2006 Dec;152(6):1096.e9-15 [17161060.001]
  • [Cites] Development. 2007 Jan;134(1):199-209 [17164425.001]
  • [Cites] Prog Retin Eye Res. 2007 Jan;26(1):1-37 [17074526.001]
  • [Cites] J Neurooncol. 2007 Jan;81(1):81-91 [16858513.001]
  • [Cites] Int J Mol Med. 2007 Feb;19(2):263-72 [17203200.001]
  • [Cites] J Virol. 2007 Feb;81(3):1511-6 [17108038.001]
  • [Cites] Cell Signal. 2007 Mar;19(3):634-45 [17045782.001]
  • [Cites] Epilepsia. 2007 Jan;48(1):175-81 [17241225.001]
  • [Cites] Cell. 2007 Jan 26;128(2):309-23 [17254969.001]
  • [Cites] Cell. 2007 Jan 26;128(2):325-39 [17254970.001]
  • [Cites] Neurobiol Dis. 2007 Feb;25(2):412-26 [17166730.001]
  • [Cites] Diabetes. 2007 Feb;56(2):295-303 [17259372.001]
  • [Cites] Diabetes. 2007 Feb;56(2):389-93 [17259383.001]
  • [Cites] Blood. 2007 Feb 15;109(4):1627-35 [17062728.001]
  • [Cites] Cell Death Differ. 2007 Mar;14(3):534-47 [16888645.001]
  • [Cites] Curr Neurovasc Res. 2007 Feb;4(1):63-71 [17311546.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 Mar;27(3):469-76 [16804549.001]
  • [Cites] J Clin Neurosci. 2007 Apr;14(4):364-8 [17236773.001]
  • [Cites] Br J Cancer. 2007 Mar 12;96(5):692-700 [17299396.001]
  • [Cites] Exp Neurol. 2007 Mar;204(1):106-17 [17157835.001]
  • [Cites] Mol Cell Biol. 2007 Apr;27(7):2676-86 [17242183.001]
  • [Cites] Mediators Inflamm. 2006;2006(5):18061 [17392570.001]
  • [Cites] Br J Pharmacol. 2007 Apr;150(7):839-50 [17339844.001]
  • [Cites] Clin Exp Dermatol. 2007 May;32(3):287-90 [17397351.001]
  • [Cites] J Biol Chem. 2007 Apr 13;282(15):11590-601 [17308309.001]
  • [Cites] Cell Signal. 2007 Jun;19(6):1150-62 [17289346.001]
  • [Cites] Eur Surg Res. 2007;39(3):189-97 [17377393.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 May;27(5):1043-54 [17077815.001]
  • [Cites] J Neuropathol Exp Neurol. 2007 May;66(5):389-98 [17483696.001]
  • [Cites] Biochim Biophys Acta. 2007 Apr;1769(4):244-52 [17482685.001]
  • [Cites] Mol Cell Biol. 2007 May;27(10):3839-3854 [17353275.001]
  • [Cites] Nat Rev Mol Cell Biol. 2007 Jun;8(6):440-50 [17522590.001]
  • [Cites] Adv Ther. 2007 Mar-Apr;24(2):346-52 [17565925.001]
  • [Cites] Clin Cancer Res. 2007 Jun 15;13(12):3536-44 [17575216.001]
  • [Cites] Mol Cell Biol. 2007 Jul;27(13):4917-30 [17452451.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 Jul;27(7):1369-76 [17264861.001]
  • [Cites] Apoptosis. 2007 Aug;12(8):1365-75 [17508273.001]
  • [Cites] FASEB J. 2007 Jul;21(9):2226-36 [17369508.001]
  • [Cites] Eur J Neurosci. 2007 Jul;26(1):90-100 [17614942.001]
  • [Cites] J Mol Neurosci. 2005;25(2):183-9 [15784966.001]
  • [Cites] Mol Cancer Res. 2005 Mar;3(3):163-9 [15798096.001]
  • [Cites] J Cell Biol. 2005 Apr 25;169(2):331-9 [15837797.001]
  • [Cites] J Am Coll Cardiol. 2005 May 3;45(9):1406-12 [15862410.001]
  • [Cites] Prog Neurobiol. 2005 Feb;75(3):207-46 [15882775.001]
  • [Cites] Nat Med. 2005 Jun;11(6):666-71 [15895074.001]
  • [Cites] Brain Res Brain Res Rev. 2005 Jul;49(1):1-21 [15960984.001]
  • [Cites] Brain Res. 2005 Jul 19;1050(1-2):15-26 [15979589.001]
  • [Cites] Mol Ther. 2005 Aug;12(2):283-9 [15935736.001]
  • [Cites] Dev Cell. 2005 Aug;9(2):261-70 [16054032.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11278-83 [16076959.001]
  • [Cites] J Biol Chem. 2005 Aug 19;280(33):29864-73 [15961397.001]
  • [Cites] Neurosci Lett. 2005 Oct 14;387(1):5-10 [16054296.001]
  • [Cites] Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1223-33 [16115027.001]
  • [Cites] Endocrinology. 2005 Oct;146(10):4370-6 [16020479.001]
  • [Cites] Curr Neurovasc Res. 2005 Jan;2(1):55-72 [16181100.001]
  • [Cites] Curr Neurovasc Res. 2005 Jul;2(3):197-211 [16181114.001]
  • [Cites] Curr Neurovasc Res. 2005 Oct;2(4):271-85 [16181120.001]
  • [Cites] Curr Neurovasc Res. 2005 Oct;2(4):331-40 [16181124.001]
  • [Cites] J Biol Chem. 2005 Sep 30;280(39):33558-65 [16061480.001]
  • [Cites] Sports Med. 2005;35(10):831-40 [16180943.001]
  • [Cites] Genes Dev. 2005 Oct 15;19(20):2435-46 [16230533.001]
  • [Cites] Biochem J. 2005 Nov 1;391(Pt 3):623-9 [15987244.001]
  • [Cites] Histol Histopathol. 2006 Jan;21(1):103-24 [16267791.001]
  • [Cites] Curr Neurovasc Res. 2005 Dec;2(5):387-99 [16375720.001]
  • [Cites] Curr Neurovasc Res. 2005 Dec;2(5):425-46 [16375723.001]
  • [Cites] Ann Hematol. 2006 Feb;85(2):79-85 [16132904.001]
  • [Cites] Cancer Res. 2006 Jan 1;66(1):212-20 [16397234.001]
  • [Cites] Gene Expr Patterns. 2006 Jan;6(2):134-40 [16326148.001]
  • [Cites] J Neurochem. 2006 Feb;96(4):1101-10 [16417583.001]
  • [Cites] J Clin Invest. 2006 Feb;116(2):344-56 [16453021.001]
  • [Cites] Curr Neurovasc Res. 2006 Feb;3(1):25-39 [16472123.001]
  • [Cites] Mutat Res. 2006 Feb 22;594(1-2):155-61 [16289600.001]
  • [Cites] J Pharmacol Exp Ther. 2006 Mar;316(3):999-1005 [16306273.001]
  • [Cites] Nat Genet. 2006 Mar;38(3):320-3 [16415884.001]
  • [Cites] Mol Cancer Ther. 2006 Feb;5(2):356-61 [16505109.001]
  • [Cites] J Neurosci Res. 2006 Mar;83(4):584-93 [16435392.001]
  • [Cites] J Infect Dis. 2006 Apr 1;193(7):987-95 [16518761.001]
  • [Cites] Brain Res Bull. 2006 Mar 31;69(2):117-22 [16533659.001]
  • [Cites] J Pharmacol Exp Ther. 2006 Apr;317(1):109-16 [16357210.001]
  • [Cites] J Pharmacol Exp Ther. 2006 Apr;317(1):68-75 [16377761.001]
  • [Cites] J Am Soc Nephrol. 2006 Apr;17(4):932-42 [16481411.001]
  • [Cites] Obesity (Silver Spring). 2006 Feb;14(2):188-93 [16571842.001]
  • [Cites] Curr Med Chem. 2006;13(8):883-95 [16611073.001]
  • [Cites] Neurosci Lett. 2006 May 1;398(1-2):39-43 [16423457.001]
  • [Cites] PLoS Med. 2006 Apr;3(4):e101 [16478293.001]
  • [Cites] Eur J Cardiothorac Surg. 2006 Jun;29(6):902-7 [16675226.001]
  • [Cites] Cancer Immunol Immunother. 2006 Sep;55(9):1064-71 [16328385.001]
  • [Cites] Curr Neurovasc Res. 2006 May;3(2):107-17 [16719794.001]
  • [Cites] Curr Drug Targets Cardiovasc Haematol Disord. 2003 Jun;3(2):141-54 [12769640.001]
  • [Cites] J Am Soc Nephrol. 2006 Jun;17(6):1576-84 [16672321.001]
  • [Cites] Nature. 2006 May 25;441(7092):523-7 [16680151.001]
  • [Cites] Cell. 2006 Jun 2;125(5):987-1001 [16751106.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9051-6 [16757565.001]
  • [Cites] Biochem J. 2006 Jul 15;397(2):233-46 [16792526.001]
  • [Cites] J Cardiovasc Pharmacol. 2006 Jun;47(6):736-41 [16810073.001]
  • [Cites] Diabetes. 2006 Aug;55(8):2231-7 [16873685.001]
  • [Cites] Clin Sci (Lond). 2006 Sep;111(3):171-83 [16901264.001]
  • [Cites] Diabet Med. 2006 Aug;23(8):839-44 [16911620.001]
  • [Cites] Acta Biomed. 2005;76 Suppl 3:49-54 [16915797.001]
  • [Cites] Curr Neurovasc Res. 2006 Aug;3(3):187-201 [16918383.001]
  • [Cites] Cancer Biol Ther. 2006 Jul;5(7):875-83 [16861905.001]
  • [Cites] Nat Clin Pract Nephrol. 2005 Dec;1(2):87-97 [16932374.001]
  • [Cites] Diabetes. 2006 Sep;55(9):2649-53 [16936217.001]
  • [Cites] Antioxid Redox Signal. 2004 Apr;6(2):277-87 [15025929.001]
  • [Cites] Science. 2004 Mar 26;303(5666):2011-5 [14976264.001]
  • [Cites] Brain Res. 2004 Mar 12;1000(1-2):19-31 [15053948.001]
  • [Cites] Cell. 2004 Apr 16;117(2):225-37 [15084260.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2004 May;31(5):733-9 [14985868.001]
  • [Cites] Exp Cell Res. 2004 Jun 10;296(2):196-207 [15149850.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9855-60 [15210945.001]
  • [Cites] J Am Coll Cardiol. 2004 Jul 7;44(1):63-7 [15234408.001]
  • [Cites] J Cereb Blood Flow Metab. 2004 Jul;24(7):728-43 [15241181.001]
  • [Cites] Restor Neurol Neurosci. 2004;22(2):87-104 [15272144.001]
  • [Cites] Restor Neurol Neurosci. 2004;22(2):105-19 [15272145.001]
  • [Cites] J Biol Chem. 2004 Aug 13;279(33):34741-9 [15184386.001]
  • [Cites] Immunity. 2004 Aug;21(2):203-13 [15308101.001]
  • [Cites] Front Biosci. 2004 Sep 1;9:2500-20 [15353303.001]
  • [Cites] Cancer Lett. 2004 Oct 28;214(2):171-9 [15363543.001]
  • [Cites] J Biol Chem. 2004 Sep 24;279(39):41114-23 [15272020.001]
  • [Cites] J Exp Med. 2004 Oct 18;200(8):1051-62 [15492127.001]
  • [Cites] Trends Pharmacol Sci. 2004 Nov;25(11):577-83 [15491780.001]
  • [Cites] Blood. 1974 Jul;44(1):77-85 [4834517.001]
  • [Cites] Nature. 1985 Feb 28-Mar 6;313(6005):806-10 [3838366.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Nov;82(22):7580-4 [3865178.001]
  • [Cites] Biochemistry. 1988 Jul 26;27(15):5646-54 [3179269.001]
  • [Cites] Cell. 1989 May 19;57(4):645-58 [2566386.001]
  • [Cites] Eur J Biochem. 1990 Mar 10;188(2):405-11 [2156701.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Aug;87(15):5978-82 [2165612.001]
  • [Cites] Kidney Int. 1990 Nov;38(5):969-75 [2266682.001]
  • [Cites] Blood. 1991 Feb 1;77(3):419-34 [1991159.001]
  • [Cites] Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):14-9 [1928074.001]
  • [Cites] Am Heart J. 1992 Aug;124(2):424-7 [1386184.001]
  • [Cites] Nature. 1993 Jul 29;364(6436):412-20 [8332212.001]
  • [Cites] J Neurosci Res. 1993 Sep 1;36(1):77-87 [8230323.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3974-8 [8171022.001]
  • [Cites] Genes Chromosomes Cancer. 1994 Oct;11(2):79-84 [7529552.001]
  • [Cites] J Cereb Blood Flow Metab. 1995 May;15(3):440-9 [7714002.001]
  • [Cites] Eur J Biochem. 1996 Jul 15;239(2):494-500 [8706759.001]
  • [Cites] J Neurochem. 1997 Feb;68(2):710-4 [9003060.001]
  • [Cites] Circulation. 1997 May 6;95(9):2303-11 [9142009.001]
  • [Cites] J Cereb Blood Flow Metab. 1997 May;17(5):560-6 [9183294.001]
  • [Cites] Blood. 1997 Nov 1;90(9):3714-9 [9345057.001]
  • [Cites] Free Radic Res. 1997 Sep;27(3):311-23 [9350435.001]
  • [Cites] Nature. 1997 Oct 30;389(6654):994-9 [9353126.001]
  • [Cites] Science. 1997 Nov 14;278(5341):1319-22 [9360933.001]
  • [Cites] Biochemistry. 1998 Apr 28;37(17):6179-87 [9558357.001]
  • [Cites] Arch Biochem Biophys. 1998 May 15;353(2):312-21 [9606965.001]
  • [Cites] J Biol Chem. 1998 Sep 25;273(39):25381-7 [9738005.001]
  • [Cites] Exp Neurol. 1999 Jan;155(1):79-94 [9918707.001]
  • [Cites] Exp Cell Res. 1999 Feb 1;246(2):290-300 [9925743.001]
  • [Cites] Cell Biochem Biophys. 1999;30(1):153-66 [10099826.001]
  • [Cites] J Histochem Cytochem. 1999 May;47(5):661-72 [10219058.001]
  • [Cites] J Biol Chem. 1999 Jun 4;274(23):15982-5 [10347145.001]
  • [Cites] J Biol Chem. 1999 Jun 11;274(24):17184-92 [10358076.001]
  • [Cites] J Neurobiol. 1999 Aug;40(2):171-84 [10413448.001]
  • [Cites] Blood. 1950 Apr;5(4):372-80 [15411424.001]
  • [Cites] Science. 2004 Nov 12;306(5699):1190-4 [15498972.001]
  • [Cites] Acta Med Okayama. 2004 Aug;58(4):197-205 [15551757.001]
  • [Cites] Diabetologia. 2004 Oct;47(10):1695-703 [15502930.001]
  • [Cites] Histol Histopathol. 2005 Jan;20(1):299-315 [15578447.001]
  • [Cites] BMC Neurosci. 2004 Nov 29;5:48 [15569384.001]
  • [Cites] Neurosignals. 2004 Nov-Dec;13(6):265-89 [15627815.001]
  • [Cites] JAMA. 2005 Jan 5;293(1):90-5 [15632341.001]
  • [Cites] Cancer Res. 2005 Jan 1;65(1):284-90 [15665305.001]
  • [Cites] Curr Opin Neurobiol. 2005 Feb;15(1):101-7 [15721751.001]
  • [Cites] Arch Intern Med. 2005 Feb 28;165(4):466-9 [15738380.001]
  • [Cites] Arthritis Rheum. 2005 Mar;52(3):940-50 [15751086.001]
  • [Cites] Br J Ophthalmol. 2009 Dec;93(12):1667-71 [19692373.001]
  • [Cites] J Med Chem. 2009 Dec 10;52(23):7883-6 [19813747.001]
  • [Cites] Oxid Med Cell Longev. 2009 Jan-Mar;2(1):1 [20046637.001]
  • [Cites] Oxid Med Cell Longev. 2009 Jan-Mar;2(1):19-25 [20046641.001]
  • [Cites] Oxid Med Cell Longev. 2009 Jan-Mar;2(1):43-51 [20046644.001]
  • [Cites] Adv Exp Med Biol. 2009;665:242-60 [20429429.001]
  • [Cites] Oxid Med Cell Longev. 2009 Jul-Aug;2(3):119-29 [20592766.001]
  • [Cites] Oxid Med Cell Longev. 2008 Oct-Dec;1(1):1-14 [19750024.001]
  • [Cites] Oxid Med Cell Longev. 2009 Nov-Dec;2(5):279-89 [20716915.001]
  • [Cites] J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1125-31 [18086112.001]
  • [Cites] Neurobiol Aging. 1999 Nov-Dec;20(6):581-9 [10674423.001]
  • [Cites] J Neurosci Res. 2000 Feb 15;59(4):568-80 [10679797.001]
  • [Cites] Genes Dev. 2000 Jan 15;14(2):142-6 [10702024.001]
  • [Cites] J Neurosci Res. 1999 Feb 15;55(4):472-85 [10723057.001]
  • [Cites] J Autoimmun. 2000 May;14(3):221-9 [10756084.001]
  • [Cites] Cell Mol Neurobiol. 2000 Jun;20(3):383-400 [10789835.001]
  • [Cites] Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):423-31 [10817926.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E1038-44 [10827006.001]
  • [Cites] J Cereb Blood Flow Metab. 2000 Sep;20(9):1380-91 [10994860.001]
  • [Cites] J Neurosci Res. 2000 Oct 15;62(2):257-72 [11020218.001]
  • [Cites] J Biochem. 2000 Nov;128(5):731-7 [11056384.001]
  • [Cites] J Biol Chem. 2000 Dec 15;275(50):39754-61 [10995753.001]
  • [Cites] Biochem J. 2000 Jul 15;349(Pt 2):629-34 [10880363.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2000 Dec;279(6):E1242-8 [11093910.001]
  • [Cites] J Cereb Blood Flow Metab. 2001 Mar;21(3):262-75 [11295881.001]
  • [Cites] J Neuropathol Exp Neurol. 2001 Apr;60(4):386-92 [11305874.001]
  • [Cites] Histol Histopathol. 2001 Apr;16(2):633-44 [11332719.001]
  • [Cites] Mamm Genome. 2001 Jun;12(6):416-25 [11353388.001]
  • [Cites] J Biol Chem. 2001 Jan 26;276(4):2571-5 [11073947.001]
  • [Cites] J Am Coll Cardiol. 2001 Jun 1;37(7):1775-80 [11401110.001]
  • [Cites] Neurosci Lett. 2001 Sep 14;310(2-3):173-7 [11585595.001]
  • [Cites] Pediatr Res. 2002 Apr;51(4):472-8 [11919332.001]
  • [Cites] J Cereb Blood Flow Metab. 2002 May;22(5):503-14 [11973422.001]
  • [Cites] J Cell Mol Med. 2002 Jan-Mar;6(1):82-92 [12003671.001]
  • [Cites] J Vasc Res. 2002 Mar-Apr;39(2):131-47 [12011585.001]
  • [Cites] J Biol Chem. 2002 Jul 26;277(30):26729-32 [12048180.001]
  • [Cites] Eur J Neurosci. 2002 Aug;16(4):584-92 [12270034.001]
  • [Cites] Microsc Res Tech. 2002 Nov 15;59(4):331-4 [12424797.001]
  • [Cites] J Biol Chem. 2002 Dec 6;277(49):47928-37 [12351634.001]
  • [Cites] Circulation. 2002 Dec 3;106(23):2973-9 [12460881.001]
  • [Cites] Histol Histopathol. 2003 Jan;18(1):173-89 [12507297.001]
  • [Cites] Exp Biol Med (Maywood). 2003 Jan;228(1):1-14 [12524467.001]
  • [Cites] Circulation. 2003 Jan 21;107(2):294-9 [12538431.001]
  • [Cites] J Neurosci Res. 2003 Mar 1;71(5):659-69 [12584724.001]
  • [Cites] J Biol Chem. 2003 Feb 21;278(8):5871-82 [12488318.001]
  • [Cites] J Hematother Stem Cell Res. 2002 Dec;11(6):863-71 [12590701.001]
  • [Cites] J Cereb Blood Flow Metab. 2003 Mar;23(3):320-30 [12621307.001]
  • [Cites] J Biol Chem. 2003 Apr 4;278(14):12361-6 [12517744.001]
  • [Cites] Br J Pharmacol. 2003 Mar;138(6):1107-18 [12684267.001]
  • [Cites] J Biol Chem. 2003 Apr 18;278(16):13898-904 [12578834.001]
  • [Cites] Transplantation. 2003 Apr 27;75(8):1356-60 [12717230.001]
  • [Cites] Arch Toxicol. 2003 May;77(5):267-73 [12734640.001]
  • [Cites] Trends Pharmacol Sci. 2003 May;24(5):228-32 [12767721.001]
  • [Cites] Science. 2003 Jul 11;301(5630):215-8 [12855809.001]
  • [Cites] Blood. 2003 Aug 15;102(4):1340-6 [12702503.001]
  • [Cites] Circulation. 2003 Aug 5;108(5):616-22 [12835226.001]
  • [Cites] Mol Pharmacol. 2003 Sep;64(3):557-69 [12920191.001]
  • [Cites] J Neurosci Res. 2003 Oct 1;74(1):37-51 [13130504.001]
  • [Cites] Cell Mol Neurobiol. 2003 Oct;23(4-5):561-78 [14514016.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11285-90 [13679577.001]
  • [Cites] Am J Obstet Gynecol. 2003 Dec;189(6):1764-70 [14710111.001]
  • [Cites] Arch Intern Med. 2004 Feb 9;164(3):262-76 [14769622.001]
  • [Cites] Clin Nephrol. 2004 Feb;61(2):127-9 [14989632.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2975-80 [14978268.001]
  • [Cites] Arch Immunol Ther Exp (Warsz). 2008 Jul-Aug;56(4):257-66 [18726147.001]
  • [Cites] Hear Res. 2008 Sep;243(1-2):121-6 [18672044.001]
  • [Cites] Carcinogenesis. 2008 Sep;29(9):1837-44 [18390843.001]
  • [Cites] J Neurosci Res. 2008 Oct;86(13):3018-27 [18512763.001]
  • [Cites] Blood. 2008 Oct 1;112(7):2787-94 [18628488.001]
  • [Cites] J Ocul Pharmacol Ther. 2008 Oct;24(5):453-9 [18788995.001]
  • [Cites] J Biol Chem. 2008 Oct 10;283(41):27810-9 [18678867.001]
  • [Cites] J Neurochem. 2008 Oct;107(1):127-40 [18665912.001]
  • [Cites] Biochem Biophys Res Commun. 2008 Nov 14;376(2):251-5 [18774777.001]
  • [Cites] Cell Cycle. 2008 Oct;7(20):3162-70 [18927507.001]
  • [Cites] Surg Neurol. 2008 Nov;70(5):498-502 [18291472.001]
  • [Cites] Epilepsia. 2008 Oct;49(10):1723-32 [18479396.001]
  • [Cites] Neurosci Lett. 2008 Dec 31;448(3):245-9 [18973793.001]
  • [Cites] Perfusion. 2008 May;23(3):187-92 [19029270.001]
  • [Cites] J Physiol. 2008 Dec 1;586(Pt 23):5757-69 [18845609.001]
  • [Cites] Crit Care. 2008;12(5):227 [18983707.001]
  • [Cites] Neuroepidemiology. 2009;32(1):40-6 [19001795.001]
  • [Cites] Ann Neurol. 2008 Nov;64(5):523-34 [19067366.001]
  • [Cites] J Neurosci Res. 2009 Jan;87(1):150-63 [18711747.001]
  • [Cites] Cell Mol Life Sci. 2008 Dec;65(24):4000-18 [18820996.001]
  • [Cites] Clin Sci (Lond). 2009 Feb;116(3):191-203 [19118491.001]
  • [Cites] J Ren Nutr. 2009 Jan;19(1):20-4 [19121765.001]
  • [Cites] Eur J Pharmacol. 2009 Jan 14;602(2-3):406-12 [19061883.001]
  • [Cites] Trends Parasitol. 2009 Jan;25(1):30-6 [19008152.001]
  • [Cites] Cell Cycle. 2008 Dec 15;7(24):3829-39 [19066462.001]
  • [Cites] J Biol Chem. 2009 Jan 23;284(4):2001-11 [19047055.001]
  • [Cites] Exp Cell Res. 2009 Feb 1;315(3):419-31 [19056379.001]
  • [Cites] Eur J Pharmacol. 2009 Jan 28;603(1-3):50-5 [19105952.001]
  • [Cites] Life Sci. 2009 Feb 13;84(7-8):205-10 [19101571.001]
  • [Cites] Brain Behav Immun. 2009 Feb;23(2):193-203 [18835350.001]
  • [Cites] FASEB J. 2009 Feb;23(2):351-61 [18827024.001]
  • [Cites] Acta Pharmacol Sin. 2009 Feb;30(2):202-8 [19122671.001]
  • [Cites] Pharmacol Biochem Behav. 2009 Apr;92(2):251-9 [19138703.001]
  • [Cites] Neonatology. 2009;95(2):105-16 [18776724.001]
  • [Cites] Placenta. 2009 Mar;30(3):256-62 [19150739.001]
  • [Cites] Crit Care Med. 2009 Mar;37(3):889-98 [19237893.001]
  • [Cites] Adv Exp Med Biol. 2009;643:359-68 [19239167.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1329-35 [18952918.001]
  • [Cites] J Urol. 2009 Mar;181(3):1434-43 [19157461.001]
  • [Cites] Mech Ageing Dev. 2009 Apr;130(4):253-61 [19162061.001]
  • [Cites] Trends Cell Biol. 2009 Mar;19(3):119-29 [19208479.001]
  • [Cites] Immunol Rev. 2009 Mar;228(1):149-69 [19290926.001]
  • [Cites] Cell Calcium. 2009 Apr;45(4):358-68 [19201465.001]
  • [Cites] Chin Med J (Engl). 2009 Mar 5;122(5):566-70 [19323909.001]
  • [Cites] Biochem Biophys Res Commun. 2009 Apr 17;381(4):491-5 [19233143.001]
  • [Cites] Hellenic J Cardiol. 2009 Mar-Apr;50(2):127-32 [19329414.001]
  • [Cites] J Neurochem. 2009 Apr;109(2):360-70 [19220704.001]
  • [Cites] Free Radic Biol Med. 2009 Apr 15;46(8):1032-41 [19136057.001]
  • [Cites] Med Res Rev. 2009 May;29(3):395-418 [18985696.001]
  • [Cites] Glia. 2009 May;57(7):734-43 [18985732.001]
  • [Cites] Curr Neurovasc Res. 2009 Feb;6(1):20-31 [19355923.001]
  • [Cites] J Comp Neurol. 2009 Jun 1;514(4):403-14 [19330822.001]
  • [Cites] Brain. 2009 Apr;132(Pt 4):879-88 [19244253.001]
  • [Cites] Brain Res. 2009 Mar 31;1263:23-32 [19368821.001]
  • [Cites] Stem Cells Dev. 2009 Apr;18(3):411-21 [18590375.001]
  • [Cites] J Neurochem. 2009 May;109(4):1157-67 [19302476.001]
  • [Cites] J Cell Mol Med. 2009 Apr;13(4):701-11 [18410524.001]
  • [Cites] Molecules. 2009;14(9):3446-85 [19783937.001]
  • [Cites] Cell Stem Cell. 2009 Oct 2;5(4):396-408 [19796620.001]
  • [Cites] ScientificWorldJournal. 2009;9:1072-104 [19802503.001]
  • [Cites] J Am Med Dir Assoc. 2009 Nov;10(9):607-16 [19883882.001]
  • [Cites] Curr Neurovasc Res. 2009 Nov;6(4):223-38 [19807657.001]
  • [Cites] Lab Invest. 2009 Dec;89(12):1397-409 [19841616.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20097-102 [19897733.001]
  • [Cites] Cancer Res. 2007 Oct 1;67(19):9018-23 [17909003.001]
  • [Cites] Antioxid Redox Signal. 2007 Oct;9(10):1659-75 [17867931.001]
  • [Cites] Cancer Sci. 2007 Dec;98(12):1949-58 [17900262.001]
  • [Cites] Neurol Clin. 2007 Nov;25(4):891-924, vii [17964020.001]
  • [Cites] Oncogene. 2007 Nov 1;26(50):7081-91 [17496928.001]
  • [Cites] Genes Dev. 2007 Nov 1;21(21):2775-87 [17974917.001]
  • [Cites] J Clin Invest. 2007 Nov;117(11):3211-23 [17965779.001]
  • [Cites] Virology. 2007 Nov 25;368(2):249-61 [17669459.001]
  • [Cites] Cancer Gene Ther. 2007 Dec;14(12):945-52 [17885675.001]
  • [Cites] Cardiology. 2007;108(4):228-36 [17106196.001]
  • [Cites] J Pharmacol Exp Ther. 2007 Dec;323(3):759-62 [17717190.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1859-67 [17828550.001]
  • [Cites] J Cell Physiol. 2008 Feb;214(2):491-503 [17960565.001]
  • [Cites] Mol Med. 2007 Nov-Dec;13(11-12):561-6 [17873969.001]
  • [Cites] Curr Neurovasc Res. 2007 Nov;4(4):295-302 [18045156.001]
  • [Cites] Nucleic Acids Res. 2007;35(20):6984-94 [17940099.001]
  • [Cites] Oncogene. 2007 Dec 6;26(55):7647-55 [17563745.001]
  • [Cites] Biochim Biophys Acta. 2008 Jan;1785(1):63-84 [17980712.001]
  • [Cites] World J Gastroenterol. 2007 Dec 14;13(46):6172-82 [18069756.001]
  • [Cites] J Pharmacol Exp Ther. 2008 Jan;324(1):160-9 [17928571.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20517-22 [18077353.001]
  • [Cites] Mol Cell Endocrinol. 2008 Jan 16;281(1-2):47-55 [18035477.001]
  • [Cites] Mol Cell. 2007 Dec 28;28(6):941-53 [18158893.001]
  • [Cites] Cell Death Differ. 2008 Feb;15(2):299-311 [17992191.001]
  • [Cites] Resuscitation. 2008 Mar;76(3):397-404 [18037223.001]
  • [Cites] Rejuvenation Res. 2008 Feb;11(1):139-50 [18069916.001]
  • [Cites] Gynecol Oncol. 2008 Mar;108(3):609-18 [18234299.001]
  • [Cites] Diabetes. 2008 Mar;57(3):563-76 [18162510.001]
  • [Cites] Clin Dev Immunol. 2007;2007:89195 [18317534.001]
  • [Cites] Br J Haematol. 2008 Apr;141(1):14-31 [18324962.001]
  • [Cites] Cell Signal. 2008 May;20(5):892-906 [18276109.001]
  • [Cites] Expert Rev Cardiovasc Ther. 2008 Mar;6(3):281-4 [18327989.001]
  • [Cites] Proteomics. 2008 Mar;8(6):1237-47 [18338825.001]
  • [Cites] Cytokine Growth Factor Rev. 2008 Apr;19(2):145-55 [18299246.001]
  • [Cites] Endocrinology. 2008 Apr;149(4):1942-50 [18096667.001]
  • [Cites] Cell Stem Cell. 2007 Jun 7;1(1):101-12 [18371339.001]
  • [Cites] Circ Res. 2008 Mar 28;102(6):686-94 [18218983.001]
  • [Cites] J Biol Chem. 2008 Apr 4;283(14):9224-30 [18250171.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):152-9 [17967510.001]
  • [Cites] Cancer Res. 2008 Apr 15;68(8):3001-9 [18413770.001]
  • [Cites] Breast Cancer Res. 2008;10(1):R21 [18312651.001]
  • [Cites] Adv Exp Med Biol. 2008;615:13-23 [18437889.001]
  • [Cites] Pharmacol Ther. 2008 Apr;118(1):58-81 [18313758.001]
  • [Cites] Acta Trop. 2008 May;106(2):104-8 [18359468.001]
  • [Cites] BJU Int. 2008 Jun;101(11):1454-60 [18336616.001]
  • [Cites] Biomed Pharmacother. 2008 Apr-May;62(4):218-32 [18342481.001]
  • [Cites] Trends Mol Med. 2008 May;14(5):219-27 [18403263.001]
  • [Cites] Curr Neurovasc Res. 2008 May;5(2):125-42 [18473829.001]
  • [Cites] N Engl J Med. 2008 May 15;358(20):2107-16 [18480203.001]
  • [Cites] Prog Neurobiol. 2008 Jun;85(2):194-213 [18396368.001]
  • [Cites] Brain Res Bull. 2008 Jul 1;76(4):424-38 [18502319.001]
  • [Cites] Neuropsychopharmacology. 2008 Jul;33(8):1942-51 [17805306.001]
  • [Cites] Eur J Pharmacol. 2008 Jul 7;588(2-3):178-88 [18502414.001]
  • [Cites] Expert Opin Ther Targets. 2008 Jul;12(7):905-16 [18554157.001]
  • [Cites] Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):834-46 [18452700.001]
  • [Cites] Neurochem Res. 2008 Aug;33(8):1599-609 [18461448.001]
  • [Cites] Neuroscience. 2008 Jul 17;154(4):1458-66 [18555616.001]
  • [Cites] J Nephrol. 2008 Jul-Aug;21(4):543-9 [18651544.001]
  • [Cites] Oncogene. 2008 Jul 24;27(32):4422-33 [18391984.001]
  • [Cites] Oncogene. 2008 Aug 7;27(34):4733-44 [18408765.001]
  • [Cites] Curr Neurovasc Res. 2008 Aug;5(3):159-70 [18691073.001]
  • [Cites] J Mol Cell Cardiol. 2008 Aug;45(2):250-60 [18586265.001]
  • [Cites] J Immunol. 2008 Sep 1;181(5):2980-9 [18713968.001]
  • [Cites] Mol Cancer Ther. 2008 Aug;7(8):2263-71 [18687658.001]
  • [Cites] Anal Bioanal Chem. 2007 Aug;388(7):1521-9 [17516052.001]
  • [Cites] Cancer Lett. 2007 Aug 18;253(2):170-9 [17462819.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H274-83 [17337594.001]
  • [Cites] Curr Med Chem. 2007;14(16):1729-38 [17627510.001]
  • [Cites] J Biol Chem. 2007 Jul 20;282(29):21542-50 [17522055.001]
  • [Cites] Semin Hematol. 2007 Jul;44(3):212-7 [17631185.001]
  • [Cites] Mod Pathol. 2007 Aug;20(8):835-42 [17491598.001]
  • [Cites] Antioxid Redox Signal. 2007 Aug;9(8):1059-96 [17571960.001]
  • [Cites] Free Radic Biol Med. 2007 Aug 15;43(4):477-503 [17640558.001]
  • [Cites] J Pharmacol Exp Ther. 2007 Aug;322(2):789-94 [17470644.001]
  • [Cites] Histol Histopathol. 2007 Nov;22(11):1251-67 [17647198.001]
  • [Cites] BMC Genet. 2007;8:43 [17601350.001]
  • [Cites] Arthritis Rheum. 2007 Jul;56(7):2180-91 [17599731.001]
  • [Cites] Curr Neurovasc Res. 2007 Aug;4(3):194-204 [17691973.001]
  • [Cites] JAMA. 2007 Aug 15;298(7):765-75 [17699010.001]
  • [Cites] N Engl J Med. 2007 Aug 16;357(7):673-81 [17699817.001]
  • [Cites] Biomed Pharmacother. 2007 Aug;61(7):390-9 [17178208.001]
  • [Cites] J Biol Chem. 2007 Aug 24;282(34):24574-82 [17604275.001]
  • [Cites] Dev Neurosci. 2007;29(4-5):321-30 [17762200.001]
  • [Cites] J Cell Physiol. 2007 Nov;213(2):434-9 [17520690.001]
  • [Cites] N Engl J Med. 2007 Sep 6;357(10):965-76 [17804841.001]
  • [Cites] Br J Pharmacol. 2007 Sep;152(2):230-9 [17641676.001]
  • [Cites] J Glaucoma. 2007 Sep;16(6):567-71 [17873720.001]
  • [Cites] J Cardiovasc Pharmacol Ther. 2007 Sep;12(3):237-47 [17875952.001]
  • [Cites] Mol Ther. 2007 Oct;15(10):1751-66 [17680029.001]
  • [Cites] Curr Med Chem. 2007;14(21):2278-87 [17896976.001]
  • [Cites] Pharmacol Rep. 2007 Jul-Aug;59(4):393-401 [17901567.001]
  • (PMID = 20064603.001).
  • [ISSN] 1873-6815
  • [Journal-full-title] Experimental gerontology
  • [ISO-abbreviation] Exp. Gerontol.
  • [Language] ENG
  • [Grant] United States / NIEHS NIH HHS / ES / P30 ES06639; United States / NINDS NIH HHS / NS / R01 NS053946-01A2; United States / NINDS NIH HHS / NS / R01 NS053946-03S1; United States / NINDS NIH HHS / NS / R01 NS053946-03; United States / NIEHS NIH HHS / ES / P30 ES006639; United States / NINDS NIH HHS / NS / R01 NS053946-02; United States / NINDS NIH HHS / NS / R01 NS053946
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers; 0 / FOXO1 protein, human; 0 / FOXO3 protein, human; 0 / Forkhead Transcription Factors; 0 / Receptors, Erythropoietin; 11096-26-7 / Erythropoietin
  • [Number-of-references] 407
  • [Other-IDs] NLM/ NIHMS169922; NLM/ PMC2827206
  •  go-up   go-down


29. Kracun SK, Cló E, Clausen H, Levery SB, Jensen KJ, Blixt O: Random glycopeptide bead libraries for seromic biomarker discovery. J Proteome Res; 2010 Dec 3;9(12):6705-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Identification of disease-specific biomarkers is important to address early diagnosis and management of disease.
  • As proof-of-principle, tumor -specific glycopeptide reporter epitopes were built-in into the libraries and were detected by tumor-specific monoclonal antibodies and autoantibodies from cancer patients.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biochim Biophys Acta. 1999 Dec 6;1473(1):67-95 [10580130.001]
  • [Cites] Cancer Res. 2010 Feb 15;70(4):1306-13 [20124478.001]
  • [Cites] J Biol Chem. 2002 Apr 12;277(15):12802-9 [11821425.001]
  • [Cites] J Org Chem. 2002 Jun 14;67(12):4143-9 [12054949.001]
  • [Cites] Nat Biotechnol. 2003 Jan;21(1):57-63 [12496764.001]
  • [Cites] Methods Enzymol. 2003;369:298-322 [14722961.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9528-33 [15210983.001]
  • [Cites] Nature. 1991 Nov 7;354(6348):82-4 [1944576.001]
  • [Cites] Epithelial Cell Biol. 1993 Oct;2(4):155-62 [7505698.001]
  • [Cites] J Pept Sci. 1995 Jan-Feb;1(1):31-44 [9222982.001]
  • [Cites] J Mol Med (Berl). 1997 Aug;75(8):594-602 [9297627.001]
  • [Cites] Tumour Biol. 1998;19 Suppl 1:1-20 [9422084.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17033-8 [15563589.001]
  • [Cites] Tumour Biol. 2005 Jul-Aug;26(4):217-20 [16006776.001]
  • [Cites] Mol Cell Proteomics. 2005 Dec;4(12):2010-21 [16249172.001]
  • [Cites] Glycobiology. 2006 Feb;16(2):96-107 [16207894.001]
  • [Cites] Curr Drug Discov Technol. 2005 Mar;2(1):1-12 [16472236.001]
  • [Cites] Nat Chem Biol. 2006 May;2(5):238-48 [16619023.001]
  • [Cites] Mol Cell Proteomics. 2006 Oct;5(10):1799-810 [16844681.001]
  • [Cites] Science. 2006 Oct 13;314(5797):304-8 [17038624.001]
  • [Cites] Methods Enzymol. 2006;415:137-53 [17116472.001]
  • [Cites] Glycobiology. 2007 Feb;17(2):197-209 [17050588.001]
  • [Cites] Anal Chem. 2007 Jan 15;79(2):477-85 [17222010.001]
  • [Cites] J Pept Sci. 2007 Feb;13(2):133-41 [17160973.001]
  • [Cites] Ann Oncol. 2007 May;18(5):868-73 [17347129.001]
  • [Cites] Clin Cancer Res. 2007 Jul 15;13(14):4170-7 [17634545.001]
  • [Cites] J Immunol. 2007 Aug 15;179(4):2380-8 [17675499.001]
  • [Cites] Nat Methods. 2007 Sep;4(9):709-12 [17721543.001]
  • [Cites] J Proteome Res. 2010 Oct 1;9(10):5250-61 [20726594.001]
  • [Cites] Chembiochem. 2008 Apr 14;9(6):883-7 [18330850.001]
  • [Cites] Semin Immunol. 2008 Oct;20(5):276-85 [18684640.001]
  • [Cites] J Allergy Clin Immunol. 2009 Jun;123(6):1268-76.e15 [19443021.001]
  • [Cites] Cancer Immunol Immunother. 2009 Oct;58(10):1535-44 [19562338.001]
  • [Cites] J Am Soc Mass Spectrom. 2009 Aug;20(8):1425-34 [19403316.001]
  • [Cites] Science. 2001 Mar 23;291(5512):2370-6 [11269318.001]
  • (PMID = 20886906.001).
  • [ISSN] 1535-3907
  • [Journal-full-title] Journal of proteome research
  • [ISO-abbreviation] J. Proteome Res.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / U01 CA128437-01; United States / NCI NIH HHS / CA / P01 CA 052477; United States / NCI NIH HHS / CA / U01 CA128437; United States / NCI NIH HHS / CA / P01 CA052477; United States / NCI NIH HHS / CA / 1U01CA128437-01; United States / NCI NIH HHS / CA / CA128437-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Autoantibodies; 0 / Biomarkers, Tumor; 0 / Glycopeptides; 0 / Mucin-1; 0 / Peptide Library; 0 / Proteins
  • [Other-IDs] NLM/ NIHMS250222; NLM/ PMC3001164
  •  go-up   go-down


30. Faça VM, Ventura AP, Fitzgibbon MP, Pereira-Faça SR, Pitteri SJ, Green AE, Ireton RC, Zhang Q, Wang H, O'Briant KC, Drescher CW, Schummer M, McIntosh MW, Knudsen BS, Hanash SM: Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains. PLoS One; 2008;3(6):e2425
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.
  • We have characterized the cell surface proteome and the proteins released into the extra-cellular milieu of three ovarian cancer cell lines, CaOV3, OVCAR3 and ES2 and of ovarian tumor cells enriched from ascites fluid.
  • CONCLUSIONS AND SIGNIFICANCE: Protein profiles of the cell lines had substantial similarity to the profiles of human ovarian cancer cells from ascites fluid and included protein markers known to be associated with ovarian cancer.
  • Proteomic analysis indicated extensive shedding from extra-cellular domains of proteins expressed on the cell surface, and remarkably high secretion rates for some proteins (nanograms per million cells per hour).
  • Cell surface and secreted proteins identified by in-depth proteomic profiling of ovarian cancer cells may provide new targets for diagnosis and therapy.


31. Guck J, Schinkinger S, Lincoln B, Wottawah F, Ebert S, Romeyke M, Lenz D, Erickson HM, Ananthakrishnan R, Mitchell D, Käs J, Ulvick S, Bilby C: Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys J; 2005 May;88(5):3689-98